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Fungi are prolific sources of structurally novel and biologically active compounds. 
Over the past decades terrestrial fungi have been a major source of bioactive 
metabolites but little attention was paid to other habitats. Recently, increasing 
attention has been devoted to marine fungi as they too are a potential source of 
compounds for the development of new pharmaceutical agents. 
In searching for bioactive metabolites from marine fungi, several extracts showed 
significant activity against the P388 murine leukaemia cell line. These strains were 
grown in different culture conditions to optimise bioactivity and the optimal 
conditions were chosen for scale up. Bioassay- and/or 1H NMR-guided separation of 
active extracts led to the isolation of twenty two compounds. The structures of these 
compounds were elucidated using spectral analysis techniques especially mass 
spectrometry and NMR spectroscopy ( 1H and 13C NMR, COSY, NOESY, HSQC and 
CIGAR). 
From a Chaetomium sp. (A34) the known compound chetomin was isolated. It 
exhibited very potent P388 activity with IC50 11.2 ng/mL. 
From an isolate of Chaetomium globosum (N60), three new cytochalasins named 
chaetoglobosins Q, R and S were isolated, together with nine previously characterised 
compounds: chaetoglobosins A, B, D and J; prochaetoglobosins I and II; 
chaetoviridins A and B, and ergosterol peroxide. In the assay against the P388 murine 
leukaemia cell line, most of these compounds exhibited significant activity (IC5o 
1943-3988 ng/mL). In addition, some compounds also showed antimicrobial 
activities. 
Examination of an isolate of Phoma resulted m the isolation of two simple 
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compounds: 2,5-dihydroxybenzoic acid and 2,5-dihydroxybenzyl alcohol. The 
former was inactive while the latter showed significant P388 activity (IC50 3660 
ng/mL). 
Three compounds, identified as bikaverin, beauvericin and bassiatin, were isolated 
from the filtrate of Fusarium sp. (Al45). In the P388 assay, these compounds 
exhibited strong, moderate and no activity respectively (IC50 304, 4126 and > 12500 
ng/mL, respectively). 
An isolate of Aspergillus fumigatus (A 151) was investigated for bioactive compounds. 
·Culture broths incubated for different periods produced different metabolites. From 
the mycelium of a broth cultured for eleven weeks, one biologically active compound, 
xanthocillin-X dimethyl ether (IC50 606 ng/mL for the P388 cell line), was obtained. 
From the filtrate of a four week culture, two known compounds, 12a-fumitremorgin 
C and fumagillin, and a novel compound, fumagiringillin, were isolated. 
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Chapter 1 
INTRODUCTION 
1 . 1 Fungal Secondary Metabol ites 
Fungi are the second largest group of organisms in the world after the insects. It is 
estimated that there are one and a half million fungi in existence, but with just 5% of 
this total having being described in the literature. ' Fungi are a very versatile and 
diverse group of eukaryotes. They have evolved to inhabit many different 
environments and have become one of the major sources in the search for bioactive 
compounds. A wide variety of biologically active fungal products, such as antibiotics, 
alkaloids, enzyme inhibitors and toxins are natural products referred to as secondary 
metabolites. For a long time secondary metabolites were thought to play no obvious 
role in the economy of the organisms. Although the evolutionary origin and the role of 
secondary metabolites for the producing organisms are still areas of vigorous debate, 
there is a growing consensus that secondary metabolism will benefit the organism and 
this benefit will usually reflect the nature of the metabolites themselves.2 
Fungal secondary metabolites are relatively small molecules characterised, not only 
by their structural diversity,3 but also by diversity of biological activity.4 There is also 
a diversity in the species specificity of production, some being produced by a limited 
number of isolates of a single species whereas others may by produced by several 
species. 
Chapter I Introduction 2 
1 .2 Important Pharmaceuticals Derived from Fungal 
Secondary Metabol ites 
The discovery of penicillin by Alexander Fleming in 1929 started the era of fungal­
derived medicines. Penicillin, one of the most famous antibiotics, is a metabolite of 
Penicillium notatum. This "wonder drug" has saved literally millions of lives. 
Penicillin G (Figure 1.1 ), the original metabolite isolated, is still a "front line" 
antibiotic, in common use for some bacterial infections although the development of 
penicillin-resistance in several pathogenic bacteria now limits its effectiveness. 
� R !j VJ"'if--J:,:: 
Or�- ?-OH 
0 
Figure 1.1 Structure of penicillin G 
The phenomenal success of penicillin led to the search for other antibiotic-producing 











Griseofulvin Me Fusidic acid 
Figure 1.2 Structures of griseofulvin and fusidic acid 
Griseofulvin is produced by Penicillium griseofulvum and related species5 and is used 
to treat athlete's foot and related fungal infections of the skin.6 Fusidic acid is a 
steroid produced by various Fungi Irnperfecti. It is clinically used as an antibacterial 
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antibiotic and is known to inhibit protein synthesis.7 
Cyclosporin A, mofetil and lovastatin are other well-known examples of fungal 
derived medicines. Cyclosporin A (Figure 1.3) was first discovered as an antifungal 
agent produced by Tolypocladium inflatum. 4 It was subsequently found to have 
excellent immunosuppressive activity and is the drug of choice to prevent the 

















Figure 1.3 Structure of cyclosporin A 
Mycophenolic acid is a fungal metabolite initially discovered from Penicillium 
compactum in 1896. In 1995, it was developed as an i1mnunosuppressive agent and 
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Figure 1.4 Structures of mycophenolic acid and mofetil 
OH 
Me 
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Lovastatin (MK-803, mevinolin) has been heralded as breakthrough-therapy for the 
treatment of atherosclerotic disease. It was initially isolated from Aspergiilus terreus 1 0  
and Monascus rubber. 1 1  Lovastatin is a highly potent inhibitor of HMG CoA 
reductase and used clinically to reduce cholesterol levels. 1 2  
Figure 1.5 Structure of lovastatin 
1 .3 Marine Fungi  as a Source of Novel ,  Bioactive Compounds 
1.3. 1 Definition of marine fungi 
Marine fungi are not a taxonomic but an ecological group. They grow in oceans and 
ocean-associated estuarine habitats that contain brackish water including river 
mouths, tidal creeks and marshes, salinas, lagoons and the like. Marine fungi are 
widely distributed and have been isolated from various niches as diverse as seawater, 
sediments, algae, marine invertebrate and the gastrointestinal tract of marine fish. The 
definition of marine fungi has been described from different perspectives by different 
authors, with the criteria varying from the ability to grow in certain salt concentrations 
to the presence or absence of certain enzymes. However, Kohlmeyer and Kohlmeyer's 
definition has gained general acceptance. 1 3 In  their proposal, 14 marine fungi are 
divided into two groups : Obligate marine fungi are those that grow and sporulate 
exclusively in marine or estuarine habitats; facultative marine fungi are those that 
originate from the land or freshwater and can grow and possibly sporulate in a marine 
environment. Fungi that are isolated from a marine environment but do not gem1inate 
in the natural marine habitat are not included in this definition. 
It is estimated that there are about 1500 species of marine fungi m existence, 
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excluding those from lichens. 1 5  Among the described manne species, the most 
evolved groups (Ascomycotina and Deuteromycotina) predominate. 1 6  Just like their 
terrestrial counterparts, marine fungi also occur as parasites, saprophytes and 
symbionts colonising a wide range of marine animals and plants and on various plant 
debris in the sea. 
As the aim of this study is to search for bioactive metabolites of halophilic fungi from 
the marine environment, any fungal strain isolated from the sea, estuaries, brackish 
waters and salt marshes that grew in a seawater medium was regarded as marine. 
1.3.2 The potential for obtaining novel bioactive metabolites from 
marine fungi 
Over the past 60 years, terrestrial fungi have been a maJor source of bioactive 
compounds but little attention was paid to other habitats. Decades of extensive 
research has made it increasingly difficult to isolate novel metabolites, hence new 
fungal sources are now under scrutiny. The oceans cover more than 70% of the 
Earth's surface, and represents a microbially-broad and diverse resource of huge 
dimensions but about which relatively little is known. According to Beman 's report, 
as of 199 1, only 321 marine fungi had been described in the literature, compared to 
69,000 terrestrial fungi. 17 Furthennore, the chemistry of marine fungi has also been 
widely neglected until recently with only some 168 metabolites from marine fungi 
reported to date. 1 6 Although terrestrial fungi will undoubtedly continue to be a 
productive source of new metabolites, increasing attention has been paid to marine 
fungi as they too are a potential source of bioactive substances for development of 
new pharn1aceutical agents. 
The initial interest in finding bioactive metabolites from marine fungi was also due, at 
least in part, to the suspicion that some metabolites obtained from marine algae and 
invertebrates could be produced by associated marine microorganisms. It has been 
established that marine macroorganisms such as algae, sponges, tunicates, molluscs 
and others have provided an enormous array of structurally unique, highly bioactive 
and biomedically utilitarian secondary metabolites. However, because of their low 
growth rate, low productivity of metabolites and complexity of chemical structures, 
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the supply of these compounds from nature is often limited, and the possibility of 
commercially viable syntheses is often eliminated. The fact that microorganisms, 
especially marine bacteria, were in some instances the true source of compounds 
isolated from marine macroorganisms has evoked wide interest in marine 
microorganisms. If a microbial origin is established for a compound of interest, it 
would in theory, be possible to obtain reasonable amounts of the valuable substance 
through large-scale fermentation. Recently, marine microorganisms especially 
bacteria and fungi, have gained prom111ence as a source of novel bioactive 
metabolites. 
The metabolic and physiological capabilities of marine fungi that allow them to 
survive in their unique habitats also provide great potential for the production of 
metabolites not found in terrestrial environments. Fungi living in marine 
environments are expected to have different biosynthetic pathways or biosynthetic 
outcomes from their terrestrial counterparts. The differences are thought to result from 
the adaptation to the higher pressure and especially to the presence of salt. For 
example, the chemical constituents of the marine fungus Trichoderma harzianum 
grown in a fresh water medium differ significantly from those grown in seawater. 1 8  
Another example is a marine strain of the genus Aspergillus from the Indo-Pacific 
sponge Spirastrella vagabunda. 1 9 This strain produces a chlorinated polyketide 
derivative in a seawater-derived medium but produces other metabolites in a 
freshwater culture medium. 
In 1995, Pietra and co-workers20 described their programme for evaluating the 
antimicrobial activity of marine and terrestrial fungi. Among the cultured 1500 marine 
and 1450 terrestrial fungal strains, more active marine strains (n=25) than terrestrial 
fungi (n=l6) were found. Marine fungi produced more compounds with antifungal 
activity, while terrestrial fungal metabolites mainly exhibited activity against Gram­
negative bacteria. In their study, only three new compounds were isolated from 
terrestrial strains, compared with 14 new compounds from marine strains. 
Although comparatively little research has been directed toward the study of natural 
products from marine fungi, results from preliminary studies are encouraging. Initial 
investigations have shown that compounds isolated from marine fungi have 
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demonstrated antibacterial , anti fungal, ant itumour and other pharmacological 
act ivities .  Therefore, marine fungi represent a relati vely untapped, but promising 
resource for new bioactive compounds. 
1 .4 Bioactive Metabol ites from Mari ne Fungi  
Cephalosporin C ,  first described in the late forties, i s  the earl iest report of a bioactive 
metabol ite i solated from a marine fungus. It was produced by Cephalosporium 
acremonium i so lated from seawater col lected near a sewage outlet off the coast of 
Sardinia.2 1 Cephalosporin C (Figure 1 .6) is a �- lactam with a mode of act ion s imi lar 
to that of pen ici l l in , but with less al lergenicity. To date, i t  i s  sti l l  the most important 




Figure 1 .6 Structure of cephalosporin C 
Although cephalospori n C was discovered in 1 940's, an analysis of the l i terature 
shows that few novel bioactive metabo l i tes from marine fungi were reported before 
the 1 980's .  From the 1 990's, there was a rapid progress in this field and a number of 
reviews have since been dedicated to th is  topic. 1 7•22-25 Two extensive revi ews of 
metabo l i tes from marine fungi were publ ished in 1 998 1 3  and 2000. 1 6 The most recent 
bioactive metabo l i tes from mari ne fungi are l i sted in Table 1 . 1 .  In th i s  chapter, rather 
than repeating the conclusions of a comprehensive rev iew, a few structurally 
i nteresting and h ighly act ive marine fungal metabol ites wil l be examined. 
Chapter 1 Introduction 
Table 1. 1 Bioactive metabolites recently isolated from marine fungi 
Producing Strain Compound Activity Reference 
Acremonium sp. Oxepinamides A a 
Fumiquinazol ines H-I b 
Anti inflammatory a 
Antifungal b 
Acremonium striatisporum I Virescenosides 0, P, Q --- - - - - - -- - - - · ····· ··········· ·· ·· ····· · · · - - + Cytotoxic ... ..... .......... ··-··· ·-·-···- - ·- -- · -- -+- - -
Acremonium striatisporum I Virescenosides M,  N Cytotoxic 






Ascosalipyrrol idinone A Antiplasmodial 
Antimicrobial 
Enzyme inhibition 
Anthcolorins A - H Cytotoxic 
Parasitenone Radical scavenging 
-- -· - - - - ···---·-··- ---- ---- -- -- -
















Pandangol ide 3 ,  4 Antimicrobial 34 
··········--·--·····---- -- - - - - - -····· - --- - ---·--· ... -- --· ----
Lunatin 
Drechslerines E, G 










............................................. ________ _  >-- - - - · 
Eutypa sp. Eutypoid A Enzyme inhibition 38 
'''"''''''''''''''''''''''''''''''''''''''''''''' '''''''''''' ''''"'"'''''-·-···--··- -------··-·· -- --- - · - - - - -··-···-·- ------ --- ---
-- - . ·- - --· --
Fusarium heterosporum Mangicols A - G 
Fusarium sp. N-Methylsansalvamide 
Fusarium sp. Sansalvamide 
Gliocladium roseum Rosel ipins 











4 1  
42 
43 
-· ---- - ························--··--·····--·-·· - -<- -·---- ..... .... , .... --····--- ---- - - ----t---·-.. · ----··--·· .... . ___ .... -.. . , 
Leptosins M ,  M 1 , N, N 1 I Cytotoxic Leptosphaeria sp. 
44 
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Producing Strain Compound Activity 
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-- - - -------1-····-- - - --····----- - ··-···-· ····-···· ·-·· 
Penicillium sp. ! Penochalasins D - H I Cytotoxic 





' "  . ... ........ ............... .... ................................... ,,, __ , ,,,........ .. ......... ,------·-··--·-·- ----· 
Penicillium sp. 
Penicillium sp. 
Sculezonones A, B 
1 1 , I I ' -
dideoxyvertici l l in A 
1 1  ' -deoxyverticil l in A 
Enzyme inhibition 
Cytotoxic 
Pestalotia sp. Pestalone 
. .. . 'l '"'"''"""""" _____ .. :········-···-·····- --·· ·-· 
! Cytotoxic 
! Antimicrobial 
··················-·--···-···········------- --- - -- -- - ___ __ .. ···t-···--·- ···-·" " 
Halovir ! Antiviral 
50, 5 1  
52 
53 
22, 54 Scytalidium sp. 
. ...... .... ........................... ,-....... ···-·----.. ,, ___  ! ___ ______ _.  _ _ _ _ , ·····-·- ·-···-- - - -
Ulocladium bot,ytis Ulocladol Enzyme inhibition 55 
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56 
Unidentified fungus Dictyonamide A 
Unidentified fungus Spiroxins 
Xylaria sp. Xyloketal A 





J ! ----- ------ -- - ---- - -- ------
1 Enzyme inhibition I 59 
Investigations into marine fungi led Gloer 's  group to isolate an obl igate marine strain 
of Leptosphaeria obiones from the coastal marsh grass Spartina alterniflora where the 
fungus is commonly found in the lower portion of the plant. Fem1entation of this  
fungus resulted in the i solation of a new polyketide, obionin A.60 Obionin A (Figure 
1 .  7) inh ibited the binding of dopamine D- 1 -selective l igands to membranes found in 
the central nervous system (IC5o of 2 .5  µ,g/rnL). 
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Figure 1.7 Structure of obionin A 
J O  
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In 1997, Varoglu et al. reported the isolation of a marine strain of Aspergillus niger 
from the sponge Hyrtios sp. A unique, asymmetric diketopiperazine dimer, asperazine 
(Figure 1.8), was isolated from the saltwater culture of the strain. Asperazine 
displayed an unusual profile of cytotoxicity and selective anti-leukaemic activity at 50 
µ,g/disk in a soft agar disk-diffusion assay. The compound showed no antimicrobial 
· · 6 1 activity. 
0 
Figure 1.8 Structure of asperazine 
Fellutamides A and B, two lipophilic tripeptides, were produced by Penicillium 
fellutanum, isolated from the gastrointestinal tract of the marine fish Apogon 
endekataenia. 62 Fellutamides A and B (Figure 1.9)  showed potent cytotoxicity against 
murine leukaemia P388 and L1210 cells, and human epidermoid carcinoma KB cells 
in vitro (IC50 0.1 - 0.8 µ,g/mL). Fellutamide A was also found to be a potent agent in 
stimulating the synthesis of nerve growth factor (NGF) and enhancing secretion of 
this factor in vitro in L-M cells, rat brain cells and rat glial cells. This compound 
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showed a different mode of action from a known NGF inducer, epinephrine. 63 
Me 
OH 
Fellutamide A R = OH 




Figure 1.9 Structures of fellutamides 
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An obligate marine isolate of Leptosphaeria, separated from the marine brown alga 
Sargassum tortile is a rich source of diketopiperazine dimers. Nineteen dimeric 
epipolysulfanyldioxopiperazines, leptosins A - F,64 the G group (G, G l, G2), H - J,65· 
66 the K group (K, K l, K2),67 the M group (M, Ml)  and the N group (N, N1)44 have 
been isolated and characterized by Numata and co-workers. Leptosins displayed 
significant P388 in vitro cytotoxicity (IC50 1 - 4 µ,g/mL for most of the compounds). 
More importantly, leptosins A and C (Figure 1.10) displayed potent in vivo 
antitumour activity against Sarcoma-180 ascites (TIC 260 % and 293 %) at doses of 
0.5 mg/kg and 0.25 mg/kg, respectively. 
Leptosin A x = 4 













Tryprostatin A R = 1-1 
Tryprostatin B R = OMe 
Figure 1.10 Structures of leptosins and tryprostatins 
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Tryprostatins A and B (Figure 1. 10) are tryptophan-based fungal metabolites that 
inhibit the mammalian cell cycle.68 The producing culture, Aspergillus fumigatus 
BM939, was isolated from a sediment sample collected at the depth of 760 m at the 
mouth of the Oi river in Japan. Tryprostatins are structurally related to 
fumitremorgins, the metabolites of the terrestrial counterpart of A. fumigatus. 
Tryprostatins A and B complete inhibited cell cycle progression of tsFT2 10 cells in 
the G2/M phase at a final concentration of 50 and 12.5 µ,g/mL, respectively. 
In an effort to discover new antitumour compounds from microorganisms inhabiting 
the marine environment, Numata's group69 reported three cytotoxic cytochalasans, 
penochalasins A-C (Figure 1.11) from a marine Penicillium sp. The producing strain 
was originally separated from the marine alga Enteromorpha intestinalis. Subsequent 
studies of this fungus Jed to the isolation of penochalasins D-H.48 Penochalasins A-D 
constitute a novel class of cytochalasins, with a macrocyclic ring including a pyrrole 
moiety. In the in vitro assay for activity against cultured P388 cells, all the 
compounds exhibited significant cytotoxicity (ED50 0.3-3.2 µ,g/mL). 
Me 
W 0 
Me,,11 Y, ,,,H ,,, .. _r ",-···' 
H vV'o./V" vV'o./V" 
Penochalasin A O 




Figure 1.11 Structures of penochalasins 
The same Penicillium sp. cultured on different media led to the isolation of four new 
compounds, penostatins A-D.70 Subsequently, penostatins F-049' 7 1 were isolated from 
the same source. It is interesting to note that this fungus produces some pairs of 
stereoisomers in which all the asymmetric centres except for C-5 have the opposite 
absolute configurations. Penostatins are terpenoids (Figure 1.12) and all the 
compounds except for penostatin D exhibited significant cytotoxicity against cultured 
P388 cells (IC50 0.5 - 1.4 µ,g/mL). 
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Figure 1.12 Structures of penostatins 
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Schlingmann and co-workers at Wyeth-Ayerst isolated an antifungal agent 1 5G256 "( 
from the marine fungus Hypoxylon oceanicum. 15G256 "( (Figure 1.13) belongs to a 
new class of lipodepsipeptides and inhibits fungal cell wall biosynthesis.72 The 
compound possesses broad-spectrum antifungal activity and is able to provide good 
disease control against a wide variety of phytopathogenic fungi when used at high 
concentrations (in the range of 500 µg/mL, in foliar sprays). In vitro testing showed 
moderate activity against a series of human fungal pathogens (MICs: 2-16 µg/mL).73 
Figure 1 .13 Structure of compound 15G256 'Y 
Me 
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In their programme to  search for biologically active secondary metabolites from 
marine fungi, Fenical's  group reported the isolation of a new class of sesterterpenes -
neomangicols A-C74 and mangicols A-G.39 The producing strain, tentatively identified 
as Fusarium heterosporum, was isolated from mangrove drift-wood. In in vitro 
assays, most of the compounds showed weak to modest cytotoxicity against a series 
of cancer cell lines. However, neomangicol B (Figure 1.14) showed potent 
antibacterial activity against Bacillus subtilis, and mangicols A and B (Figure 1.14) 




Neomangicol A R = Cl 
Neomangicol B R = Br OH 
Mangicol A R 1 = OH R2 = H 
Mangicol B R 1 = H R2 = OH 
Figure 1.14 Structures of neomangicols and mangicols 
Recently, the same group22'54 reported the isolation and characterization of three novel 
peptides, halovirs A-C. These compounds are produced by a marine Scytalidium sp., 
separated from a sample of sea.grass, Halodule wrightii. Halovir A (Figure 1.15) 
exhibits potent antiviral activity against the Herpes simplex virus 1 (IC5o 1. 1 µ,g/mL). 
Furthermore, 0.6 M halovir A completely inhibits HSY-I-induced cell lysis after an 
exposure of 30 minutes. The compound thus may be of potential use as a lead for a 
topical antiviral agent. 
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Figure 1.15 Structure of halovir A 




The secondary metabolites reported to date from marme fungi represent diverse 
structural classes that include polyketides, alkaloids, terpenes and compounds of 
mixed biosynthetic origin. An interesting characteristic of the alkaloids found to date 
is the high frequency of occurrence of complex diketopiperazines. These occur as 
monomers or dimers and quite often possess sulfanyl groups of different chain 
lengths. 
It is noteworthy that many of the metabolites of marine fungi are similar to or 
identical to those found from terrestrial fungi. One reason suggested for this 
observation is that some of the species studied only occasionally inhabit the marine 
environment. Another reason is that the same or similar secondary metabolites could 
be produced by diverse microbial taxa. However, marine fungi can also produce 
metabolites with unique carbon skeletons. Marine fungi general ly follow the broad 
outlines of terrestrial fungal biosynthesis, but there are some examples indicating that 
marine conditions can modify the nature of the metabolites produced leading to the 
production of novel compounds not found in the terrestrial environment. 
The majority of biologically active metabolites from marine fungi reported to date 
show cytotoxic and/or antimicrobial activity. This is mainly due to the fact that most 
isolations have been carried out with the assistance of bio-assay guided separation 
since the l 990's. Since the assays are generally selected based upon the source of the 
research funding or availability through col laborators, cytotoxic and antimicrobial 
assays are widely used in most laboratories. With increasing interest in this field, it is 
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believed that metabolites with more diverse biomedical activities will soon be 
explored. 
The number of secondary metabolites isolated from marine fungi is still small but is 
rapidly increasing. There is speculation that highly adapted marine fungi such as 
symbionts, or those inhabiting extreme environments such as the deep sea, offer 
greater opportunity for the production of novel metabolites. Being an unexplored 
field, exploration of marine-based fungi may afford unexpected new metabolites 
endowed with interesting pharmacological properties. 
1 .6 Work Done at the Un ivers ity Of Canterbury 
The Marine Chemistry Group at the University of Canterbury initiated a programme 
for exploring bioactive metabolites from fungi in 1998. The majority of the fungal 
strains have been isolated from the New Zealand marine and terrestrial environment 
such as marine algae, marine and freshwater sediments, rainforests, endemic plants 
and insects. Some strains have been isolated from other niches such as Himalayan 
soils, Antarctic soils and marine sediments. The extracts from the culture of these 
strains have been tested for cytotoxicity, antimicrobial and antiviral activity in vitro. 
Promising extracts are evaluated further by chemical screening before starting a 
bioassay-guided separation. To date, a series of biologically active metabolites, 
including some novel compounds, have been isolated from these strains. 
1 .  7 The Aim of This Study 
The aim of the research is to investigate isolates of fungi separated from saline 
environments which have initially been shown to possess biological activity. The 
metabolite(s) responsible for the activity will be isolated using bioassay-guided 
separation and the structures of pure compounds will be elucidated using mass 
spectrometry, 1H NMR, 13C NMR and a series of 2D NMR spectroscopic techniques. 
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Chapter 2 
CULTURE AND SCREENING 
PROGRAMME 
2 . 1  Introduction 
In the search for biologically active compounds from natural resources, the Marine 
Chemistry Group at the University of Canterbury isolated a large number of fungal 
strains from the marine environment. These strains were cultured on a smal l-scale 
(250 mL) and tested for cytotoxicity against the P388 murine leukaemia cel l l ine, and 
for antimicrobial activity against a range of bacteria and fungi and antiviral activity 
against Herpes simplex and Polio viruses (see section 7.1 .3 , Chapter 7). Active 
strains were chosen for further investigation to isolate the bioactive compounds. In 
this study, eight strains which showed significant cytotoxicity were screened and 
grown in different culture conditions to optimise bioactivity. In addition, other strains 
were also surveyed for P388 activity. Finally, five fungi were targeted for further 
investigation and it is these fungi that form the basis for this research. 
Before initiating a bioassay-guided isolation, the extracts from those fungi of interest 
were usual ly examined by a strategy called "chemical screening". Chemical screening 
is a method used to assess the properties of an extract and is used routinely at the 
University of Canterbury (see section 2.5 ). 
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2.2 Selection of Culture Conditions to Optimise Bioactivity 
Biological activity of fungal extracts is mediated by the production of one or more 
compounds (secondary metabolites). It is generally known that the production of these 
metabolites can be influenced by many factors such as the composition of medium, 
temperature, aeration, culture time, etc. For the eight bioactive fungal strains isolated 
in our primary screen, a survey of different media and agitation conditions was 
undertaken to optimise bioactivity. The isolates were first cultured on different solid 
media to test their growth. They were then cultured in liquid media to obtain extracts 
and to assay for P388 activity. Finally, the optimal culture conditions were chosen for 
scale up in order to obtain the pure compounds. 
The fungal isolates used for optimizing activity were as follows: Al45 (Fusarium 
sp.); A l5 1  (Aspergillus sp.); K3 1 (Phoma sp.); A34, A l  16, A l27, A 128 and A266 
(Chaetomium spp.). 
2.2. 1 Growth of isolates on solid media 
The selected isolates were tested for growth rate on six different nutrient agar media: 
potato dextrose agar (PDA), seawater potato dextrose agar (S-PDA), malt extract agar 
(MEA), yeast extract agar (YEA), Sabouraud dextrose agar (SDA) and Czapek 
solution agar (CSA) (see section 7.1.2 , Chapter 7). Although all isolates were from a 
marine environment, none was obligately marine and all grew in the absence of 
seawater on normal media. 
Process for measuring growth rate: A mycelial disc (4 mm in diam.) was cut from the 
growing margin of a PDA colony of the appropriate isolate. The disc was placed at 
the centre of an 85 mm Petri dish containing 20 mL of test medium. The dishes were 
then incubated at 25 °C in darkness. Measurements were made at known intervals 
along two diameters of the colony at right angles to each other. The diameter of a 24-
hour colony was used as a base to calculate the rate of growth over the following few 
days until the colony reached the edge of the plate. Results are shown in Table 2.1. 
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Table 2.1 The growth rate of marine fungi on different agar media 
Growth Rate on Different Media (mm/day) 
Code 
Al45 
Al 5 1  
K3 1 
A34 
Al 1 6  
A 1 27 









Chaetomium I -- ... r 
Chaetomium I 
.... ....... ..... . ! .............. -...... ..... ....... ] ........ _,_ .._____ ..PDA S-PDA SDA ! 
9.2 
9 .6  
9 . 1 
6.0 
5 .2  
4 .7 
4.9 
5 .2  
9 2  11 3 I 
1 1 . 2 1 2 .2 
8.0 1 0. 8  
6. 1 7 .0 
..... ....... ·�·--·-·········-······ 
3 . 8  7 .0  
4 .4  7.3 
5 . 6  6.3 
5 . 2  6.4 
2.2.2 Growth of isolates in liquid media 
M EA I YEA I CSA 
1 0.8 1 1 .7 1 1 1 .2 ·-· - r - -----
1 2 .2 __ -=._ _ L _1 1 .4 
9 .4 9 .o I 1 .0 
8 . 5  
7 .7  
8 . 1 
1 0.5  r ··· ;-;--
9.5 
1 0.4 
8 .0 8 .4 - -t -
7 .7  I 7 .4 
6 .5 
6. 1 
5 .2  
4 .5  
1 9  
Each isolate was cultured in four different liquid media previously shown to be 
beneficial for secondary metabolite production: potato dextrose broth, malt extract 
broth and yeast extract broth at half normal strength (1/2 PDB, 1/2 MEB and 1/2 
YEB, respectively). In addition, a seawater medium (S-XXB) was also prepared for 
each fungus based on its growth and sporulation on solid medium. For each medium, 
both shake (rotary shaker at 1 80 rprn) and static conditions were used to determine if 
agitation would improve the production of bioactivity. 
Each fungus was grown in two 250 mL Erlenmeyer flasks each containing 1 25 mL of 
appropriate medium. Following a 28 day fennentation period at 26 °C, the mycelium 
and broth were separated by filtration and extracted with EtOAc respectively. The 
extracts were then combined and made up to 10 rng/mL of methanol solution for P388 
assay. The results are summarized in Table 2.2 (for strains A145, A 1 5 1  and K3 1 )  and 
Table 2.3 (for strains A34, A l  1 6, A127, A128 and A266). 
For each fungus, the optimal culture condition was selected based mainly on the P388 
activity. Where P388 activities were close, the yield of extract was used as an 
additional selection criterion. 
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Table 2.2 Yield and P388 activity of isolates cultured in different broths 
Code 
A 1 45 
A l 5 1  
Genus 
Fusariurn 
Medium Condition Extract Yield I P388 Activity 
(m2) I (IC50 ng/mL) 
1 /2 PDB j __ Shake�-- - 1 42.9 _ __ _  [ ____ _ _ Ji!7 . 
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Table 2.2 indicates that the P388 activity of fungus A145 (Fusarium sp.) was largely 
influenced by agitation rather than by medium type. Activities in the four different 
media were generally similar while cultures in shaken conditions were more active 
than those in static conditions. Since a good extract yield was afforded in a culture of 
Yi PDB (shake), this condition was chosen for the large scale fermentation (more than 
4 litres). 
Most cultures of the fungus A15 1 (Aspergillus sp.) showed similar moderate P388 
activity except for Yi MEB (shaken), Yi YEB (shaken) and Yi S-PDB (static) which 
exhibited very weak activity. Since a considerable amount of extract was yielded from 
the culture of Yi PDB (shake), this condition was chosen for the scale up. 
For the fungus K3 1 (Phoma sp.), only cultures in Yi PDB (shaken and static) and Y2 
MEB (static) showed moderate P388 activity. It is clear that Yi PDB in static 
conditions was best for this fungus. 
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Table 2.3 Yield and P388 activity of Chaetomium isolates cultured in different broths 
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The P388 activity for strains cultured in 'h S-MEB were measured at 0.02 mg/mL 
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Table 2.3 indicates that the medium had significant influence on P388 activity of 
Chaetomium isolates while agitation did not improve the bioactivity. Most cultures in 
Yi PDB and Y2 YEB showed very weak or no activity while cultures in Yi MEB and Yz 
S-MEB exhibited very significant activity. The presence of seawater in any medium 
was irrelevant to bioactivity but increased the extract yield. 
The consistent bioactivity of strains A34, A 128 and A266 m different media and 
agitation conditions suggested that these strains might belong to one species and 
produce the same bioactive compounds. The observation of growth rate, maturation of 
the ascomata, size and shape of ascomata and ascospores revealed that these 
morphological characteristics were identical in all the five strains (A34, A 1 16, A 127, 
A 128 and A266). HPLC analysis as shown in section 2.3 indicates that these strains 
showed exactly the same HPLC profiles. 
To screen for the most active strains, A l  16 and Al27 were cultured on Y2 S-MEB in 
agitation since this condition was found to give best activity and extract yield. By 
comparing the P388 activity and extract yield, strain A34, which showed the strongest 
activity against the P388 murine leukaemia cell line (IC50 19.4 ng/mL), was chosen 
for large scale fermentation. 
2 .3  H PLC of Extracts from the Chaetomium Isolates 
2. 3. 1 HPLC of different strains cultured on the same medium 
The 5 strains of Chaetomium (code: A34, A l  16, Al27, A l28 and A266), as 
mentioned above, belonged to one species and exhibited consistent bioactivity in the 
P388 assay. To examine the composition of their secondary metabolites, extracts of Y2 
S-MEB broths (shake conditions) of these 5 strains were subjected to high 
performance liquid chromatography (HPLC), eluted with a ACN/H20 gradient 
(standard conditions, see section 7.1.4 , Chapter 7). Identical HPLC profiles (UV 
detector at 203 nm) are shown in Figure 2.1, indicating these strains produce the same 
secondary metabolites under the test conditions. 
Chapter 2 Cultme and Screening Programme 
2 5 0 0  
2 0 0 0  
1 5 0 0  
m A U  
1 0 0 0  
" '  
2 0 0 0 
1 5 0 0  
"'i ��o 
, o o  
2 0 0 0  
1 5 0 0  
m A U  
1 O O O  
"'  
2 0 0 0  
1 5 0 0  
nl i '!I'  
"'  
2 0 0 0  
1 5 0 0  
orl l t,O 
. . .. . ... . . . . .... 
- . . . . . . .  1 , • • 1 > 
. . . . . . .  1 • • • 1 > 
1 0  
. ... . .. . . .. . . .. _ , . , . . . . . . . . . , . . . . . .  , . , , . , 1  
1 0  
. . .. . .. . . .. . , .. - . . . . . . . .  , ... , . . . . . . . .  , ... , 
" 
. .. . .... . . . . .. - , , . . . . . . .... , . . . . . . . . .... , 
" 
. . .. ... . . . . . . . - • 11• • • • • 1 • • • 1  . . . . . .. . . ... . ,  
1 0  
J I  
" 
M l <1 11 te 1  
JL 
, ,  
M ' " "' ' • •  
�L 
" 
M l n u t• •  
Jt. 
" 
M \r, u t1 1  
. 
M l n .., 1 1 1  
Figure 2.1 HPLC profiles of 5 
24 
A34 Extract 
2 0  3 0  
A I 16 Extract 
' 
A 127 Extract 
2 0  " 3 0  
A 128 Extract 
2 0  " 3 0  
A226 Extract 
2 0  3 0  
strains of Chaetomium 
Chapter 2 Culture and Screening Programme 25 
2.3.2 HPLC of extracts from strain A34 (Chaetomium sp.) 
Results as shown in Table 2.3 indicate that growth medium has a considerable effect 
on P388 activity of the 5 Chaetomium strains and differences in bioactivity suggest 
the production of different metabolites. To confirm this assumption, one strain (A34) 
was cultured in Yi PDB, Y2 MEB, Yi S-MEB and Y2 YEB (all shake cultures) and the 
extracts were tested by HPLC (standard conditions). The profiles are shown in Figure 
2.2 (UV detector at 31 1 nm). 
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It was noted that the chemical constituents of strain A34 grown in Yz MEB and Y2 S­
MEB were similar and differed significantly from those grown in Yi PDB and Y2 YEB. 
Seawater did not induce the production of different metabolites but increased the 
concentration of bioactive compound(s). This result is consistent with the P388 
activity observed in Table 2.3. 
2.4 Screen ing of Other Fungi  for P388 Activity 
Four more fungal strains, one of Chaetomium and three of Phoma, were also surveyed 
for their activity against the P388 cell line. Initial cultures were grown on PDA for 7 
days. Mycelial discs were then transferred to liquid media. Following a 28-day 
fermentation period at 26 °C, the mycelium and broth were separated by filtration and 
extracted with EtOAc respectively. The extracts of both parts were assayed for P388 
activity and the results are presented in Table 2.4. 
Table 2.4 Screening of fungal strains for P388 activity 
Extract Yield I, P388 activity 
Fungus Culture Condition . ( ICso ng/mL) ·---·····-·-·-·-·············- r···-········-········· . ····- f--·-········· ....... ·--· ·1· ··-· ...... . .......... . . .Mycelium [ Filtrate : Mycelium Filtrate 
Three isolates of Phoma (T88 1 ,  T882 and T883) showed very weak or no activity 
against the P388 murine leukaemia cell line while the isolate of Chaetomium (N60) 
exhibited good activity. Since the morphological characteristics and the HPLC 
profiles of N60 were totally different from those of Chaetomium A34, it was chosen 
for further investigation. 
In conclusion, the following fungi were chosen for detailed study of their bioactive 
metabolites : A 1 45 (Fusarium sp.), A l5 1  (Aspergillus sp.), K3 1 (Phoma sp.), A34 
(Chaetomium sp. ) and N60 (Chaetomium sp.). 
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2 .5  Chemical  Screening 
Chemical screening, the chemical equivalent of biological screening, is a procedure 
developed by the Marine Chemistry Group at the University of Canterbury. The aim 
of the method is to achieve a rapid evaluation of physical, chromatographic and 
stability properties of interesting components and the dereplication of the known 
compounds before starting a fom1al separation. 
2. 5. 1 Chemical screening (1) - solid phase extraction 
In chemical screening (1 ), a crude extract of a fungus was passed through three 
cartridges of different sorbent phases. Generally, C, 8, CBA and LH-20 cartridges were 
selected, and they separated components by polarity, charge and molecular size 
respectively. Three or four fractions were taken from each cartridge, and these along 
with the standard were tested to ascertain where the bioactivity had been distributed. 
Table 2.5 summarizes the results for five targeted fungi. It is observed that most 
active components in the tested fungi were small to medium size molecules, non­
cationic and with medium polarity (except for K31 in which the most active 
components were very polar). 
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2.5.2 Chemical screening (2) - HPLC microtitre plate collection 
In chemical screening (2), the most active fraction(s) from each cartridge and the 
standard were analysed by HPLC under identical conditions (C 1 8 column, ACN/H20 
gradient, standard conditions). The peaks in common on these HPLC profiles were 
likely to be the compound(s) responsible for the bioactivity observed. A search on 
Antibase75 using the UV data of active peak(s) resulted in a few cases where a unique 
answer could be obtained, however, in most circumstances tens to hundreds of hits 
were found. To establish a more meaningful search, the HPLC eluents of the most 
active fraction from the LH-20 cartridge in chemical screening (1) were collected into 
a microtitre plate (total 89 fractions) which was called the master plate. Two daughter 
plates were generated from it and assayed for P388 activity. Once the wells containing 
the bioactivity were located, ESMS of the corresponding active wells in the master 
plate were carried out. For example, in the case of A34 (Chaetomium sp.), chetomin 
was identified from the active microtitre plate wells by searching in Antibase using 
MW(MH+ 711 ), UV data and fungus source. Another example can be seen for N60 
(Chaetomium sp.) where ESMS of the components in the active wells established 
compound(s) with MW of 590 Daltons. A searching in Antibase came up with three 
components : chaetoglobosins A, B and D. 
2.6 Discussion 
Results in the experiments for optimising the P388 activity of isolated marine fungi 
revealed that bioactivity (or the secondary metabolites) can be significantly influenced 
by the composition of the medium (isolate A34) and agitation conditions (isolate 
A l45). There appears to be no rnles about which factor will lead to the desired results. 
As for industrial fem1entations, optimal conditions are achieved largely by trial and 
error. 
Seawater was expected to have some effects on the production of secondary 
metabolites, but no significant changes were observed for the tested fungi. 
As indicated in section 2.5 , physical, chromatographic and stability properties of an 
extract can be rapidly obtained by chemical screening. With the help of this 
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information, the dereplication, isolation of active compounds and structural 
elucidation can be carried out more efficiently. 
Chapter 3 Chaetomium spp. (A34 and N60) 30 
Chapter 3 
CHAETOMIUM SPP.  (A34 AND N60) 
3 . 1  I ntroduction 
3. 1 .  1 General 
Chaetomium is one of the largest genera of saprophytic Ascomycetes and more than 
300 species have been described. Chaetomium species are characterised by their 
ascomata (perithecia), being covered with numerous long hairs which give the genus 
its name (Greek Chaite == long hair, mane). The ascomata are produced superficially 
and are connected to the substrate by rhizoidal hyphae. They usually have an opening 
(ostiole) through which the ascospores are released. The ascospores are aseptate, often 
limoniform, brown or grey-olivaceous with a ge1111 pore at one or both ends and often 
pushed out of the ostiole in a cirrhus.76 Chaetomium species are notable as producers 
of cellulases and so commonly occur on wood and paper products. 
3. 1 .2  Bioactive metabolites from Chaetomium species 
Species of Chaetomium occur widely in nature, and certain Chaetomium species are 
known to produce biologically active metabolites. Chaetoglobosins, 
epipolythiodioxopiperazines, chaetochromins and cochliodinols are among the most 
important bioactive compounds isolated from Chaetomium species and are further 
discussed here. 
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Cbaetoglobosins 
Chaetoglobosins are a family of secondary metabolites belonging to the cytochalasins. 
The name "cytochalasin" originates from the Greek word cytos (cell) and chalasis 
(relaxation) and refers to the cytological effects of the metabolites. The cytochalasins 
are remarkable in their biological activity including the inhibition of movement and 
cytoplasmic cleavage of mammalian cells. Much of the biological activity can be 
accounted for by an interaction with the common target protein actin. These 
biological activities are unprecedented by any other chemical cornpounds.77 
Chaetoglobosins contain an indolyl group (Figure 3.1) in place of the phenyl group 
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Figure 3.1 Structures of some chaetoglobosins 
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So far more than 20 chaetoglobosins have been reported and most of them are 
produced by Chaetomium species. Chaetoglobosins A, B, C, D, E, F, G and J, isolated 
from Chaetomium globosum, 79•80 show cytotoxicity against HeLa cells with an IC5o 
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value of 3.2 - 10 µg/mL (IC50 of chaetoglobosin C is 20 µg/mL).8 1  Most 
chaetoglobosins can induce polynucleation in HeLa cells. Apart from cytotoxicity, 
some chaetoglobosins (A, C and 0) also show phytotoxicity against alfalfa 
seedlings.82 Chaetoglobosin A (Figure 3.1) is the most widely studied metabolite in 
the chaetoglobosin family and has been reported to exhibit strong cytotoxicity against 
other human cancer cell lines,83 antibacterial activity against Helicobacter pylori and 
Staphylococcus aureus84 and anti fungal activity towards a series of plant pathogens.85 
Epipolythiodioxopiperazines 
Epipolythiodioxopiperazines such as gliotoxin and sporidesmins occur widely as 
fungal secondary metabolites and possess antiviral and antimicrobial properties as 
well as high mammalian toxicities. Chaetomium is one of the main genera which 
produce such compounds. Compounds belonging to this class include chetomin, 
dethio-tetra(methylthio)chetomin, chetocin, chetocins B and C, chetracin A and 1 l cx, 
11 'cx-dihydroxychaeocin (melinacidin IV) (Figure 3.2). These have been isolated 
from a series of Chaetomium species86-89 and most exhibit quite remarkable 
cytotoxicity against HeLa cells (with IC50 values of 0.02 - 0.04 µg/mL).88 These 
compounds also show remarkable activity towards Gram-positive bacteria while 
exhibiting only weak or no activity towards Gram-negative bacteria.88•9° Chetomin, 
the first epipolythiodioxopiperazine isolated from Chaetomium species, also shows 
strong antifungal activity against Pythium ultimum. This activity is comparable to the 
fungicide metalaxyl and is 5- 10 times higher than gliotoxin.9 1  
In  studies of  the structure-activity relationships of epipolythiodioxopiperazines 
isolated from Chaetomium species and their derivatives, it was found that the number 
of sulphur atoms influences the antimicrobial and cytotoxic activities.88•92 Compounds 
with trisulfide bridges showed the strongest activities, followed by compounds with 
disulfide or tetrasulfide bridges, whereas the derivatives without bridges show much 
less or no activity. 
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Figure 3.2 Structures of some epipolythiodioxopiperazines 
Chaetochromins 
33 
Chaetochromins are bis (naphtho-y-pyrone) derivatives (Figure 3.3). Chaetochromin 
A was first isolated from Chaetomium thielavioideum93 and chaetochromins B, C and 
D were isolated from C. gracile thereafter.94 Although chaetochromins A-D exhibit 
strong cytotoxicity in assay against KB cells, and chaetochromin A is effective in the 
treatment of MX-1 breast xenograft, M5076 ovarian carcinoma, and P388 
lymphocytic leukaemia in mice, development of these compounds as antitumour 
agents was abandoned due to their toxicity and marginal activity.95 On the other hand, 
according to a patent by Merck & Co. , certain chaetochromins are useful in the 
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inhibition of HIV (human immunodeficiency virus) integrase, for the prevention or 
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Cochliodinols are purple pigments with a bis(3-indolyl)-dihydroxybenzoquinone 
nucleus in their structures. Cochliodinol (Figure 3.4) was isolated from Chaetomium 
cochliodes and C. globosum97 while two related compounds, isocochliodinol and 
neocochliodinol (Figure 3.4) were isolated from C. murorum and C. amygdalisporum 
respectively.98 Cochliodinol shows remarkable antibacterial and antifungal activity.99 
Brewer and colleagues 1 00• 1 0 1  compared the antibacterial and antifungal activity of a 
number of naturally occurring 2,5-dihydroxy- 1 ,4-benzoquinones against a range of 
bacteria belonging to 8 genera and 1 2  species of fungi belonging to 6 diverse genera. 
Among the tested compounds, cochliodinol exhibited relatively high antibacterial 
activity and was more active against Gram-positive bacteria. In the antifungal assay, 
cochliodinol was the most active compound and showed remarkable activity in both 
inhibiting vegetative growth and spore gem1ination of fungi. 













Figure 3.4 Structures of chochliodinols 
35  
Chapter 3 Chaetomium spp. (A34 and N60) 36 
Part I Chaetomium sp .  (A34) 
3.2 Cu lturi ng and Isolation of Chaetomium sp. (A34) 
3.2. 1 Culturing and extraction 
The fungal strain CANU A34 was isolated from saline mud in we tern Australia and 
identified as belonging to the genus Chaetomium (Figure 3 .5) .  The isolate was grown 
on PDA for 7 days at 25 °C. The mycelial disks ( 8  mm in diameter) were then cut 
from the agar and transferred into eleven litres of half-strength seawater malt extract 
broth. The broth was incubated at 26 °C for 30 days under agitating conditions. The 
culture was filtered through Celite 545 under suction to separate mycelium and 
filtrate. The mycelium and filtrate were then extracted separately with EtOAc. The 
extracts were evaporated under reduced pressure to give 284.2 mg of filtrate extract 
and 2242.9 mg of mycelial extract. In cytotoxicity assays against the P388 cell line, 
the mycelial extract showed stronger activity ( IC50 25 ng/mL) than the filtrate extract 
( ICso 234 ng/mL). 
Figure 3 .5 Chaetomium sp. (A34) (a)  colony on CMA (26 day , 25 °C) (b)  ascomata 
(c) ascospores; Bars: (b) = 1 00 µm; (c) = 1 0  µm 
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3.2.2 Chromatography 
An outline of the chromatography is shown in Scheme 3 . 1 . 
Scheme 3 . 1  
Mycelial extract (2000 mg, IC50 25 ng/m.L) 
C 1 8  column (50 g) 
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The mycelial extract (2000.0 mg) was chromatographed by a reverse phase (C 1 8 , 50 g) 
column, eluted with a stepped gradient from 10% MeOH/H20 to MeOH then to 
CH2Ch. Fifteen fractions were collected and most showed activity against the P388 
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murine leukaemia cell line (IC50 < 97.5 - 5199 ng/mL). The activity focused on the 
fractions A34-1-6, 7, 8 and 9 and decreased gradually in adjacent fractions (Scheme 
3. 1). High performance liquid chromatography (HPLC) revealed fractions A34- 1-6, 7, 
8, 9 and 10 had very close HPLC profiles, and all contained a major peak at RT 15.00 
minutes with several minor peaks varying only in ratios. However, fractions A34-1-5 
and A34- 1- 11 had different HPLC profiles with a small peak at RT 15.00 minutes. 
This suggested that the compound at RT 15.00 minutes in the HPLC profiles 
represented the major activity observed and that the wide distribution of the activity 
was due to the poor solubility of the active compound(s). The 1H NMR spectra also 
indicated that the major compound in fractions A34-1-6, 7, 8, 9 and 10 was the same. 
A34-1-11 was predominantly fatty acids whilst A34- l-5 was a complex mixture. 
Fractions A34-l -6 and A34- l -7 were combined (totally 366 mg) and loaded onto a 
normal phase (Diol, 15 g) column. The column was eluted with a stepped gradient 
system from 5% Et0Ac/CH2C)z to EtOAc and then to MeOH. Thirteen fractions were 
collected and combination of the fractions made after analysis by TLC. In the P388 
assay, all the fractions were active (Scheme 3.1). Fractions A34-D1 and D2 were the 
most active fractions and the activity decreased gradually thereafter. In the HPLC 
profiles, A34-D2 was relatively pure, showing a major peak at RT 15.00 minutes and 
several very small minor peaks. The major peak of A34-D2 was also observed as a 
major peak on the fractions A34-Dl , D3 to D6, and as a minor peak in fractions A34-
D7 to Dl3. Again, the major peak was responsible for the P388 activity and the poor 
solubility of the compound led to the wide distribution of the activity. 
A34-D2 (65.0 mg) was further purified using semi-preparative HPLC (C 18 column, 
reverse phase), eluted with 40% ACN/H20 isocratically. Six fractions were collected 
and fraction A34-D2-2 was afforded as a pure compound (47.9 mg). This compound 
was the major active compound observed previously and showed very significant 
activity against the P388 murine leukaemia cell line (IC50 11.2 ng/mL). Fractions 
A34-D2-3, 4 and 5 were mixtures in which A34-D2-2 was still a major compound 
while two or three related compounds were the minor ones. To obtain these minor 
compounds, A34-D2-3 and A34-D2-4 were further purified using chromatography on 
a LH-20 column and reverse phase HPLC respectively. However, due to poor 
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solubility of the maJor compound (A34-D2-2) and the small amount of related 
compounds in the mixture, no pure compounds were isolated. 
Since fraction A34-D2 showed a very close HPLC profile to that of fraction A34-1-9, 
the latter was selected for chromatography to obtain related compounds of A34-D2-2. 
A34- l-9 (306 mg) was further purified using two normal phase (Diol, 15 g) columns, 
and eluted with gradient solvent systems consisting of CH2Ch - EtOAc - MeOH and 
hexane - CH2Ch - EtOAc respectively. The chromatography was guided by both 
HPLC and 1 H NMR spectroscopy to locate related compounds. The fractions of 
interest were purified finally by semi-preparative HPLC (C 18 column, reverse phase). 
Unfortunately, no pure related compounds were obtained. The reasons for failing to 
achieve pure related compounds were ascribed to the poor solubility of the major 
compound A34-D2-2 and the small content of related compounds: A34-D2-2 always 
appeared as a major compound in the fractions containing related compounds and the 
poor solubility of this compound made it very different to separate it from other 
components during chromatography. 
3.3 Structural  E lucidation of A34-D2-2 
A34-D2-2 was obtained as pale-yellow powder. High-resolution electrospray mass 
spectrometry (HRESMS) showed the [M+ H+] ion at 711.1181, indicating a molecular 
formula C3 1H3 1N606S4 (calculated mass 711.1 188). The 
1H NMR spectrum (Table 
3.1) revealed signals for three methyl groups, four AB quartets, two singlets at � 
5.29 and 6.20 (each representing a proton), and nine aromatic protons. The 
heteronuclear single quantum coherence (HSQC) spectrum (Table 3.1) revealed four 
methylene groups. Two were assumed to be hydroxymethyl groups by chemical shifts 
(� 6 1 .2 and 60.6, � 4.25 - 4.34). 1 3C NMR spectrum by attached proton test (APT) 
indicated the presence of the following signals: three N-methyl groups (� 27.4, C-
17 ' ;  � 27.5, C-13 and � 28.2, C-16 '), four methylene groups (� 27.0, C-7 ' ;  � 42.6, 
C-11; � 60.6, C-12 and � 61.2, C- 1 5'), one aliphatic methine (� 80.1, C-5), four 
amide carbonyls (� 1 63.2, C-4; � 165.5, C-1 and C-1' and � 166.8, C-4'), five 
aliphatic quaternary carbons (� 73.5, C- l la; � 73.7, C- l Ob; � 74.8, C-3 ' ;  � 76.1, 
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C-3 and � 76.6, C-6 ') and fourteen aromatic carbons (Table 3.1). 
The appearance of an indole and an indoline fragment was suggested by the 1 H and 1 3C NMR data. Analysis of 1 H- 1 H correlation spectroscopy (COSY), total correlation 
spectroscopy (TOCSY) (Table 3.1) and HSQC spectra led to the assigrunent of C-7 to 
C-10 and C- 1 1' to C-14' (bold line in Figure 3.6). Analysis of the heteronuclear 
multiple bond coherence (HMBC) spectrum (Table 3.1) confirmed all the other 
assignments in the fragments. The principal correlations were as follows: H-7 (OJ 1 
6.77) to � 126.5 (C- l Oa), H-8 (OJ1 7.27) to � 148.3 (C-6a), H-5 (OJ 1 6.20) to � 73.7 
(C- lOb), � 126.5 (C- l Oa) and � 148.3 (C-6a), H-12' (bi- 1 7.22) to � 134.0 (C- lOa'), 
H-11' (OJ 1 7.30) and H-13' (bi- 1 7.20) to � 130.4 (C-14a'), H-9 ' (OJ1 7.19) to � 134.0 
(C- 10a') and � 107.6 (C-8 ') and H-14' (bi- 1 7.65) to � 107.6 (C-8 ')  (Figure 3.6). 
COSY 
� H M BC 
Figure 3.6 Structure for A34-D2-2 
The connection of the functional groups was also demonstrated on the basis of HMBC 
correlations (Table 3.1 ). Two hydroxymethyl groups were connected to two amide 
carbonyl groups through a quaternary carbon respectively based on the long-range 
correlations of H-12 (1'!1 4.26 & 4.34) to � 76. l (C-3) and � 163.2 (C-4) and H-15' 
(bi- 1 4.25 & 4.33) to � 74.8 (C-3 ') and � 166.8 (C-4') (Figure 3.6). The long-range 
correlations of N-methyl protons at OJ 1 3.17 (H-13) to carbons at � 76. l (C-3) and � 
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165.5 (C-1) and the other N-methyl protons at �-1 3.15 (H-17') to carbons at e t  74.8 
(C-3 ') and et 165.5 (C-1 ') led to the connection of C-1 to N-2 then to C-3 and C- 1 '  to 
N-2 ' then to C-3' respectively. The third N-methyl group was assigned by the long­
range correlations of H- 16' (Oi- 1 2.95) to et 76.6 (C-6 ') and et 166.8 (C-4 '). The Jong­
range correlations of H-7 '  (�-1 3.69 & 3.85) to et 107.6 (C-8 '), et 76.6 (C-6 ') and et 
165.5 (C- 1 ') allow the connection of C-8 ' to C-1' through C-7 ' and C-6 '. The 
connection of C-5 to C-11 a through a nitrogen was suggested by the chemical shifts 
of the methine group (et 80. 1, �-1 6.20) and the long-rang correlation between H-5 (�-1 
6.20) to et 42.6 (C-11) and et 73.5 (C- 1 la). The connection of C- 1 1  to the indoline 
group and to C- 1 through C- 1 1  a was assumed by the long-range correlation of H-11 
(� 3.09 & 4.40) to et 73.7 (C-lOb), et 126.5 (C- l Oa), et 80.1 (C-5), et 73.5 (C- 1 la) 
and et 165.5 (C-1). The assignment of four sulfur atoms was based mainly on the 
chemical shifts of C-3, C-1 la, C-3 ' and C-6' and the molecular formula. Thus, a 
planar structure as shown in Figure 3.6 was proposed for compound A34-D2-2. 
On a literature search, compound A34-D2-2 was identical to chetomin, an 
epipolythiodioxopiperazine previously isolated from several species of 
Chaetomium. 1 02 The stereostructure was decided as shown in Figure 3.7 by comparing 
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Table 3 . 1  1 H, 1 3C, HSQC, COSY, TOCSY and HMBC NMR data for A34-D2-2" 
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4' 1 66 . 8  (C) 
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6' 76 .6 (C) 
"
[
'"'" . ........ --. .  ·-·--·-·-·-· -!------- ----·-· 
- - 76 .6, 1 07 .6, 1 27 .2 ,  1 30.4, 
1 65 . 5  3 .69 ( I H, d ,  1 5 .5 )  
3 . 85  ( I H , d ,  1 6.0) 
3 . 85, 7. 1 9  
3 .69, 7 . 1 9  
3 .85 ,  7 . 1 9  
3 . 69, 7. 1 9  
.......... ..... ...... ---
76 .6 , 1 07 .6, 1 27.2,  1 30.4, 
1 65 . 5  ,,,,,,,, .. 
-
................. --1------ ·---8' -· · 
9' 
1 0a' 
1 07 .6 (C) 
1 27 .2 (CH) 
1 34 .0 (C) 
7. 1 9  ( J H, s)  3 .69, 3 .85 3 .69, 3 .85 27 .0 ,  73 .7 ,  1 07 .6, 1 34 .0 
.. ... , .. , ____ _  ..__ _____ .. _ __  ................... -1- - --+------i-- --·--
1 1 ' 1 1 1 .4 (CH) 7 .30 ( I H, m) 7.22 7 .20, 7.22, 7 .65 1 20.6, 1 22 . 8, 1 30.4, 1 34 .0 ............................ ..................................... 
1 2' 1 22 .8  (CH) 7.22 ( I H, m) 7.30 7 .30, 7 .65 1 1 1 .4, 1 1 9. 1 ,  1 34.0 
t----·-··· .......... ____ ._ .............. ,---+- ------·- ----·-··--- ----- -+- -----· 
1 3 '  1 20.6 (CH) 7.20 ( 1 H, m) 7 .65 7 .30, 7 .65 1 1 1 .4, 1 1 9. 1 , 1 22 .8, 1 30.4 
. .............. ... ···- -- ··- . ... _ ......... -·· ···---·· .. ·--·····-----·--.. --.. --.. -. .  ---·-.. ·-· -1 4' 1 1 9. 1 (CH) 7 .65 ( l H, d, 9 .0) 7 .20 1 7.20, 7.22, 7 .30 1 07 .6, 1 22 . 8, 1 30.4, 1 34.0 
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,
' 1 30 �(C) 




6 1 . 2 (CH2) 





;j ' '""' I ----,- " 27.0, 7-6.6�- 165 . 5, 1 66 . 8  
3 . 1 5  ( 3H ,  s )  6 1 .2, 74.8, 1 65 .5  
• 1 H NMR spectra recorded a t  500 MHz in CDCl3, 1 3C MR spectra recorded a t  75  MHz in CDCl3 • 
b 
1 H chemical sh ift values fol lowed by number of protons, multipl icity and coupl ing constant (J/Hz). 
c primary, secondary, tertiary and quaternary carbons, assigned by APT. 
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Biological Activity: 
P388 activity: IC50 = 11.2 ng/mL 
43 
Antimicrobial activity: 4 mm inhibition zone against Bacillus subtilis at a 
concentration of 40 µg/disk. 
Antiviral activity: CYT 4+, TYP 4/5 for Herpes simplex virus, CYT 4+, TYP 4/5 
for Polio virus at a concentration of 30 µg/disk. 
Chetomin is an antibiotic discovered in 1944. 1 04 It has also been associated with poor 
growth in young ruminants. 1 05 Chetomin has been reported to show high antibacterial, 
antifungal, antiviral and antitumour activity.92• 1 05• 1 06 It is bacteriostatic for a series of 
bacteria and is mainly active against Gram-positive bacteria.9° Chetomin is one of the 
most active compounds among epipolythiodioxopiperazines in the assay against the 
HeLa cells. It has potent cytotoxicity with IC50 values of 0.02 µg/mL.88 The disulfide 
bond in chetomin is thought to be essential for its activity. 
3.4 Discussion 
In the literature, 1 03 the assignment of 1 3C and 1 H signals was made using known 
chemical shift trends and published chemical shift data for indoline, chaetocin, and 
substituted indoles. Chemical shifts and spin-spin couplings for the benzene-type 
protons were obtained by spectral simulation techniques. Because 2D-NMR spectra 
(COSY, TOCSY, HSQC and HMBC) were acquired in this experiment, 
reassignments for H-9 ', C-3 '  and C-6 'were made and the ambiguities in the NMR 
assignment of C-8 (H-8) and C-10 (H-10), C-12 and C-15' ,  C-13 (H-13), C-16 ' (H-
16 ' )  and C-17' (H-17 ' )  in the literature were removed. 
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Part I I  Chaetomium sp. (N60) 
3.5 Taxonomy of Chaetomium sp. (N60) 
Strain No. N60 was isolated from saline sand in New Zealand. 
Morphological and cultural characteristics :  Colonies on malt extract agar (MEA) 58-
67 mm in diameter (7 days, 25 °C, Figure 3.8), with a buff aerial mycelium, reverse 
pale. Colonies on 25% glycerol nitrate agar (G25N) 2-3 mm diameter (7 days, 25 °C). 
No growth at 5 °C. At 37 °C, colonies 15-16 mm in diameter (MEA, 7 days). 
Ascomata maturing at 7-10 day , brown, superficial, spherical or ovate, ostiolate, 145-
238 x 173-252 µm (Figure 3.8) ;  ascomatal hair numerous, unbranched, undulate or 
coiled, eptate, pale greenish brown; asci clavate, 22-33 x 1 1 - J  7 µm, 8 spored, 
evanescent ; ascospores limoniform, browni h when mature, containing numerous 
droplets, 6-8 x 7-9 µm, with an apical germ pore (Figure 3.8). 
Figure 3.8 Chaetomiwn globosum (a) colonies on MEA (7 day , 25 °C); 
(b) ascocarp (stained with lactophenol cotton blue) ;  (c)  ascospore, . 
Bars: b = I 00 µm, c = 2 µm 
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After comparing the characteristics of this strain with descriptions by Von Arx et al. 76 
and Pitt and Hocking, 1 07 strain No. N60 was identified as Chaetomium globosum 
Kunze. 
3.6 Cu lturi ng and Extraction of Chaetomium globosum 
C. globosum (N60) was inoculated onto potato dextrose agar (PDA) and incubated for 
five days at 25 °C in darkness. Mycelial disks (8 mm in diameter) were cut from the 
growing margin of the colony and transferred into 2 litres of half strength malt extract 
broth. The broth was incubated for four weeks at 26 °C under agitating conditions. 
The broth was then filtered through Celite 545 under suction and the mycelium and 
filtrate extracted four times with EtOAc respectively. The extracts were dried over 
MgS04 and evaporated under reduced pressure to give a mixture of crude metabolites 
(mycelial extract: yellowish brown, 234 mg; filtrate extract: brownish red, 294 mg). 
On the assay against the P388 murine leukaemia cell line, the filtrate and mycelial 
extracts showed similar activity (IC50 1942 and 2325 ng/mL, respectively). Because 
the HPLC profiles of mycelium extract and filtrate extract were identical, they were 
combined before further chromatography. 
3.  7 Chromatography of Chaetomium globosum 
A general outline of the chromatography is given in Scheme 3.2. 
The crude extract (480 mg) was separated on a C 1 8  column (reverse-phase), eluted 
with a stepped gradient from 10% MeOH/H20 to MeOH and then CH2Cl2 . Fourteen 
fractions were collected. Fractions N60 1.5, 1.6, 1.7 and 1.8 (eluted with 70% 
MeOH/H20, 70% MeOH/H20, 80% MeOH/H20 and 90% MeOH/H20 respectively) 
showed strong activities against the P388 cell line (IC50 3660 - 8469 ng/mL). Fraction 
N60 1.9 (eluted with 100% MeOH) exhibited weak P388 activity (IC50 12134 ng/mL). 
The UV profiles of major compounds in fractions N60 1.5, 1.6, 1.7 and 1.8 were 
similar, indicating a series of closely related compounds responsible for the observed 
activity. Therefore, further purification was guided mainly by UV profiles in the 
HPLC and I H NMR spectra. 
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Scheme 3.2 
Crude Extract ( 480 mg) 
I C 18 column (50 g) 
70% MeOH/H20 80% MeOH/H20 90% MeOH/H20 I 00% MeOH 
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Fraction 60 1 .5 N60 1 .6 60 1 .7 N60 1 . 8 N60 1 .9, 60 I .  I 0 
Weight (52.3 mg) ( 1 1 6 .5 mg) (78.5 mg) ( 1 5 .2  mg) ( 1 5 .7  mg) (6.4 mg) 
[8469] [3660] [3660] [3886] [ 1 2 1 34] [> 1 2500] 
Diol Column Diol Co lumn 
( 1 2  g) ( 1 6  g) 
N60 1 .5 . 1 0  N60 1 .5 .  I 1 - 1 3  N60 1 .6 .3 60 1 .6. 7+8 
(5.0 mg) 
Chaetoglobosin D 
[ 49 1 9] 
( 1 3.5 mg) (20.3 mg) (4.9 mg) 
Diol Column 
( 1 6  g) 
Chaetoglobosin Q 
[> 1 2500] 
Diol Column( 1 2  g) 
N60 1 5  I I .4+5 
(5 . 1  mg) 
Chaetoglobosin R 
[2 1 90] 
N60 1 .6 .3 . 1 0- 1 9  




( 1 2  g) 





( 1 2  g) 
N60 1 9 1 0. l a  
(6.6 mg) 
60 1 . 8 . 1 2+ 1 3  Diol Column 
( I  O g) (6. 1 mg) 
Prochaetoglobosin I + I I  
[3988] 
Diol Column 
( 1 6  g) N60 1 9 1 0. l a.22-25 
(3.2 mg) 
Ergosterol perox ide 
[8469] 
N60 1 .7 .2 
(6 .7 mg) 
Chaetoviridin A+B 
[>6250] 




N60 1 . 7.4+5 
( 1 4 .4 mg) 
Chaetoglobosin A 
[ 1 943] 
60 1 .7 .8  (2.6 mg) 
l LH-20 (2 g) 
[ ]: P388 activity (IC50 = ng/mL) 
N60 1 78 .8 
( 1 .5 mg) 
Chaetoglobosin S 
[ 1 5 75] 
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3. 7. 1  Separation of fraction N60 1 .6  
Fraction N60 1.6 (116.5 mg, Scheme 3.2) was further chromatographed on 16 g of 
Diol (normal phase), using a gradient system consisting of CH2C)z-Et0Ac-MeOH. 
Fifteen subfractions were collected. A pure compound, N60 1.6.7+8 (4.9 mg), was 
achieved from subfractions N60 1.6.7 and 1.6.8, eluted with 50% and 80% 
Et0Ac/CH2C)z respectively. Subfractions N60 1.6.3 and N60 1.6.4, eluted with 5% 
Et0Ac/CH2Ch, contained a major compound of crude N60 1.6. Because subfraction 
N60 1.6.3 was purer than N60 1.6.4, the former was used to obtain the major 
compound. Subfraction N60 1.6.3 was applied on another Diol column (12 g) and 
eluted with 70% CH2C]z/hexanes isocratically. Thirty-four fractions were collected. 
Pure compound N60 1.6.3.10-19 (4.9 mg) was obtained in the fractions N60 1.6.3.10 
to N60 1.6.3. 19. 
The structural elucidation of N60 1.6.7+8 and N60 1.6.3. 10-19 1s discussed m 
sections 3.8.3 and 3.8. 1 
3. 7.2 Separation of fraction N60 1 . 7  
Fraction N60 1.7 (78.5 mg) was separated with a normal phase (Diol, 16 g) column, 
using a stepped gradient solvent system from CH2Ch to EtOAc then to MeOH. 
Seventeen subfractions were collected. Subfraction N60 1.7.3, eluted with 100% 
CH2Ch, afforded a pure compound (N60 1.7.3, 4.4 mg). Subfractions N60 1.7.4 and 
1.7.5, eluted with 5% Et0Ac/CH2Ch, gave another pure compound (N60 1.7.4+5, 
14.4 mg). N60 1.7.4+5 was the major compound of crude N60 1.7. 
1H NMR spectra indicated that subfraction N60 1.7.8, eluted with 20% 
Et0Ac/CH2Cl2 , contained a compound closely related to N60 1.7.4+5. Subfraction 
N60 1.7.8 (2.6 mg) was further chromatographed by a LH-20 (2 g) column using 
100% MeOH as the eluent. The expected pure compound (N60 178.8, 1.5 mg) was 
achieved in fraction N60 178.8. 
The HPLC profile and 1H NMR spectrum indicated that subfraction N60 1.7.2 was a 
mixture of nearly equal amounts of compound N60 1.7.3 and a related compound, 
namely N60 1.7.2A. Because no P388 activity was detected in this fraction and 1H 
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NMR signals of compound N60 l.7.2A and N60 1.7.3 did not overlap, identification 
of compound N60 1.7.2A was made by removal of the signals of N60 1 .7.3 from the 
1 H NMR spectrum of N60 1.7.2. Therefore, no further purification was necessary for 
subfraction N60 1.7.2. 
The structural elucidation of compounds N60 1.7.4+5, N60 178.8, N60 1 .7.3 and N60 
l .7.2A is discussed in sections 3.8.2 , 3 .8.5 , 3.8.6 and 3.8.7 respectively. 
3. 7.3 Separation of fraction N60 1 .8  
The fraction N60 1.8 (15.2 mg) was chromatographed on 1 2  g of Diol, usrng a 
gradient solvent system from hexanes to EtOAc, then to MeOH. Twenty-nine 
subfractions were col lected and combination of the sub fractions was based on analysis 
of 1H NMR spectra. Pure compound N60 1.8. 1 4+ 1 5 (7.9 mg) was afforded in the 
subfractions eluted with 1 00% EtOAc. Subfractions N60 1 .8.12 and N60 1.8.13, 
eluted with 80% EtOAc/hexanes, were combined (N60 1.8.12+ 13). The HPLC profile 
and 1 H NMR spectrum indicated that subfraction N60 1.8.12+ 13 was relatively pure, 
and contained two compounds (namely N60 1.8. 1 2+ 1 3 A and B), structurally related 
to compound N60 1 .8. 1 4+ 1 5. The ratio of the two compounds was nearly 1 :  1. 
Because 1H NMR signals of the two compounds could be distinguished from each 
other in the spectrum, it was concluded that the structural elucidation could be done 
by combining MS and a series of 2D NMR spectra. Due to the small mass (6.1 mg) of 
the fraction and the fact that they were known compounds (see section 3.8.2 ), no 
further purification was carried out for this subfraction. 
The structural elucidation of the three compounds is discussed in section 3.8.2 . 
3. 7.4 Separation of fraction N60 1 .5  
Fraction N60 1 .5 (52.3 mg) was applied onto a Diol column (12 g) and eluted with a 
gradient solvent system from 10% EtOAc/hexanes to 100% EtOAc then to MeOH. 
Thirty subfractions were collected and combination of the subfractions was based on 
analysis of 1H NMR spectra. A pure compound (N60 1.5.10, 5.0 mg) was isolated in 
the subfraction eluted with 80% EtOAc/hexanes. Subfractions N60 1.5.11, 12 and 13, 
eluted with 90% EtOAc/hexanes, contained the same compound structurally related to 
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compound N60 1.5.10. The three subfractions were combined (13.5 mg) and further 
purified on another Diol column (16 g). The column was eluted with a gradient 
system from 10% EtOAc/hexanes to 100% EtOAc and nine fractions were collected. 
A pure compound (N60 1511. 4+5, 5.1 mg) was achieved in the fractions N60 15 1 1.4 
and N60 15 1 1.5, eluted with 70% EtOAc/hexanes. 
The structural elucidation of N60 1.5.10 and N60 15 1 1.4+5 is discussed in sections 
3.8.2 and 3.8.4 . 
3. 7.5 Separation of fractions N60 1 .9  and N60 1 . 10 
Fraction N60 1.9 showed mild activity against the P388 cell line (IC50 12 134 ng/mL) 
while fraction N60 1.10 was inactive in the assay (IC50 > 12500 ng/mL). Because the 
1H NMR spectra of these two fractions were i dentical, they were combined for further 
puri fication. 
The combined fractions (22.1 mg) were chromatographed on a 12 g Diol (normal 
phase) column, using a gradient solvent system from hexanes to EtOAc, then to 
MeOH as the eluent. A total of twenty-eight subfractions was collected and combined 
after analysis by 1H NMR spectroscopy. The compound of interest was collected in 
subfraction N60 1910. la (eluted with 100% hexanes to 30% EtOAc/hexanes). This 
subfraction (6.6 mg) was further purified on Diol ( 10 g), eluted with a gradient from 
100% hexanes to 50% EtOAc/hexanes. Twenty-six fractions were collected. Pure 
compound N60 1910. 1 a.22-25 (3.2 mg) was obtained in the fractions eluted with 30% 
EtOAc/hexanes. 
The structural elucidation of N60 1910.l a.22-25 is discussed in section 3.8.8 . 
3 .8  Structu ral E luc idation 
3.8. 1 Structural elucidation of compound N60 1 .6.3. 10- 19  
N60 1.6.3 . 10-19 was one of the main compounds isolated from the culture of 
Chaetomium globosum (N60). 
The molecular formula of N60 1.6.3.10-19 was detem1ined to be C32H360sN2 based 
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on analysis of the HRESMS (found: 529.2714 [M+ H+], calcd: 529.2702) and the 1 3C 
NMR spectrum (Table 3.2). 
The 1 H NMR and HSQC spectra (Table 3.2) disclosed the presence of the following 
groups: a secondary methyl (bj 1 1.02, H- 16'), three allylic methyls (bi ;  1.37, H- 18 ' ;  
bi- 1 1.65, H-11 and bi-1  1.73, H-12), two trans -CH=CH- groups (bi ;  6.75 and 7.75, J 
= 16 Hz, H-2 1 and H-22; bi -1 6.19 and 5.36, J =15 Hz, H-13 and H-14), two methylenes 
(bi -1  2.65 and 2.88, H- 10; bi ;  2.06 and 2.32, H-15), six methines (bi; 3.55, H-3; bi; 3.42, 
H-4; bi 1  3.94, H-7; bi-1 2.04, H-8; bi ;  2.52, H-16 and bi ;  5.07, H- 19) including two 
oxymethines (et 68.9, C-7 and et 82.2, C-19) and an olefinic proton (bi -1 5.61, H-17). 
The presence of a 3-substituted indole group was also deduced by comparing the 1 3C 
NMR data (see Table 3.2). 
The identity of the remaining groups was revealed by the analysis of APT: two 
conjugated ketones (et 197.3, C-23 and et 201.3, C-20), an amide (et 173.2, C-1 ), an 
aliphatic quaternary carbon (et 6 1.5, C-9) and three olefinic carbons (et 126.3, C-5; 
et 132.0, C-6 and et 132.5, C-18). 
Close inspection of the 1 H spectra of N60 1.6.3. 10-19 by COSY experiment (Table 
3.2) led to the partial structural units as shown by bold-faced lines in Figure 3.9. The 
assignments of C-5, C-6, C-1 1 ( et 18.1 ), C- 12 ( et 14.1) and C-18 were made by long­
range correlations (CIGAR) between H-3 to C-5, H-4 to C-6, H- 12 to C-7 and H-18' 
to C-18 (Figure 3.9). 
The assignments of C-1 'a (et 136.5), C-3' (et 111.2) and C-3'a (et 127.0) in the 
indole group were determined by long-range correlations in the CIGAR spectrum 
(Table 3.2), mainly between H-2 ' (bi-1 6.99) and H-6 ' (bi; 7.2 1) to C- 1 'a, H-4' (bi 1 
7.48) to C-3 'and H-5' (bi-1 7.13) to C-3'a (Figure 3.9). 
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Figure 3.9 Planar structure of compound N60 1.6.3.10-19 
1 6' 
Me 
5 1  
The long-range correlations of H-4 and H-8 to C-9 led to the connection of a six­
membered ring from C-4 to C-9. The long-range correlations of H-3, H-4 and H-8 to 
C-1 and H-2 (� 5.68) to C-9 allowed the connection of N-2 to C-1 then to C-9. The 
connection of C-18 to C-21 through C-19 and C-20 was based mainly on the long­
range correlations of H-19 to C-18, H-17, H-18 ' and H-21 to C-19 and H-19 and H-22 
to C-20. The connection of C-23 to C-9 and C-22 was indicated by the long-range 
correlations of H-4, H-8, H-21 and H-22 to C-23. Finally, the connection of C-10 to 
the indole group was made by the long-range correlations of H-1 Oa, H-1 Ob and H-3 to 
C-3' .  
On the basis of these findings, the planar structure in Figure 3.9 was proposed for 
compound N60 1.6.3.10-19. From a literature search, this compound was identified as 
chaetoglobosin B, previously isolated from Chaetomium spp.8 1  The stereochemistry of 
N60 1.6.3.10-19 was determined as shown in Figure 3.10 by comparison with the 
literature.8 1 • 1 08• 1 09 Because a high resolution NMR instrument was used and 2D-NMR 
data (COSY, HSQC and CIGAR) were obtained for compound N60 1.6.3.10-19, the 
ambiguities in the NMR assignment in the literature were removed by our own more 
precise data. 
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no. 
I '  
Table 3 .2 1 H, 1 3C, HSQC, COSY and CIGAR NMR data for 60 1 .6 .3 . 1 0- 1 9" 
COSY 
8.09 ( I  H, br s) (N-H) H-2' C-2'(w), C-3', C-3'a 
53 
1 s __ 1 3_2_.5 _(C_) _._ ...................
....... 




............ -........... _. __ ........ , _________ .. ___ ________ _ 
•-j-9"f's:ii'ccH) I 5 .07 ( I  H, d, 5 )  
·
i--H-- 1·9-.-(-1 9--0-H--) -
.... C- 1 7:-c="is: - c�1s::-c-20 ' 
1 8' I 0.9 (CH3) i l . 37 (3H , s) .. .
.
. H- 1 7  I 
C- 1 7  C- 1 8  C- 1 9  
·�•�••--•-M•-------+----------- -
3 . 82 ( I H ,  d, 4.5 )  (0-H)  H- 1 9  I 1 9' 
20 20 1 .3 (C) 
.................. ___ _ ......... ... .... _. ___ ..__ _ .... _.. _ _ -- ---··r--- ·- --- ............ _________  _
t--+----- --- ----.-............ , .. --·------+-- ---- ---+----- ---
2 1  1 33 .3 (CH) 6.75 ( 1 H , d, 1 6) H-22 C- 1 9(w), C-22, C-23 
� : ���  













. _ ..... + 






-_ .. --_----_ 
' 1 H NMR spectra recorded at 500 MHz in CDCh. 1 3C NMR spectra recorded at 1 2 5  M Hz in CDCh. b 1 H chemical shift values 
(oppm from SiMe4) fol lowed by number of protons, multipl ici ty and coupling constant (J/Hz). ' primary, secondary, tertiary and 
quatemary carbons, assigned by APT. d long range 1 H- 1 3C correlation observed in the CIGAR experiment. 
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3.8.2 Structural elucidation of five related compounds 
3 .8 .2 . 1  Structura l e lucidation of compound N60 1 .7 .4+5 
54 
Compound N60 1.7.4+5 was another major compound isolated from the culture of 
Chaetomium globosum (N60). 
The HRESMS indicated that compow1d N60 1.7.4+5 had the same molecular formula 
(C32H3605N2) as that of chaetoglobosin B. The general features of its 
1 H and 1 3C 
NMR spectra (Table 3.3, Table 3.4) closely resembled those of chaetoglobosin B 
(Table 3.2) except for the differences in the region of the six-membered ring. Two 
ally Ilic methyl groups ( � 1.65, 1. 73) in chaetoglobosin B were replaced by a 
secondary methyl group (bi-1 1.24, H- 1 1) at C-5 and a tertiary methyl group (� 1.29, 
H- 12) at C-6 in N60 1.7.4+5. The C-5, C-6 olefinic carbon signals and a secondary 
alcohol group at C-7 in chaetoglobosin B were absent, and instead a methine group 
(� 36.3, bi-1 1.84) and an aliphatic quaternary carbon (� 58.3) appeared in N60 
1.7.4+5. The presence of a trisubstituted expoxide (C-6 and C-7) was suggested and 
the structure depicted in Figure 3.11 was proposed. This structure was further 
confirmed by a series of 2D NMR experiments (COSY, HSQC and CIGAR). A 
literature search revealed this compound to be chaetoglobosin A, previously isolated 
from Chaetomium spp.8 1  The stereochemistry of N60 1.7.4+5 was detennined by 
· · h h j " 8 I I 08 I 09 comparison wit t e 1terature. · 
1 2  
1 1  




1 4  
1 5  




· · ,,,,,/ Me 
7' H 0 
2 1  1 8  Me 
0 OH 1 8' 
Figure 3. 1 1 Structure of chaetoglobosin A (N60 1.7.4+5) 
1 6' 
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3 .8 .2 .2  Structural  e lucidation of compound N60 1 . 5 . 1 0  
Compound N60 1.5 .10 had the same molecular formula (C32H3605N2) as 
chaetoglobosin B, as deduced from HRESMS (found: 529.2702 [M+H+] ,  calcd: 
529.2702). The 1 H and 13C NMR spectra (Table 3.3, Table 3.4) showed close 
correspondence with those of chaetoglobosin B except for the absence of an allylic 
methyl group at C-6 and the presence of a methine (8::: 32.7, bi-1 2.84) and a terminal 
methylene group (8::: 113.4, bi-t 5.21 & 5.44). The methine group (C-5, H-5) was 
assigned by the COSY coupling of H-5 (81-1 2.84) to H-4 and H-11. The long-range 
correlations (CIGAR) of the tenninal methylene protons to C-5 and C-7 led to the 
connection of C-6 (8::: 148.7) to C-12 (8::: 113.4). The chemical structure of N60 
1.5.10 was detem1ined as shown in Figure 3.12. A literature search revealed this 
compound to be chaetoglobosin D with the stereochemistry assigned after comparison 
to the literature.79 ·80 · 1 09 
1 2  
1 1  
Me11t,,, OH 
' • .  
4' 1 4  
3' 1 5  
1 '  2' 1
6 ' •, 
''111 
N 0 7' H 
0 
Me 
0 1 8' 
Figure 3.12 Structure of chaetoglobosin D ( N60 1.5.10 ) 
3 .8 .2 .3  Structu ral e lucidation of compound N60 1 .8 . 1 4+ 1 5 
Me 
1 6' 
The molecular formula of compound N60 1.8.14+ 15 was determined to be 
C32H3604N2 based on HRESMS (found: 513.2749 [ M+H
+J ,  calcd: 513.2753). This 
formula corresponded to a deoxygenated congener of chaetoglobosin B. Comparison 
of the 1 H and 13C NMR signals (Table 3.3, Table 3.4) revealed the presence of a 
secondary methyl group (bi-t 1.43) at C-5, the appearance of an olefinic proton (bi-1 
5.30) at C-7, and the absence of the C-7 alcohol of chaetoglobosin B. The assignment 
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of C-5 (H-5) was based on COSY correlations between H-5 (bi; 2.47) to H-4 and H-
11. The assignments of C-6 and C-7 (H-7) were made by the long-range couplings 
(CIGAR) of H-4 to C-6 (� 141.2) and H-12 to C-7 (� 125.8). The latter was also 
supported by the COSY correlation between H-7 (bi ;  5.30) to H-8 and H-12. Based on 
the information from COSY, HSQC and CIGAR spectra, the structure of compound 
N60 1.8.14+ 15 was suggested as depicted in Figure 3. 13. This compound was found 
to be identical with chaetoglobosin J, previously isolated from Chaetomium spp.,80 
and the stereochemistry of N60 1.8. 14+ 15 determined by comparison of the NMR 
data with the literature.80· 1 09 
7' 
1 '  
N 
H 
1 2  
Me 
Figure 3.13 Structure of chaetoglobosin J (N60 1.8.14+ 15) 
3.8 .2 .4 Structu ra l e lucidation of compound N60 1 .8 . 1 2+ 1 3A 
The molecular formula of compound N60 1.8.12+ 13A was determined to be 
C32H3s02N2 by HRESMS (found: 483.2995 [M+H
+] ,  calcd: 483.3012). Its close 
relationship to chaetoglobosin J (N60 1.8.14+ 15) was revealed by the 1H and 13C 
NMR spectra (Table 3.3, Table 3.4) in which the majority of the chemical shifts were 
practically identical. Since the difference between chaetoglobosin J and N60 
l .8.12+13A was in the number of hydrogen and oxygen atoms, N60 l.8.12+13A was 
assumed to be the reduced form of chaetoglobosin J. After comparing the 1 3C and 1 H 
NMR spectra of chaetoglobosin J and N60 1.8.12+ 13A (Table 3.3, Table 3.4), it was 
found that the difference between the structures were concentrated around C-19 (H-
19) and C-20 (H-20). The oxygenated carbon at C-19 (� 81.5) and the carbonyl 
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group at C-20 (&:: 20 1.2) in chaetoglobosin J were changed to &:: 35.8 and &:: 28.7 
respectively. These two carbons were determined to be two methylene carbons by 
HSQC correlations (l\! 2.36 and bi-1 2.13 to &:: 35.8, bi-1 2.38 and bi-, 2.39 to &:: 28.7), 
and the double triplet (H-21) at (\{ 6.79 coupling with a methylene group at bt- 1 2.38, 
2.39 supported this elucidation. On the basis of the above observation, the structure of 
compound N60 l .8.12+ 13A was proposed as shown in Figure 3. 14. A literature 
search found this compound to be prochaetoglobosin I, previously isolated from a cell 
free system of Chaetomium subaf ine, treated with cytochrome P-450 inhibitors. The 
stereochemistry was decided by comparison with the data in the literature. 1 1 0• 1 1 1  
7' 
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Figure 3.14 Structure of prochaetoglobosin I (N60 1.8.12+13A ) 
3 .8 .2 .5  Structu ral e lucidation of compound N60 1 .8 . 1 2+ 1 3B 
The molecular formula of compound N60 1.8. 12+ 13B was deduced as C32H3603N2 by 
HRESMS (found: 497.2796 [M+H+] ,  calcd: 497.2804), a deoxygenated congener of 
chaetoglobosin J (N60 1.8.14+ 15). Comparison of the 1 H and 1 3C NMR spectra of 
N60 1.8.12+ 13B with those of chaetoglobosin J (Table 3.3, Table 3.4) noted that the 
differences between the structures Jay at C-19. The HSQC spectra revealed the 
oxygenated methine group at C-19 (&:: 8 1.5, bi-i 5. 10) in chaetoglobosin J was replaced 
by a methylene group (&:: 53.2, bt- 1 3.05 and 3.70). This was also supported by the 
isolated germinally signals (l\! 3.05 and 3. 70) of N60 1.8. 12+ 13B in the COSY 
spectrum. Therefore the structure of compound N60 1.8.12+ 13B was detem1ined as 
shown in Figure 3. 15. A literature search found this compound to be identical to 
Chapter 3 Chaetomium spp. (A34 and N60) 58  
prochaetoglobosin II, preciously isolated from a cell free system of Chaetomium 
subaffine under treatment with cytochrome P-450 inhibitors. The stereochemistry was 
decided by literature data comparison. 1 1 0 
4' 
7' 
1 '  
N 
H 






1 4  
8 ' • ,,,,,,,,,,# 1 5  




1 1 8 
2 1 20 19  Me 
0 1 8' 
Figure 3.15 Structure of prochaetoglobosin II (N60 l.8.12+13B) 
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Proton 
Table 3.3 1 H NMR data3 of chaetoglobosins (500 MHz in CDCI3) 
Chaetoglobosins 
atom A ! D J Pro I Pro I I  
. ... . ·-·- -··· . ·······--·---·-···--- __ , ... , ··· ····-·-"""'- .............. ---· -----+-------, 
1 7  5 .57 ( I H , d, 9 .5 )  5 . 62 ( I H ,  d, 8 .0) 5 . 66 ( I  H ,  d, 8 .5)  4 .95 ( I  H, d, 8.0) 5 .36 (I H ,  d, 8.0) _ ______  ,._.. ...... ,_,, ..... 
1 8' 1 .3 1  (3 H,  s )  1 .33 (3H,  s) 1 .3 5  (3 H,  s) i 1 .5 1  (3H,  s) 1 .48 (3 H,  s) 
. 
__ 1 9  ____ __ ,, .. 
, 5 . 0 1  ( I  H ,  d, 4 .5 )  ..
.... -;�-(,�)---- ... 5.IO(IH�� .. 1- 2.36_(_�H, d, !.?:_?.) .. 1 . -�:2..��'. .�'_13 .0) __ 







H . .  � •..�d __ ,-_4._5)  __ 
. 

















�:�  = 




·d·:· 16�5) " ·
-
-6:79 ( i"H�·ITT)·t 6.44 ( I  H, d, .. 17�0)·--2 1  
22 
6.45 ( I H , d, 1 6 .5 )  
7 .7 1 ( I H , d, 1 6 .5 )  
···-,-----
8.02 ( 1 H , d, 1 7 .0) 8 .23 ( I H , d, 1 6 .5 )  7 .07 ( I H , d, 1 6 .0) I 8 . 1 8 ( 1 H, d, 1 6 .0) 
' 1 H chemical shi ft values (o ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). 
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Table 3.4 1 3C NMR data (o, ppm) of chaetoglobosins (recorded at 1 25 MHz in CDC13) 
Chaetoglobosins 
60 
Carbon I ,___----�----��----�----�-------< 
A D J Pro I I atom Pro I I  





.. -.--� 4' . .. T" """ 1 1 8 .5  (CH) - _' ........ -1 18. 7 (CH) .. _ __ ----· 5 ( J ·· · -� .. ............... ..... __ 22_3_.6 ��H) 1 20.0 (CH) � :?:?i��L ) _l_�?:? ����-J- _ _  1,_20.0 ��-I-I) _ _  6' 1 20. 1 (CH) 1 22 .7 (CH) 1 22.6 (CH) I 1 22 .5 (CH) ! 1 22 . 5  (CH) _-... -...... _?-. -·- -r:_-_1.-1. 1.::���!i)_·- _- .:·_ ........_ .. 11.x:?c��2��- . .2!.. l : !L��) 1 1 1 .  7 (CH) _ 1 _ � . -\�!?_) . 1 i 1 73 .4 (C) 1 72 . 1  (C) 1 72 .8  (C) 1 72 . 8  (C) I 1 72 . 8  (C) 
E 
_ .... -····- l.-----
Bf c; 1��s� ··············.-1:-.:-}�-}-;L= - - :�.--·•-� : :---�-=-t-_Jl--... _ .  ·_- :_:.-�:-f-1-/- ---_--
·1 
...... .............. _ .. __ _ . .......... __ ,, __  ---·--.... - --· .... ................. -·-·-........ _ 6 58 .3  (C) 1 48 .7 (C) 1 4 1 .2 (C) 1 39 .9 (C) 1 4 1 .0 (C) -·-- --·-"· .. -·-·- ···· -- -·-- ............. ·----··-·-------·-···-·-.. ·-·-7 I 62 .6 (CH) 69 .7  (CH) 1 25 . 8  (CH) 1 26.8 (CH) 1 26.0 (CH) 




(� - �_\�;- �L��? __ 1- ��;)_ .. ... 
. 34.9 (CH2) .... 1 .. __ 3.�:9 \�8-2_) _ ... -�·7 (CH:� .. ·-1 3 . 7  (CH3) , 1 5 .8 (CH3) 1 5 .0 (CH3) 1 4 .2 (CH3) 1 4 .9 (CH3) 
0�H� C6-�2H3) 20. 1 (CH3) � (CH2) 20.5 (CH3) 1 9 .9 (CH3) · -� (C� 1 3  1 28.4 (CH) ! 1 28.2 (CH) 1 30.9 (CH) 1 29 .6  (CH) 1 30 .8 (CH) =-��·- ___ ; . .. 1 33 .9_ (CH)�t� 1 36.6 (CH) ��,=>32 .2 ccH) =�-· .. 1 ;i-o ... (cH)-- ---- ;-iuccii> __ _ 
- :� - - :::��:,: I :t��:H :i::�:;-�-·-.. -:1:·�ciit--· · - - - · ·:��:- --... -............ _..._._ .......... 1-·--- · ....-.... --·--·-.... ·- ·-- .. ·---· ...... ,__ 1 6' 2 1 .2 (CH3) 2 1 .2 (CH3) 2 1 . 1 (CH3) 2 1 .5 (CH3) 2 1 . l (CH3) ( J 6-CH3 )_ _ j __ ----· ··-
: ;  ';;�6,c�g�- � --'!i2·�- � -�- 1��7c:2- -,--1 8-, .......... --·-............... ________ ' _.. .. .......... -- ·--.. -·-·1 0 .8  (CH3) I 1 0.8 (CH3) 1 0 . 8  (CH3) 1 6 .5 (CH3) 1 5 .5 (CH3) ( l  8-Cl l3) _ .... ..... t--·-· - -- --- --· .......... ·-·- -----.. ·-·-.......... ..... _______ ... _ __ ................... - ................ _ ......... . 1 9 8 1 .9 (CH) 1 8 1 .7 (CH) , 8 1 . 5 (CH) 35 .8 (CH2) I 53 .2 (CHz) ......... _ _  ....... -................................... �· -.................. __ .. _ . ..... ........... 1 .. -, ..... ............. __ .................. _._ . ....... .... _................ . _._ ---20 20 1 .5 (C) 20 1 .3 (C) I 20 1 .2 (C) 28 .7  (CH2) 20 1 .3 (C) ___ .......... _ . .............. --.-............... -........... -.. -·- r . .... -.... -.... .. ___ .. 
-:; -- ::: : :�:; H:: � :�:H- -::� :-:�:; - + -::: : ;�:; : :: : ;�:: --- 23 I 1 96�1-<c)·---r -· 1 96.9 cq 1----imcc)-- ---1- 1 98 .3  cq --- -198.3·-(q 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
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3. 8.3 Structural elucidation of compound N60 1 .6. 7+8 
6 1  
Compound N60 1 .6 . 7+8 was obtained as a pale yel low powder. The molecular 
formula of N60 1 .6 .7+8 was determined to be C32H3806N2 after H RESMS analysis 
(found: 547.2805 [M+H
+
] ,  calcd : 547.2808), corresponding to a· hydrated congener of 
chaetoglobosin D. The IR spectrum showed characteri stic absorptions at 3060-3240 
cm- 1 (due to NH and OH groups), and 1 695, 1 685  cm- 1 (due to carbonyl groups). 
Comparison of the 1 H and 1 3C NMR spectra of N60 1 .6.7+8 (Table 3 . 5 )  with those of 
chaetoglobosin D (Table 3 . 3 ,  Table 3 .4) showed good agreement except for 
d ifferences at C-6. The olefinic carbon (� 1 48 .7, C-6) and the terminal methylene (� 
1 1 3 .4, C- 1 2, bi -i 5 .2 1 and 5 .44, H- 1 2) i n  chaetoglobosin D were replaced by  an 
oxygen-bearing aliphatic carbon (� 76. 1 )  and a methyl group (� 22.3, 8H 1 . 1 6) . The 
assignment of C-6 in N60 1 .6 .7+8 was also supported by long-range correlations of 
H-7 (bi-i 3 . 54), H- 1 1 (bi-1 1 .32)  and H- 1 2  ( bi-i 1 . 1 6) to C-6 (� 76. 1 )  (Figure 3 . 1 6) . Two 
alcohol groups in the six membered ring suggested the 6, 7-dio l  structure in the 
cyc lohexane part of N60 1 .6.7+8. Thus, a planar structure as shown in Figure 3 . 1 6  
was proposed for N60 1 .6. 7+8 and the structure confirmed by a series o f  2 D  NMR 
experiments (COSY, HSQC and C IGAR, Table 3 . 5) .  N60 1 . 6 .7+8 is a new compound 
and was named as chaetoglobosin Q. The 6, 7-diol in cyclohexane was a new type of 
structure in chaetoglobosins, but  had been reported previously in  cytochalasins P, Q 
and R. 1 1 2 
4' 
7' 








1 5  
i
22 




Figure 3 . 1 6  Planar structure of chaetoglobosin Q (N60 1 .6.7+8) 
Me 
1 6' 
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The relative stereochemistry of chaetoglobosin Q (N60 1.6.7+8) was assigned by a 
NOESY spectrum (Table 3.5) and by reference to that described for chaetoglobosin A 
as detem1ined by X-ray diffraction analysis.79 The coupling constant (17•8 11.5 Hz) 
showed the � configuration of the C-7 hydroxyl group. Since a positive NOE was 
observed from H-5 and H-8 to H-12, the methyl group of C-6 was suggested to be � 
while the C-6 hydroxy group was found to be in an a configuration. NOEs between 
H-3 to H-7 and H-11 suggested that these protons are in the a configuration, and 
NOEs from H-15a to H-16', from H-17 to H-16' and H-19, and from H-19 to H-17 and 
H-22 indicated these protons are also a. NOEs from H-15b to H-14 and from H-18 '  to 
H-16 implied that these protons are in the � configuration. Based on the evidence 
summarized above, the stereochemistry for chaetoglobosin Q (N60 1.6. 7+8) was 
elucidated as depicted in Figure 3 .17. 
7' 
1 '  
N 
H 
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Figure 3.17 Structure of chaetoglobosin Q 
1 5  
Me 
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no. 
Table 3 . 5  1 H, 1 3C, HSQC, COSY and CIGAR MR data for 60 1 .6 .7+8• 
COSY OESY 
63 
+, h-. 6 cC) i 83 4 c , ": b,_s)(N:J H_-2' J �-2� ... .. _ _ _ L_ 
2.--
-
r l-22.9 (CH)l_ 6 97 ( 1 H ,_d , 20) _ _  j H- 1 '  _ _ ,,_ I H- 1 '  ·.1 C- l 'a, C-3 ', C-3'a 
3 '  i 1 1 1 .9 (C) I 
I 
,,,, ___ __ ,,,_ .. : ..... _,, __ ,, ____ ............ -.. -·-·-·1'--·-· - -- -- ---- -- - - -- ................ _ _ .. __ __ ..... ....... _ .. __ ..... , ______ .. .. 3'a 1 27. l (C) 
4' ,-1 1 9 .0 (CH)  j 7 .5 8 ( I  H , d , 7 .5 ) H-5 ' I H-5 ' , H-6'(w) 
........... -......................... . .................................. ---···· ---· -···-· _ _ ,._; _ ---· C- 1  'a, C-6' 
5 ' 1 20.0 (CH)  I 7 . 1 0  ( I H , t, 7 . 5 )  H -4', H=_6' -·---- . \ H -4', H -6' _ ·····--· - -��3-·a, C�}'_\V:..! 6' 1 22.6 (CH)  I 7. 1 8  ( I H , t, 7 .5 ) H-5 ' , H -7' I H-5' , H-7' 
7' 1 1 1  6 ccH) 1 7 35 c , ;:;· .. d s·s·) H-6' - -- · --- 1 H -6· . . 1----� ' , . - --- .... .... __ _ . - - r· --
C- l 'a, C-4' ___ , 
C-3'a, C-5 ' 
l 7 1 . 9 (C) ! l 
_, __ ,._ _ -- -··· .. ·-
- ----,,----- -----1·-··· --·-·- --- -
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. 3 __  
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•--+- ---.. ·-�-· L_ ... .. - - -- -- · --.... ·-···- -.. ... ,_ ...... _ .. ...... __ ... _ .. ........... _____  _ 
5 38 0 (CH)  i 1 ·92 ( l H , dd, 7 . 5 ,  H-4, H - l l ·1 H -4 H- 1 1  H- 1 2  · I 4.02 , • •--+-- . r· ···········--..... _ __ ....... __  -
-
-......... ... ........... _____ ____ ____ ... _ .... _.. __ ___ ____ ............ --- -______ _ _ _ ..... . 
6 76. l (C) 















, 2:04 ( l  H , m) 'I H -7, H - 1 3  l"H�7, ·;--1-2 ---- -f'-C- 1 ,  C-7, C- 1 4 -
. - 9 · 63 .7 (C) 
· 
___ I _ __ __  ---�-- --- --- ·--:= 
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...... [ H - l Ob H- 1 1  C-2' C-3' 
1 0  i 35 1 (CH2) I (_I H , bi:..s!,__! 4 � . , - __ '__ 
-
-- --.'-,- -, I : H- l Ob . 2 .47 H-3 , H- l Oa ! H- l Oa C-2 , C-3 , C-3 a, 
_ 1 1  ! 1 3  • ccH,)t\'  :; �{� .' :: �·,� 0 s i I H_-_s _ _ j ".:':.".:':. ":', H: , o, :f � c: 5, c:0---.. �-:_! ??:3- <��_3)_ ] �6. !3-H , s) _ ____ Ti __ _ _ _ __ __ j __ �-5 , H-8 ---�=5 , C-6, � -
: : I*�:�:; i !��1c'.
1
:.·�::� �:::::��'- H- I Sb - :: : �H- ,-,� -1 - -
,::. ··· .;� : ;�:ir��1�:�: ��:/�� --I ��[�;b: -�--t c-;�_ c�n--












l 8', C- l 9 
', : ! :� : :�:;
) #�m�f I H - l 7 - � :: ::. H -22(w) {��t{��t�:� 
... -.......... ,,,,,,_,; ....................... _ _ , ______ .. , ,  · · ···-········---· ······-- ·------- ---··· .. -·----··--·- ... 't'-"'" --·-··--· - ·-- -
20 t 20 1 . 1  (C) I 
t 




�I H_:c'·l �- � ----·-.. 
-- -
-
��- - - __ 
__ _ __ _ ��?:�), C-23-
_ _ 22 • 1 37. 7 (CH)  8 .22 ( l H , d , 1 6 .5 ) __ _ H -2 1_ .
..
.
.... _____ .. _
_ H-_l 7(w), H- 1 9 , H-2 1 C-20, C-23 
23 i 1 91. 1 cq I I 
' 1 1- 1  NMR spectra recorded at 500 M Hz in CDCl3, 13C NMR spectra recorded at 1 25 MHz in CDCh. b 1 1-1 chemical shift values (b'ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). ' primary, secondary, tertiary and quaternary carbons, assigned by APT. d long range 1H- 13C correlation from H to C observed in the CIGAR experiment. 
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3.8.4 Structural elucidation of compound N60 151 1 .4+5 
Compound N60 1511.4+5 had the same molecular formula C32H3806N2 as 
chaetoglobosin Q (N60 1.6.7+8), as deduced from HRESMS (found: 547.2796 
[M+ H+] ,  calcd: 547.2808). The 13C NMR spectra of chaetoglobosin Q (Table 3.5) and 
N60 1511.4+5 (Table 3.6) were also similar except for slight differences at C-6, C-7, 
C-8, C-11 and C-12. From the molecular formula and the spectral data, N60 1511.4+5 
was suspected to be an isomer in the cyclohexane moiety of chaetoglobosin Q. In the 
case of N60 1511.4+5, 1 H and 13C NMR data including those obtained by COSY, 
HSQC and CIGAR (Table 3.6) revealed the connection from the C-10 to the C-5 
methyl and from C-7 to the macrocyclic ring beyond C-8 as well as the quaternary 
carbon at C-6 bearing hydroxyl and methyl groups. The a configurations of H-7 and 
H-12 were determined from coupling constant (J7_8 10.5 Hz) and OE interaction (H-
7 to H-12) respectively. The structure shown in Figure 3.18 was proposed for N60 
1511.4+5. This was proved to be the epimer of Q at the C-6 position. 
N60 1511.4+5 is another new compound and was named chaetoglobosin R. As far as 
we know chaetoglobosin Q (N60 1.6.7+8) and R (N60 1511.4+5) are the only 
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Figure 3 .18 Structure of chaetoglobosin R (N60 1511.4+5 ) 
1 6' 
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Table 3 .6  1H, 1 3C, HSQC, COSY and CIGAR NMR data for 60 1 5 1 1 .4+5• 
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35 .4 (CH2) I (I H , .�d, _1 4.0, I I . SL - 1- - , - . .  ····-- - - . ' . . . ..... -__ ' -
-
----1-- -- --
1 H I  Ob. 2 .52 H -3, H-4, H -3 , H-4 ,  H - 1  Oa, C-2', C-3', C-3'a, 
··· -· - --· ··· ·-- l ( I H , dd , 1 4.5 ,  I Q.l)__ _ H- 1 0�. ----l-H-2'�----- C::-3-··· ··· ----- · _!_!_ _�5 .2_�_!;� -�_Q H, d , 8 .5 )  H-5 1 H-3, H -4, H -5, H - ! Oa C-4, C-5, C-6 
1 2 25 . 1 (CH3) ---�-]_9. (3 H , s) -·-·-- . .  _ _ j_.
H-3, H -7 -····· C-5, C-6, C-7 
1 3  1 27_7 (CH) 5 .76 ( !  H ,  dd , 1 4.5
,  
f-- t-- -··- -- ... _1 0.5) _ 
H-8, H - 1 4 H- 1 4, H - I Sb C- 1 S(w) 
"'"""- ·-·-····· .. ··--···---····- ·
··- -·, .....
.
. -··-···----.. -- - -· ----'-------! 
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H I Sa: 2 .33 ( !  H ,  m) H- 1 6 _L!:1:l f __ ··-· --····-···-- --1---
1 H ! Sb: 2 .06 ( ! H , m) H- 1 4,
H - I Sa, H - 1 3 , H - 1 5a, H - 1 6(w), 1 C 1 3  I H - 1 6 H - 1 6', H - 1 7(w) I -
----
1 6 32.5 (CH ) 2 .54 ( !  H ,  br m) 
·--------····-·---····· 
; H - I Sb, H - 1 6', H - 1 4, H - ! Sa, H - 1 6', r
- ·-·· ·· 
: H - 1 7 H - 1 8' ··-· ---L ·--- ··---··-
;\
. 
H- 1 6 
. 
H- I Sa, H - ! Sb, H - 1 6 , ! C 1 5 C 1 6 C 1 7 
1 7 1 40.3 (CH ) 
1 .0 1 (3H, d, 4.5 )  H- 1 7  , - ' - ' -.. ->-H-:T6:°-
. ---H:Isb: --H-- ,-6-,-,-H-·_-,·-9,-·--'--c---, s-(-w-),-C-- 1-8-', 5 .63 ( I H , d, 1 0.0) H - I S'(w) H-22 C- 1 9 �--··-·.f-···· -····-················-··-·-·--!---------!- -"-'-----1- ------
1 8 1 32 .8 (C) ···- · -- ·······-- ···-- -····· ····-···---------1-- ---
1 8' 1 0.9 (CH3) l .35(3H,  s) - ----· - -- _ 
H - 1 7. __ _ .__ __ f:i- 1 6, r!��---- - -· ···-- -·-C_- I_?c_C_- 1 �.'.- C:- 1 9 
H- 1 9'  
1 9 8 1 .4 (CH) 5
.��� ���'. �'. ��- ·- · -- _{_!_?�_9!i) ·····-· - -- ····
H- 1
?'. .��==--- ---- ·-1-- ---
=�f iO l·:-l(C) _ ,-
3 .  95 
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·· j_!i=..!.2_ ..-... ---•--.. --... _..�· �----
=�--_-::�----1-······_·······_---_--_--_---_-·-_···-_-·-_-
� J_U2.5 (CH)__j 6 .  72 ( I H ,  d, 1 6 .5 )  1 H-22 _____ , __ H_-._2_2 -·-
22 ! 3 7.4 (CH ) 8 . 1 7 ( 1 H , d, 1 6 .5 )  H-2 1 
23 1 96.0 (C) 
···-·· .. ·····-----·-.... ----··-·-·· 
C- 1 9, C-22, C-23 
H-2 1 , H - 1 7, H- 1 9 C-20, C-23 
----·- - ·········-· ·-----·- -··--··----f--- '-- --·-
' 
1 H NM R spectra recorded at 500 MHz in CDCh, 13C NMR spectra recorded at 1 25 MHz in CDCl3. b I H chemical shi fi values 
(oppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). ' primary, secondary, tertiary and 
quaternary carbons, assigned by APT. d long range 1 H- 13C correlation from H to C observed in the CIGAR experiment. 
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3.8.5 Structural elucidation of compound N60 1 78.8 
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Compound N60 178.8 had the molecular formula C32H3803N2 by analysis of 
HRESMS (found: 499.2955 [M+H+] ,  calcd: 499.2961). The general features of its 1 H 
and 1 3C NMR spectra (Table 3.7) closely resembled those of chaetoglobosin J (Table 
3.3, Table 3.4) except for differences at C-20 (H-20) and C-19. The conjugated 
carbonyl signal at C-20 (� 201.2) in chaetoglobosin J was replaced by a methylene 
signal (� 35.4, 6J-i 2.48) and the chemical shift of C-19 in N60 178.8, due to absence 
of the conjugated ketone group, shifted to a higher field (� 76.6) than that found in 
chaetoglobosin J (� 81.5). The assignment of C-20 (H-20) was also supported by the 
appearance of a doublet of triplets for H-21 (6J-i 6.80) in the 1 H NMR spectrum, and 
correlations between H-20 (6J-i 2.48) to H-21 and H- 19 (6J-i 4.38) in the COSY 
spectrum (Table 3.7). Therefore, N60 178.8 was proposed as another reduced 
analogue of chaetoglobosin J. The structure was elucidated as shown in Figure 3. 19 
and this elucidation confirmed by a series of 2D NMR experiments (COSY, HSQC 
and CIGAR, Table 3.7). N60 178.8 was the third new compound and was named 
chaetoglobosin S. 
The stereochemistry of N60 178.8 was deduced from NOESY spectral analysis (Table 
3.7). The principal NOEs were : H-5 to H-8, H-3 to H-11, H-7 to H-12, H-8 to H-14, 
H-16 to H-18' and H-19 to H-17, H-22. These observations implied that the 
stereochemistry of N60 178 .8 was the same as that of chaetoglobosin A (N60 
1.7.4+5). 108, 1 09 
7' 
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Figure 3.19 Structure of chaetoglobosin S (N60 178.8 ) 
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Table 3.7 1 H, 13C, HSQC, COSY and CIGAR NMR data for N60-178.8a 
I I JC �c no. I u COSY I '  I 8.22 ( I H , br s) (N-H) H -2' I H-2' NOESY I 
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1 ·a 1 36�6- -cc·) - -l ..... ... _l__ _ ...... -- .. ---
._....._ __ ....• ··-·-·-······· h••-·-----··· ··""' ·---- ···- •. 
2'·-·- _!._��:��CH) .1 .. ?:??_i_l __ �� ��·?.} _ ____ _ ... _ H-L: _ ____ - ·- _ _J H- 1 ' _j __ C- 1  'a, _C-3':...C-3'a __ 3' 1 1 2.0 (C) I : 
::• : �;��) , 7 .5 1 ( I H , d, 7 .5) H-5 '  �- �  -i:., ·,=i�c-:.-5 '  1 1 9 .9 (CH)! 7. 1 2  ( I H ,  t ,  7 .5) H-4', H-6' .. r-H�4;, -1-i'�6' - - -- -rc:3;� C-=-7'(w) - -
·::� mH:t�';';)� = ::::· "·"- �l;:;:· : ,. · _ - �::� -- _ 
r----+--�-���-��! .. ...... 11 ..... ..................... .. --·--- . : -- - ······ ...................... \' ...... _ .................... ___ ., ....... --.. .... ............ ......... -........... .. ... _. -2 5.67 ( I H , br s) (N-H) H-3 I C-3(w), C-4 (w),  C-9 3 ;�:�-(·��)--1 3 .30 ( I H , m) H -2(w)�-�-4,-H - 1 0b .. . t� : �a, H - fob(w), j .... -
i--- .;�� ,� �)1: ; :�: :::/,'i\'� _ :::::;: �:�t:-� 1�=�·:i'.:'e:� -�i!\�J(�1'{;�· 
c-_ 
I�������-�� ,t��- �I - =� = I H I Oa: 3 .03 I I 1 0  35 .0 (CH2) l ( I H ,  dd, 1 4.0, 1 0 .5) �-3, H - I Ob --J H-3, H - I Ob - · j---- -........... _. _  _ 
_ -I 8 �.b�:·�� ·5 ,  I O .O) __ _ H-3 , H - 1  Oa .... _  1 H - 1 Oa _ ---+ C-2', C-3', C-3 'a, C-3 _ 1 1  1 4.6 (CH3) I I 34 (3 H ,  d, 7 .5) H-5 
I �:�2 H-4, H-5 ,  C-4, C-5 ,  C-6 
:: ! :t:Ji�::j Il : ;: :::: �)==1=::;: :::, ·=J H-7, H.-, ,  - :.=��:''. c:7 - -1 4  1 32 .3 (CH )  5 . 1 0  ( I  H ,  m) I H - 1 3 , H - 1 5b(;L__ I H-8 15 4 1 .3 (�H�)- .. H 1 5a: 2.2 1 ( I H , m) l H- I 5b - - - ·  '-._!:i-.::-1_5_b-_�--�-�--l 6-' --� -- -: .. =-=-=-....--... --.. -· _ ...... ,., .. _ __ ,..,,, "' H I  5b :  l .90 ( I H ,  m) H - 1 4, H- 1 5a H - 1 5a 1 6  32.3 (CH )  2.47 ( I H ,  br m) H- 1 6' ,  H- J 7(w) H - 1 6', H - 1 8' 
7,--����� ,(���) l �:�: ·��: : :: �:�� - -:� : �. H·�-i s;c�_) _ 
- ::::;: H . , 6 - ----- ·- -r�: ::::�.'��i7 
j g  r 13i3-(C). i ........ · :=�= 
..... _ ..... . _.... __. ... _....___ .. .... . . .......... ---· T ·-·--· -· 
1 8' .J 9 .9 (C� l .52 (3 H , d, 1 .0) H - 1 7  I H - 1 6  -i--C- 1 7, C- 1 8, C- 1 9  
·�i\·�II3L:t�:81i------��:;�:::;w) 23 1 97. 7 (C) I I ---1 ------ - ·' ' H NMR spectra recorded a t  500 MHz in CDCl3, 13C NMR spectra recorded a t  1 25 MHz in CDCii. b 1 1 -1  chemical shift values (b'ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). ' primary, secondary, tertiary and quaternary carbons, assigned by APT. d long range 1 H- 13C co1relation from 1-1 to C observed in the CIGAR experiment. 
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Biological Activity: 
The biological activities of chaetoglobosins isolated from Chaetomium globosum 
(N60) are listed in Table 3.8. 






Chaetoglobosi_n B 3447 
Chaetoglobosin D 49 1 9  
Chaetoglobosin J 2469 
Chaetoglobosin Q -
Chaetoglobosin R 2 1 90 
Chaetoglobosin S 1 575 
Prochaetoglobosin I 3988 
Prochaetoglobosin I I  3988 
P388 = Murine leukaemia 
A-549 = Human lung carcinoma 
HT-29 = Human colon carcinoma 
H- 1 1 6  = Human colon carcinoma 
PC-3 = Human prostate carcinoma 
Bs = Bacillus subtilis 
Cr = Cladosporium resinae 
Tm = Trichophyton mentagrophytes 
Cytotoxicity 
(IC so ng/mL) 
A-549 HT-29 H- 1 1 6  
5000 >5000 >5000 
>5000 >5000 5000 
>5000 5000 >5000 
>5000 >5000 >5000 
>5000 >5000 >5000 
>5000 >5000 5000 
5000 5000 2500 
BsX ( or CrX) :  X mm inhibition at a concentration of 1 5  �tg/disk. 
TmX: X mm inhibition at a concentration of 30 µg/disk. 





>5000 Bs3, Cr5 
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3.8.6 Structural elucidation of compound N60 1. 7.3 
The molecular formula of compound N60 1.7.3 was determined to be C23H29Cl07 
based on analysis of HRESMS (found 433.1429 [M-H+-H20], calcd: 433. 14 18) and 
1 3C NMR (Table 3.9). The 1 H NMR and HSQC spectra (Table 3.9) disclosed the 
presence of one primary methyl group (&-! 0.89, H-13), three secondary methyl groups 
(bi- 1 1.06, l l-CH3; bi 1 1. 12, 4 '-CH3 ; bi 1 1.39, H-6 ' ), one tertiary methyl group (&-! 1.39, 
7-CH3), one methylene group (bi1 1.41, H- 12), five methine groups (bi1 1.89, H-4 ' ;  bj 1 
2.25, H- 1 1; bi1 2.98, H-8; bi 1 3.06, H-2 ' and bi 1 4.30, H-5' ) including one oxygen­
bearing methine (� 77.2, C-5') ,  two trisubstituted olefinic protons (bi 1 6.54, H-4; bi- 1 
7.27, H- 1) and one trans-oletinic group (bi1 6.05, H-9; &- i  6.51, H-10, J=l6.0 Hz). 
The identity of the remaining groups was revealed by analysis of the 1 3C NMR (APT) 
spectra: two carbonyl carbons (� 170.8, C- 1 ' ;  � 189.5, C-6); four olefinic carbons 
(� 110.2, C-5; � 1 14.5, C-8a; � 140.7, C-4a and � 157.9, C-3) and two oxygen­
bearing quaternary carbons ( � 84.1, C-7 and � l 04.4, C-3 ' ). 
The analysis of the COSY spectrum (Table 3.9) led to the partial structural units as 
shown by bold-faced lines in Figure 3.20. 
Cl Me 
long-range correlations (H to C) 
Figure 3.20 Structure of chaetoviridin B (N60 1.7.3) 
The connection of functional groups was demonstrated on the basis of long-range 
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correlations observed in the CIGAR experiment (Table 3.9, Figure 3.20). The long­
range correlations of H-9 to C-3 and C-4 and H- 10 to C-3 led to connection of C-9 to 
C-4 (� 105.2) through C-3. The long-range correlations of H-1 to C-3, C-4a, C-8a, 
H-4 to C-8a and the chemical shifts of C-1 and C-3 (� 145.8 and 157.9, respectively) 
allow the connection of C-1 to C-3 through an oxygen and C-1 to C-4 through C-8a 
and C-4a. The long-range correlations of H-8 to C-7, C-6, C- 1, C-4a and to 7-CH3 
carbon (� 23.5) and correlations between the protons of 7-CH3 to C-6 resulted in 
connection of C-6 to C-8a through C-7 and C-8 and the assignment of 7-CH3 . 
Connection of C-4a to C-6 through C-5 was deduced by long-range correlations 
between H-4 to C-5 and the chemical shift of C-6 (� 189.5, a conjugated carbonyl 
carbon). Connection of C-2 ' (� 58.5) to C-4' (� 45.2) through C-3' (� 104.4) was 
indicated by the long-range correlations of H-2 ' ,  H-4' ,  H-5' and the protons of 4 '  -CH3 
to C-3 '. Connection of C-1'  to C-2 '  was determined by the long-range correlations 
between H-2 '  and H-8 to C-1 '. The appearance of a chlorine atom in the molecule 
was suggested by the isotope peaks in the mass spectrum. The connection of C-7 to C-
3 '  through oxygen and all the other assignments were made by analysis of chemical 
shifts and the molecular formula. Finally, the structure as shown in Figure 3.20 was 
proposed for compound N60 1.7.3. After a literature search, this compound was found 
to be identical to chaetoviridin B, previously isolated from the culture of Chaetomium 
l b  jl 
' 'd 1 13 g o  osum var. avo-vLn ae. 
Biological Activity: 
P388 activity: IC50 > 12500 ng/mL 
Antimicrobial activity: none detected 
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Table 3.9 1 H, 1 3C, HSQC, COSY and CIGAR NMR data for compound N60 1.7.3a 
no COSY 
1 45 . 8  (CH) 7.27 ( l H , s) ·--.. --------+-·------+--- - -
: -Jg::� - 6 ����) C-3, C-5, C-8a, C-9 --+---------·-·- .. ---· ---·-·---- - - -· - ---
:· I :� :�= - -=-��------ -·-- - -·-. ....... ..... --·--- ·-· - -\ 
�9.5 (C) 
,,,,,,,,,,,,,-, .. -+---·--- - -- -··-· ···---......... --.. ----·-.. -··-·--........ ........... ,----·-·-··-·-- - --·----.. -···-······-
- :- -C-��-�: �;;- 1 .39 (3H, s) F6, �-7-:-C-:; ! - -····--- --+-- - -----•· ·--
:, -�?,f���:: : :::��i .. . :'�:�� - - �::·=�
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C- 1 0, ��1 �
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3. 8. 7 Structural elucidation of compound N60 1. 7. 2A 
72 
The 1 H and 1 3C NMR spectra (Table 3.10) of compound N60 l .7.2A were similar to 
those of chaetoviridin B (N60 1.7.3, Table 3.9) except for the differences in C-8 (H-
8), C-2 ' (H-2')  and C-3'. Two methine groups at &: 50.7 (C-8) and &: 58.5 (C-2') in 
chaetoviridin B were replaced by two olefinic carbons (&: 163.1 and 125.1, 
respectively) in N60 l.7.2A. The oxygen-bearing quaternary carbon at C-3' (&: 104.4) 
in chaetoviridin B was absent and instead a conjugated carbonyl (&: 201.1) observed 
in N60 l .7.2A. These observations, along with the molecular formula (C23H25Cl06), 
were accommodated by the structure as shown in Figure 3.21. This compound was 
identical to chaetoviridin A, isolated previously together with chaetoviridin B from 
the culture of Chaetomium globosum var.flavo-viridae.
1 13 
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Figure 3.21 Structure of chaetoviridin A (N60 l .7.2A) 
Biological Activity: 
P3 8 8 activity: IC50 > 125 00 ng/mL 
Antimicrobial activity: none detected 
Chaetoviridin A has been reported to exhibit a weak inhibitory activity on monoamine 
oxidase (IC50 1.2 x 10·2 g/mL), an induction of chlamydospore-like cells ( 40-50% at 
100 µg/disc), and an inhibition of growth of Pyricuralia oryzae (2.5 µg/mL). 1 13 
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no 
Table 3.10 1 H and 1 3C NMR data for compound N60 1.7.2Aa 
no 
1 1  39 .2 (CH)  2 .28 ( I H, rn) 
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1 5 1 . 8 (CH)  [ 8 .77 ( ! H, s) ! 
3 >-1 57 .2 (C) j 
- - - -














·· ..... ·····-·------ ··················--!--






4 1 05 .6  (CH) ! 6 .54 ( ! H, s) , ! 1 2  29.4 (CH2) 1 1 .4 1  (2H, rn) _  l ____ - ,· ·········· ··············- -·· ·····"(·-····· ··----- ······--·- ·r-············· ·--······- ····-··---4a 1 39 . 8  (C) 1 3  
- -- - - - --- -- ·-+-- --- - --
5 1 09. l (C) 






_ _  --- - I _ ____ ____ [.. ____ --












��'. I - I I, :. --·- : ;:-�fc-: T� - �T I - ··-:H, f :2::; -;-;: ;�::�)7 O) 
---+-------i-· -···-- ----
1 I I 9 1 1 9.9 (CH)  6.07 ( I H, d, 1 5 . 5 )  \ 1 6' 1 3 .8 (CH3) 1 . 1 6  (3H, d, 6.0) ... . . .. ·······-·-··-········· . . ·······-- - ·----·· ··-·····-·-········· ··----········ ··1'·-1 ·········· - ·-· .. .... ········- ·-·---·--·-· ----·-·-··· ··- ..... -1 0  1 48 .3  (CH) ! 6 .59( 1 H, dd, 1 6.0, 8 .0)  I I ! 
' 1 1-1 MR spectra recorded at 500 MHz in CDC13. 13C M R spectra recorded at 1 26 M Hz in CDC'3 . 
b 'H chemical shift values (oppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
3.8.8 Structural elucidation of compound N60 1910. 1a.22-25 
Compound N60 1910.1 a.22-25 was isolated as a crystalline compound. The molecular 
formula was determined to be C28H4403 by analysis of the 
13C NMR and 1H NMR 
data (Table 3.11). Ions in the EIMS spectrum m/z 428, 410 and 396 correspond to 
[MJ\ [M-H20t and [M-02]\ respectively. The 1H NMR spectrum showed signals 
due to two tertiary methyl groups ( bi-i 0.80, H- 18; bi-1 0.87, H-19) and four secondary 
methyl groups (bi -1 0.8 1, H-26; bi-1 0.82, H-27; bi-1 0.90, H-28 and bi-i 0.99, H-2 1), which 
suggested an ergostane skeleton. 1 14 Other signals in the 1 H NMR spectrum disclosed 
an oxygenated methine proton (bi-i 3.96, H-3) and four disubstituted olefinic protons 
(bi- ,  5.13, H-22; bi-, 5.2 1, H-23; bi- , 6.24, H-6 and bi-1 6.50, H-7). The identity of the 
remaining groups was indicated by HSQC and APT spectra (Table 3.11): seven 
methylene groups (<\: 20.8, C- 15 ; <\; 23.6, C- 11 ;  <\; 28.8, C-16; <\; 30.3, C-2; <\; 34.9, 
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C-1;  � 37.1, C-4 and � 39.5, C-12); six methine groups (� 33.2, C-25; � 39.9, C-
20; � 42.9, C-24; � 51.2, C-9; � 51.8, C-14 and � 56.4, C-17) and four quaternary 
carbons (� 36.3, C-10; � 44.7, C-13; � 79.6, C-8 and � 82.3, C-5). The chemical 
shifts of C-5 and C-8 suggested the presence of a peroxy group. 1 15 
A close inspection of the 1H and 1 3C NMR spectra of N60 191 O. la.22-25 by COSY 
and HSQC experiments (Table 3.11) Jed to the assignments of partial structural units 
as shown by bold lines in Figure 3.22. These assignments were confirmed by long­
range correlations observed in the CIGAR experiment (Table 3.11). 
The assignments of the remaining groups were based mainly on the CIGAR data 
(Table 3.11, Figure 3.22). The principle correlations were as follows: H-18 to C-12, 
C-13, C-14 and C-17; H-19 to C-1, C-5 and C-9; H-4 to C-5; H-6 to C-4, C-5 and C-
8;  H-7 to C-5, C-8 and C-9 and H-15 to C-8 and C-13. 
OH 
21  










Figure 3.22 Planar structure ofN60 1910. l a.22-25 
The planar structure as depicted in Figure 3.22 was proposed for compound N60 
1910. la.22-25. The stereochemistry of N60 1910. la.22-25 was confirmed to be 
5a,8a-epidioxyergosta-6,22-dien-3�-ol ( ergosterol peroxide) (Figure 3.23) by 
comparing its spectral data (MS, 1 H NMR, 1 3C NMR) with that reported in the 
literature. 1 16-1 19 
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Figure 3 .23 Structure of ergosterol peroxide (N60 1910. 1 a.22-25) 
Biological Activity: 
P388 activity: IC50 8469 ng/mL 
Antimicrobial activity: none detected 
75 
This is the first report of the production of ergosterol peroxide by a Chaetomium sp. 
although it has been reported from a wide variety of fungi, lichens, sponges and some 
marine organisms. 1 1 8 It has been suggested to be an important intermediary in the 
biosynthesis of ergosterol. 1 17 Ergosterol peroxide is reported to have antitumour, 
antiviral, antioxidant and anticomplementary activity, and displays potent antitumour 
activity against Walker 256 carcinosarcoma and MCF-7 breast cancer cell lines. 1 1 8 In 
the antiviral test, all 4 influenza A virus strains on chick chorioallantoic membrane 
were inhibited in a concentration-dependent manner by 10-40 µg ergosterol 
peroxide/mL. 1 20 Ergosterol peroxide shows potent inhibition of lipid peroxidation and 
exhibits higher antioxidant activity than the well-known antioxidants, ax-tocopherol 
and thiourea. 1 1 6 It also shows very strong anticomplementary activity on the classical 
pathway, the IC50 values being 5.0 µM and 1.0 µM, respectively. 1 2 1  
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Table 3.11 'H,  1 3C, HSQC, COSY and CIGAR NMR data for N60-1910.1 a.22-25a 
no. COSY 
1 .94 ( I H, m) 1 .69, 1 . 52 
1 .69 ( I H, m) 1 .94 
1 8 .3, 5 1 .2 
-2l�CH,) : i�{:z: :� - r ��:t:. ���-� ==-�= 3 J 66 . 6 (CH) : 3 .96 ( I H, m) 
_ j 1 .8:!
.
_ _ 
1 __ _ _ __ _
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I 2 . 1 0  ( I H, m) I 3 .96, 1 .90 ! 82 .3 ,  66 .6, 30.3 
4 
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' 1H NMR spectra recorded al 500 MHz in CDCJ3. !JC NMR spectra recorded at 1 26 MHz in CDC!i . b 1H chemical shift values 
(8ppm from SiMe.) followed by number of protons, multiplicity and coupling constant (J/Hz). ' pimary, secondary, tertiary 
and quaternary carbons, assigned by APT. d long range 1H- 1 3C correlation from H lo C observed in the CIGAR experiment. 
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3.9 D iscussion 
Bioassay- and 1 H NMR-guided fractionation of the EtOAc extract of Chaetomium 
globosum (N60) by C 1 8 column chromatography, followed by normal phase 
chromatography (Diol column), afforded twelve compounds. These compounds 
belong to three structural classes: cytochalasins, azaphilones and steroids. On the 
basis of the molecular formulae determined by high resolution MS and the 1 H and 1 3C 
NMR data, it was determined that nine of the compounds had been previously 
characterised and were: chaetoglobosins A, B, D, J, prochaetoglobosins I and II, 
chaetoviridins A and B, and ergosterol peroxide. Prochaetoglobosins I and II were 
produced previously by treatment of Chaetomium subaffine with specific cytochrome 
P-450 inhibitors by Oikawa 1 1 0 and hence this is the first report of naturally occurring 
prochaetoglobosins I and II. Ergosterol peroxide has been isolated from several fungi 
previously but has not been recorded from Chaetomium spp. Three new members of 
the chaetoglobosin family were isolated and were named chaetoglobosins Q, R and S. 
In the assay against the P388 murine leukaemia cell line, most of the chaetoglobosins 
exhibited significant activity (IC50 1 943-3988 ng/mL). Most also showed antibacterial 
or antifungal activities. 
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Chapter 4 
PHOMA SP. (K31 ) 
4. 1 I ntroduction 
Phoma is a large and variable genus with more than 2000 species described. 1 22 The 
genus is characterised by the production of black subsurface pycnidia which extrude 
small ,  single-celled conidia in slime. Some species are plant pathogens, for example, 
Phoma exigua var populi var. nov. causes necrotic lesions on poplars, 1 23 Phoma 
gentianae-sino-ornatae sp. nov. causes root rot in Gentiana sino-ornata plants. 1 24 
Although Phoma is a large genus, the literature on the bioactive metabolites isolated 
from this genus is relatively smal l and only 98 compounds have been recorded on 
Antibase.75 Several important metabolites produced by Phoma species will be 
discussed in this chapter. 
Phomactins 
Phomactins are diterpenes first isolated by Sugano and co-workers in their screening 
for platelet activating factor (PAF) antagonists from marine fungi. 1 25 P AF causes 
platelet aggregation, chemotaxis and degranulation of polymorphonuclear leukocytes, 
smooth muscle contraction, vascular permeability and hypotension. P AF may be 
involved in many inflammatory, respiratory, and cardiovascular diseases. So far nine 
phomactins (phomactins A, B, B 1 , B2 , C-G) have been isolated from a culture broth of 
a marine Phoma sp. (SANK 11486) and most antagonise PAF action. 1 26• 1 27 Phomactin 
D (Figure 4.1) is the most potent P AF antagonist of the phomactin family and inhibits 
the binding of P AF to its receptors and P AF-induced platelet aggregation with IC50 
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values of 2. 8 x 10·7 M and 8.0 x 10·7 M respectively. 126 Phomactin B (Figure 4.1) is 
thought to have potential for treatment of asthma, peptic ulcers, renal disorders and 
1 · 128 1ypertens1on. 
Putaminoxins 
Phomactin B Phomactin D 
Figure 4.1 Structures of phomactins B and D 
Putaminoxins are metabolites produced by the fungus Phoma putaminum, the 
pathogen of leaf necrosis of Erigeron annuus, a common weed of field and pasture. 
When assayed on leaves of host and non-host plants, putaminoxin and putaminoxin C 
(Figure 4.2) showed toxic effects 1 29  while putaminoxin B (Figure 4.2), D and E 
showed no phytotoxicity. 1 30• 1 3 1  Considering the semiselective phytotoxic activity 
against the host plant, putaminoxin and putaminoxin C could be used as herbicides or 
as analogues for the development of selective and safe herbicides. 
R 
Putaminoxin C H2CH2CH3 
R 
Putarninoxin B CH2CH2CH2CH2CH3 
0 
Putarninoxin C 
Figure 4.2 Structures of putan1inoxins 
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Cytochalasins 
Several cytochalasins have been isolated from the filtrate of Phoma exigua var. 
heteromorpha, the fungal causal agent of a foliar disease of Oleander (Nerium 
oleander L.). Besides known cytochalasins such as cytochalasins A, B, F, 
deoxaphomin and ascochalasin, four new cytochalasins, cytochalasins T, 1 32 U, V 1 33 
and W 1 34 have also been isolated from this fungus. Cytochalasins U and V (Figure 
4.3) represent the first natural occurrence of a 25, 26-dioxa (16] and 25-oxa ( 1 5] 
cytochalasan, respectively. Most of the cytochalasins isolated from P. exigua var. 
heteromorpha showed toxic activity against the larvae of the brine shrimp (Artemia 
salina). 







I 1 7 





Figure 4.3 Structures of cytochalasins U and V 
1 8  
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4.2 Cu lturing and Isolation of Metabol ites 
4.2. 1 Culturing and extraction 
Isolate K3 l belonging to the genus Pho ma (Figure 4.4) was collected from a 
driftwood sample in Vancouver, British Colombia (BC), Canada. 
Figure 4.4 Colonies of Phoma sp. ( K3 1 )  on PDA (6 days) (a) top; (b) reverse 
K3 l was cultured on PDA Petri dishes for eight days at 25 °C. The mycelial discs 
were then cut from the growing margin of the colony and inoculated into 1h PDB. 
Two batches of the broth were cultured at 26 °C in static conditions. A 'big broth' I 
was cultured for four weeks and the 'big broth' II was cultured for eleven weeks. 
Each culture was filtered under suction and the mycelium and filtrate were each 
extracted separately with EtOAc. EtOAc extracts were evaporated under reduced 
pressure and then assayed for activity against the P388 cell line. Among the four 
extracts assayed, only the filtrate extract from 'big broth' I showed moderate activity 
(Table 4. 1 ). Since no P388 activity was detected from the extract of 'big broth' II, it 
was assumed that any active compounds might have decomposed or been metabolised 
or converted into inactive compounds during the long period of culture. The active 
extract from 'big broth' I was selected for further purification. 
Yield 
Table 4. 1 Yield and activity of extracts from Phoma sp. ( K3 1 )  
'Big Broth' I (6 L, 4 weeks) 'Big Broth' II (2 L, 1 1  weeks) 
Fil trate Extract Mycelial Extract Filtrate Extract Mycelial Extract 
867.8 mg 1 632.5 mg 392 .5 mg 467 .7  mg 
P388 act iv i ty ( JC50 ) 6248 ng/mL 45 1 4 1  ng/mL > 62500 ng/mL 22499 ng/mL 
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4.2.2 Chromatography of Phoma sp. (K31) 
An outline of the isolation is given in Scheme 4 . 1 . 
Scheme 4. 1 
Filtrate extract of big broth I (867 .8 mg, IC50 6248 ng/mL) 
C 1 8 column (50 g) 
K3 l -x 1 
Yield(mg) ( 1 67.9) 
2 
(256.3 )  
[8688] 
3 
(242 .5)  
[ 1 1 377] 
4 
(89.8) 
[> 1 2500] 
5 
(33 .8) 
[> 1 2500] [ 1 2447] 
LH-20 ( 1 2  g) 
MeOH MeOH MeOH MeOH MeOH 
K3 J -2-x 1 2 3 4 5 
Yield (mg) (2 .3 )  (0.2) (I 09.0) (29.9) (0 .7) 
[>25000] [>25000] [ 1 853 1 ]  [ 1 7984] [>25000] 
K3 l -2-(3+4)-x 
Y ield (mg) 
MeOH 
1 
(2 .8 )  
[>25000] 
a-2 
LH-20 ( 1 2  g) 





3 4 (K3 l -a) 5 
(64 .9) (97 .9) (6.7) 
[>25000] [ 1 8224] [>25000] 
Diol column ( 1 5  g) 
hexane :EtOAc ( 1 :2 )  1 00% EtOAc 
a-4 a-5 �a-�6=.a�-7-�a-�8�to�a-�1-1 (K3 1 -a-6 to a-1 1 )  K3 1 -x 
Yield (mg) ( 1 5 . 1 )  (22.8) (9 .2) (3 .7) (5 .2)  [>25000] 
Fraction 
Y ield(mg) 
K3 l -a-4-l 
( 1 . 1 )  
[ ] :  P388 activity ( IC50 = ng/mL) 
Preparative HPLC 
5% ACN/water ( isocratic) 
K31 -a-4-2 
( 1 .3 )  
[3660] 
K3 l -a-4-mixture 
(3 .5 )  
82  
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The filtrate extract (867.8 mg) from the big broth I of Phoma sp. (K31) was separated 
on a C 1 8  column, eluted with a stepped gradient from 10% MeOH/H20 to MeOH and 
then to DCM. Fourteen fractions were collected and combination was based mainly 
on TLC. Both mass and P388 activity were concentrated in the first three fractions 
(Scheme 4.1), suggesting the active compounds were polar. Among the three active 
fractions, fraction K3 l-2 showed moderate activity (IC50 8688 ng/mL) while fractions 
K31-l and K31-3 showed very weak activity (IC50 > 10, OOO ng/mL). 
Fraction K31-2 (256.3 mg) was applied to a LH-20 column (12 g) and washed with 
straight MeOH. Fourteen fractions were collected. Bioassay analysis of all eluted 
fractions only recovered very weak activity in  the fractions K3 l -2-3 and K3 l -2-4 
(Scheme 4.1 ). The possible reasons for the activity decreasing after purification is the 
decomposition of active compounds during chromatography or the active compounds 
being retained on the columns. 
Fractions K31-2-3 (109.0 mg) and K31-2-4 (29.9 mg) were combined based on the 
H PLC profiles and puri fied on another LH-20 column. The column was eluted 
isocratically with MeOH and seven fractions collected. Weak activity (IC50 18224 
ng/mL) was obtained in the fraction K31-2-(3+4)-4 (renamed as K31-a). 
The fraction K3 l -a (97.9 mg) was subjected to further purification using normal phase 
(Diol, 15 g) chromatography. The column was eluted with a stepped gradient from 
hexane/EtOAc (1 :2) to l 00% EtOAc and then to EtOAc/MeOH ( l :  l ). Sixteen 
fractions were collected and combined after analysis by TLC. After checking with 
HPLC profiles and 1 H NMR spectra, it was found that K31-a-6 to a-11 (5.2 mg) was a 
pure compound, K31-a-4 was a mixture containing a major compow1d closely related 
to K31-a-6 to a-11, K31-a-5 was a mixture of K31-a-4 and K31-a-6 to a-11, K31-a-2 
and K31-a-3 were complex mixtures with the major compound being the same to that 
of K31-a-4, while K31-a-12 to a-16 showed no signals of interest in the 1H NMR 
experiment. 
The further puri fication of K3 l-a-4 (9.2 mg) was carried out by preparative HPLC 
(C 1 8  column, reverse phase), eluted with 5% ACN/H20 isocratically. The expected 
pure compound was obtained in fraction K3 l-a-4-2 (1.3 mg). 
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4.3 Structu ral E lucidation of K31 -a-6 to a-1 1 
K3 1 -a-6 to a- 1 1  was obtained as colourless crystals. The ESMS showed a molecular 
weight of 1 54 Daltons [measured 1 53.00 (M-H+)], indicating a simple structure. The 
1H NMR spectrum (Table 4.2) showed only three aromatic protons. The proton at � 1 
6.8 1  (d, J =  9.0 Hz) was in the ortho position with the proton at 5i-i 7.06 (dd, J =  9.0, 
3.5 Hz). The later was in the meta position with the third proton at bi -1 7.33 (d, J = 3.5 
Hz). The APT spectrum (Table 4.2) indicated three tertiary and four quaternary 
carbons among which six carbons were aromatic. The chemical shifts suggested that 
the quaternary aromatic carbons at (\: 1 49.6 and (\: 155.7 were oxygen-bearing 
carbons while the quaternary carbon at (\: 1 7 1 .8 was a carbonyl. Considering the 
molecular weight of 1 54 Daltons, the molecular formula C7H604 and the structures as 
shown in Figure 4.5 were suggested for compound K3 1-a-6 to a- 1 1 .  
I 
7 7 7 






4 OH HO 4 4 
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Figure 4.5 The suggested structures for K3 1 -a-6 to a- 1 1  
OH 
To decide the positions of three substituent groups, the chemical shifts of 1 H and 1 3  C 
NMR of the three suggested structures were estimated by Chem NMR from the H- 1 
Estimation (in spectra ChemDraw) and ACD/CNMR Predictor. Among the three 
structures, the estimated chemical shifts of structure (b) were the closest to those of 
K3 1 -a-6 to a- 1 1 . Therefore, compound K3 1 -a-6 to a- 1 1  was proposed as 2,5-
dihydroxybenzoic acid. To further confirm this proposal, 1 H and 1 3  C NMR spectra of 
authentic 2,5-dihydroxybenzoic acid was obtained. Again, both spectra were identical 
to those of K3 1-a-6 to a- 1 1  (Table 4.2). 
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Table 4.2 1H and 13C NMR data for K3 l -a-6 to a-11 a 
K 3 1 -a-6 to a-1 1 2, 5-dihydroxybenzoic acid 
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_ _  J___ ··--· . : 1 55�8 (C) . _1-- •• . -. _  -_- --3. ·t 1 1 4.9 (CH) I �s-1 ( I H, d, 9.0) ! _1_1 4_.9 (_cH_) · ·· l - -6._82 ( I H, d, 9.o� 
� - �H_,_d-�, �:��3-.5-) _ ��3-(c_H_) _I 7��� .. _c i_H_, _dd�- �-·o, 3 . 5) 5 ! 1 49.6 (C) 1 49 .7 (C) 
... ··········-.. ··-"·-· -·· ......... ·-----"·- - ·-··········-·- -······ 6 -+-rn· l (CH·)- ------ -�-:33 ( l �,--�·-'-3_.5) __ , _ _,__ 1 1 8 . 1 (CH)_,___. __ 1_.3_4_(_I H , d, 3 .5 ) 1 7 1 . 8 (C) 1 7 1 .8 (C) 
' 1 1- 1 NMR spectra recorded at 500 M l  lz in acetone-d6, 1 3C NMR spectra recorded at 1 25 M Hz in acetone-d6. 
b 
1 1-1 chemical shift values (oppm from SiMe,) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
Biological Activity: 
P388 activity: IC5o >25000 ng/mL 
Antimicrobial activity: 2 mm zone of inhibition against Bacillus subtilis at a 
concentration of 80 µg/disk. 
Antiviral activity: none detected 
Gentisic acid (2,5-dihydroxybenzoic acid) is found in numerous families and genera 
of green plants 1 35 and has also been isolated from some species of fungi such as 
Penicillium patulum. 1 36 Just like many other phenolic acids, gentisic acid also shows 
antioxidative activity. 13 7• 1 3 8 
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4.4 Structural  E lucidation of K31 -a-4-2 
K31-a-4-2 was obtained as colourless crystals. The 1H and 13C NMR spectra of K31-
a-4-2 (Table 4.3) were similar to those of K31-a-6 to a-11 (Table 4.2) except for the 
carbonyl carbon at &:: 171.8 in K3 1-a-6 to a- 11 being replaced by an oxygen-bearing 
methylene group (Oc 60.9, � 1 4.65) in K31-a-4-2. The APT spectrum (Table 4.3) of 
K31-a-4-2 showed one secondary carbon ( &:: 60.9), three tertiary carbons ( &:  1 14.1, 
1 14.3 and 1 15.7), one quaternary carbon (Oc 128.5) and two oxygen-bearing 
quaternary carbons (Oc 148.1, 150.4). In the 1H NMR spectrum, three aromatic 
protons and two methylene protons were observed. The aromatic proton at bi-1 6.55 
(dd, J = 8.0, 2.5 Hz) was located ortho to the proton at bi-1 6.33 (d, J = 8.0 Hz) and 
meta to the proton at � 1 6.76 (d, J = 2.5 Hz). The chemical shifts of the methylene 
group (Oc 60.9, bi -1  4.65) suggested that this is a hydroxymethyl group attached to an 
aromatic ring. Thus, structures as shown in Figure 4.6 were proposed for K31-a-4-2. 
7 7 
CH20H CH20H CH20H 
I OH OH 




� 3 5 5 5 
OH HO 4 
OH OH 
(a) (b) (c) 
Figure 4.6 The suggested structures for K31-a-4-2 
To detem1ine the positions of three substituent groups, HSQC and CIGAR 
experiments were carried out. The long-range correlations (Table 4.3, Figure 4.7) of 
H-7 (bi- ,  4.65) to C-1 (Oc 128.5), C-2 (Oc 148.1) and C-6 (Oc 1 14.3) led to the 
assignments of C- 1, C-2 and C-6, while the long-range correlations of H-3 ( �1 6.63) 
to C-5 (Oc 150.4) and H-4 (bi-1 6.55) to C-6 (Oc 114.3) led to the assignments of C-3, C-
4 and C-5. Thus, the structure as shown in Figure 4. 7 was decided for K31-a-4-2. 





Figure 4. 7 Structure for K3 1-a-4-2 
Table 4.3 1 H, 1 3C, HSQC and CIGAR NMR data for K31-a-4-2a 
No. I 1 3c o < I 
1 28 .5  (C) 
.... ... ,, .. ____  -+- --- -------+- -------···-·· .. ·-
2 148 . 1 (C) 
3 i 1 1 5 . 7  (CH) ; 6.63 ( I H, d, 8.0) 1 28 .5 ,  1 48 . 1 ,  1 50.4 
6 1 1 4 .3 (CH) 1 6.76 ( 1 H, d, 2 . 5 )  60.9, 1 1 4 . 1 ,  148 . 1 ----· ........  ...............  _________         -   
60.9 (CH2) I 4 .65 (2H, s) 7 1 1 4 .3 ,  1 28 .5 ,  148 . 1 
'
1 1- 1  NMR spectra recorded at 500 MHz in acetone-d6, "C NMR spectra recorded at 1 25 M Hz in acetone-d6. 
b ' H  chemical shift values (b"ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). ' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
d long range 1 1- 1- 13C correlation from H to C observed in the C IGAR experiment. 
Biological Activity: 
P388 activity: IC50 = 3660 ng/mL 
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Antimicrobial activity: 3 mm zone of inhibition against Bacillus subtilis at a 
concentration of 40 µg/disk. 
Antiviral activity: CYT 4+, TYP 7 for Herpes simplex virus, CYT 4+, TYP 7 for 
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Polio virus at a concentration of 30 µg/disk. 
Gentisyl alcohol has been isolated from several species of Phoma and 
Penicillium. 139• 1 40 It is reported that gentisyl alcohol, isolated from the culture broth of 
Penicillium vulpinum, exhibited relatively strong cytotoxic activity (IC50 10 µg/mL) 
against leukaemia cells (L 1210) in tissue culture. 1 4 1 Gentisyl alcohol has also been 
isolated from Penicillium commune and shown to be a potent antioxidant and 
synergist for tocopherol. 1 42 
4.5 D iscussion 
Two simple compounds were isolated from the filtrate of a marine Phoma sp. (K31) 
through bioassay-guided separation. The compounds were determined as 2,5-
dihydroxybenzoic acid (gentisic acid) and 2,5-dihydroxybenzyl alcohol (gentisyl 
alcohol) based mainly on 1H, 13C NMR and mass spectra. Although the crude extract 
of Phoma sp. (K3 l) showed moderate activity (IC50 6248 ng/mL) against the P388 
murine leukaemia cell line, this activity was reduced rapidly during chromatography. 
This was assumed to be due to the active compound(s) being retained on the columns 
or that the active compound(s) decomposed during chromatography. There was also a 
possibility that the initial activity was a synergistic action with the less active 
compounds. 
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Chapter 5 
FUSARIUM SP. (A1 45) 
5.1  I ntroduction 
5. 1. 1 General 
Fusarium species are widely distributed in soils and are known to react very readily to 
the substrate in which they are growing. 1 43 This is due to their genetic make up and 
morphological responses to changes in their environment. Since Fusarium strains 
degenerate very rapidly when cultured on rich media, they should be isolated on poor 
media and identified as soon as possible after primary isolation. 
The most definitive character of this genus is the presence of fusoid macroconidia 
with a foot cell bearing some kind of heel. This foot cell separates it from 
Cylindrocarpon, the most closely related genus. Some species of Fusarium also 
produce microconidia and tem1inal or intercalary chlamydospores. 143 
Fusarium species are among the most important plant pathogens, causmg a wide 
range of diseases such as seedling blights, root, stem and ear rots and head blights. 
They are also responsible for storage rots on tubers and kernels. These diseases can 
cause not only a serious reduction in grain yield, but also an accumulation of toxic 
metabolites in plant tissues which contaminate human and animal food. 1 07 
5. 1 .2 Bioactive metabolites from Fusarium species 
There is an extensive literature on Fusarium metabolites, with mycotoxins being the 
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most important ones reported. This chapter will consider specific groups of 
metabolites isolated from Fusarium spp. based on chemical structures and biologic_al 
activity. 
Trichothecenes 
The trichothecenes are a group of mycotoxins which are mainly produced by some 
species of Fusarium. They are chemically the most diverse of all the mycotoxins, with 
more than 50 trichothecenes having been isolated from this genus. 1 07 T-2 toxin, HT-2 
toxin, nivalenol, diacetoxyscirpenol (DAS) and deoxynivalenol (DON) (Figure 5.1) 
are the most common compounds of this group. Trichothecenes are classified as 
sesquiterpenoid derivatives containing a trichothecane ring system with a double bond 
between C-9, 10 and an epoxy group at C- 12, 13 (Figure 5.1). The research on 
structure-function relationship revealed that a 12- 13 epoxide group plays an essential 
role in the high toxicity of trichothecenes. 1 44• 1 45 When the epoxide group is modified 
the toxicity of the compound is lost. 




R , Nivalenol OH DON OH 
O H 
H 
1 �'- · · R 
1 3 ,0 
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4 • · H 
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H H 
3 - - R1 
4 - - H  
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Figure 5.1 Structures of some trichothecenes 
Trichothecenes have been implicated in human mycotoxicoses such as Alimentary 
Toxic Aleukia (AT A) in Russia. 1 46 The occurrence of trichothecenes in foods and 
feeds is often associated with intoxications in humans and animals and is responsible 
for gastrointestinal disorders, 1 47 skin inflammation, 1 48 blood disorders, destruction of 
bone marrow and nerve disorders. 1 49 
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The correlation between trichothecene production and Fusarium pathogenicity in 
cereals has Jong been suggested. 1 50 Some trichothecenes have proved to be a major 
component for fusariosis of wheat heads. 1 5 1 
Although known as mycotoxins, trichothecenes also exhibit other activities such as 
high antimalarial activity 1 52 and antitumour properties. 1 53 
Zearalenones 
Several species of Fusarium are capable of producing zearalenones. 1 54• 1 55 Zearalenone 
(Figure 5.2) and its derivatives are oestrogen mimetics and consist of a resorcinol 
moiety fused to a 14-mernber rnacrocyclic lactone. The natural occurrence of 
zearalenone has been detected in a number of feeds and grains. As a result 
zearalenones have been implicated in numerous incidences of reproductive disorder 
(e.g. hyperoestrogenism; vulvovaginitis; infertil ity; reduced litter size and weak 
offspring) particularly in swine, and to a lesser extent, in poultry and laboratory rats 
and mice. 1 56• 1 57 
Fu monisins 
OH 0 Me 
0 
HO 
Figure 5.2 Structure of zearalenone 
0 
Fumonisins are another important class of rnycotoxins produced by Fusarium 
moniliforme and other Fusarium species grown on cereal and cereal-based food 
products. 1 58• 1 59 They are sphingosine analogues characterized by a 19- or 20-carbon 
aminopolyhydroxyalkyl chain which is diesterified with propane-1,2,3-tricarboxylic 
acid. Fumonisins are further classified as A-, B-, C-, and P-series, with fumonisins B 1 , 
B2 and B3 being the major ones produced in nature (Figure 5.3).
1 60- 1 62 
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Figure 5.3 Structures of fumonisins (B-series) 
92 
Me 
Fumonisins have been pointed to as a natural cause of leukoencephalomalacia m 
horses 1 63 and pulmonary edema in pigs. 1 64 Evidence also suggests that consumption of 
fumonisin-contaminated corn contributes to human oesophageal cancer in Southern 
Africa and China 165· 1 66 and is a risk factor for promotion of human primary liver 
cancer. 1 67 
Fumonisin B 1 (FB 1), the most important compound of the group, has been reported to 
be a hepatotoxic and hepatocarcinogenic agent in rats. 1 68 FB 1 has also been shown to 
inhibit sphingolipid biosynthesis, which has been co1Telated with both animal toxicity 
d · · · 1 69 1 70 an carcmogemc1ty. · 
Pigments : 
More than 30 pigments have been isolated from Fusarium species. They are 
naphazarin derivatives such as aurofusarin (yellow prisms) from F. culmorum, 1 7 1 
bostrycoidin (red plates) from F. solani, 1 72 bikaverin (red crystals) from F. 
oxysporum, 1 73 fusarubin (red prisms) and marticin (dark red needles) from F. martii 
var. piso., F. solani, F. solani var. minus and F. javanicum 1 74 and solanilo (dark red 
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needles) from F. solani. 1 75 Many of the pigments isolated from Fusarium species are 























Figure 5 .4 Structures of pigments isolated from Fusarium species 
5.2 Cu ltu ri ng and Isolation 
5.2. 1 Culturing and extraction 
Me 
Me 
A fungal strain CANU A l45, isolated from saline lake sand in western Australia, was 
identified as belonging to the genus Fusarium (Figure 5.5). The isolate was grown on 
freshly prepared PDA Petri dishes for 7 days at 25 °C. Then mycelial disks (8 mm in 
diameter) were cut from the agar and transferred into 4 litres of half-strength potato 
dextrose broth. The broth was incubated for 5 weeks at 26 °C under agitating 
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conditions. The culture was filtered under suction and the mycelium and filtrate 
extracted separately with EtOAc. The EtOAc extracts were then evaporated under 
reduced pressure to give 243.6 mg of filtrate extract and 674.8 mg of mycelial extract. 
On the P388 assay, the filtrate extract showed significant activity ( ]C50 < 975 ng/mL) 
while the mycelial extract exhibited very weak activity (IC50 23167 ng/rnL). The 
filtrate extract was therefore selected for further purification. 
Figure 5.5 Colony of Fusarium sp. (A145) on PDA (7 days, 25 °C) 
(a) top; (b) reverse 
5.2.2 Isolation of active metabolites 
An outline of the isolation of bioactive compounds from Fusarium sp. (A l45) 1s 
illustrated in Scheme 5. 1 .  
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Scheme 5.1 Isolation of Active Compounds from Fusarium sp. (A145) 
Broth (4 L) [ 1 /2 PDB, 26 °C, shake, 5 weeks] 
Filtrate extract (243 . 6  mg) 
[ <975 ] 
Extract with EtOAc 
Mycelial extract (674 .8 mg) 
[ 23 1 67 ] 
I C 1 8  column (50 g) 
70% MeOH/H20 80% MeOH/H20 90% Me01 -UH20 20% DCM/MeOH 1 00% DCM 
WJ3.25 .x  5 
Yield(mg) ( 1 2 .8) 
[ >1 2500 ] 
6 
(78.2) 
[ > 1 2500 ] 
Diol column (20 g) 
WJ3 .3 J .  l (0.9 mg) 
( compound 5.3, bassiatin) 
[ ] : P388 activity (IC50 = ng/mL) 
8 
(87.2) 
[ 4 1 26 ] 
WJ3 .25 .8 
( compound 5.2) 
beauvericin 
1 1  
(30.2) 
[ 1 83 ] 
1 2  
(30.6) 
[ 232 ] 
Diol colunm ( 1 6  g) 
WB.28 . 1 3-32 (20.4 mg) 1 Wash w;th hexwes 
Residues 1 Crystalhse with CHCJ, 
red needles (7 .5  mg) 
(compound 5. 1 ,  bikaverin) 
[ 304 ] 
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The filtrate extract (243.6 mg) was applied to a C 18 (reverse-phase) column, eluted 
with a stepped gradient from 10% MeOH/H20 to MeOH and then CH2Ch. Fourteen 
fractions were collected. Fractions WJ3.25.7 to WJ3.25.12 were active in the assay 
against the P388 cell line. By checking with HPLC traces (ACN/H20 gradient, C1 s  
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column, standard conditions) and 1H NMR spectra of the active fractions, fraction 
WJ3.25.8 (eluted with 90% MeOH/H20) afforded a pure compound (87.2 mg, 
compound 5.2). WJ3.25.1 l and 12 (eluted with 20% DCM/MeOH and 100% DCM 
respectively) were combined for further purification. WJ3.25.9 and 10 were found to 
be a mixture of WJ3.25.8 and WJ3.25.11+12, and no further work was required for 
these two fractions. WJ3.25.7 was a mixture containing more than 90% of WJ3.25.8. 
Since there was only 6.6 mg of this fraction, no further purification was carried out. 
Fraction WJ3.25. l 1+ 12 (60.8 mg) was chromatographed on a Diol column (nonnal 
phase, 16 g) using a gradient solvent system from hexanes to DCM then to MeOH as 
eluents. Thirty seven subfractions were collected. Subfractions WJ3.28.13 to 32, 
eluted with 70% - 90% DCM/hexanes, 100% DCM and 50% MeOH/DCM, contained 
compound 5.1. Because of its poor solubility, compound 5. 1 was always mixed with 
fatty acid in the subfractions collected. Subfractions WJ3.28.13 to 32 were combined 
and dried, and then washed three times with hexanes to remove the fatty acid. The 
residue was crystallised with chloroform to give red needles (7.5 mg). 
Although fraction WJ3.25.5 was inactive in the P388 assay, its 1H NMR spectrum 
indicated that it might contain a metabolite closely related to compound 5.2. 
Therefore, this fraction was purified through a Diol column, eluted with a gradient 
solvent system consisting of hexanes - DCM - MeOH. Twenty one subfractions were 
collected. Subfraction WJ3.31.1, eluted with 100% hexanes to 60% DCM/hexanes, 
afforded pure compound 5.3 (0.9 mg). 
5.3 Structural E lucidation of Compound 5 . 1  (B ikaveri n) 
Compound 5.1 was obtained as red needles. The HREIMS showed a peak at 
382.06961 (M+) indicating the formula C20H 1 408 (calcd: 382.06887, M
+). The 1 H 
NMR spectrum (Table 5.1) showed signals of two methoxy groups (� 3.93, 3.96), 
one methyl group ( �1 2.86), and three aromatic-type protons (OJ -1 6.35, 6.80, 6.93). 
Assignment of peaks was complicated by the absence of hydrogen, and by the poor 
solubility of compound 5.1 in most solvents. No 1 3C NMR spectrum was achieved 
and very little information could be obtained from the CIGAR spectrum (Table 5.1) 
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due to its low solubility in the ordinary solvents for NMR spectroscopy. 
From its physical characteristics (Table 5.2), 1H NMR spectrum and molecular 
fommla, a partial structure with an aromatic ring and a quinonoid was proposed for 
compound 5. 1 .  After a literature search for pigments isolated from Fusarium species, 
one compound, bikaverin, seemed promising. Comparison of 1H NMR (Table 5. 1) 
and mass spectrum with those of the literature proved that compound 5.1 was 
identical with bikaverin (Figure 5.6), previously confirmed by a series of chemical 
reactions and single-crystal X-ray diffraction. 1 73• 1 77• 1 78 
Me 0 OH 0 
2 � ' 9 
I 8 
3 �4 4a Meo 0 OMe 
OH 0 
Figure 5.6 Structure of bikaverin 
Table 5. 1 1H, 1 3C, HSQC, COSY and CIGAR NMR data for compound 5.1 a 
1 3C O c  I 
! 
COSY I no. 
I 1--- •-u---1--- ,. .. """""'"" H••---·-·••• •••••••- ································ii ······ ·-··-·---, - - -· ····----····· ····--
1 - Me 23 .5  2 .86 (3H, s )  6 .80 (w) 1 44 .3, 1 1 7 . 5  2.86 I ....... ___  .. -- -----+----------+-------+-----........... ,_ --·-·-·-·-··········-- --· 
__ 
2 
___ '. '. �:� _ _ l �:�����'. �· � :o�- -- 2 .86 (w), 6.93 6.77 
3-0Me 57 .0 3 .96 (3H, s )  1 59.0 3 .95 







- ·········-- ------ ·--- •- -- ---·-·-···-
4 90.9 6.93 ( I H, d, 1 .5 )  6.80 6.92 
8-0Me 56.0 3 .93 (3H, s) 1 64.5  3 .93 
9 I 1 1 2 .5  6 .35 ( I H, s )  
6 .35 
• 
1 H NMR spectra recorded a t  500 MHz in CDCli, 'JC NMR spectra recorded a t  1 25 MHz in  CDCli. 
b 1 1-1 chemical shift values (8ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz) ' 'JC chemical shift values were measured by HSQC and CIGAR spectra. d long range 1 1-1-DC correlation from H to C observed in the CIGAR experiment. 
'
1 1- 1  chemical shifts on the literature report (in CDC'3) 1 77 . 
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Table 5.2 UV, IR and MS data for compound 5. 1 
UV (CHCl3) :  Ainax (CHCl3) run (log E) 254 (4. 1 8), 278 (4. 1 7) and 520 (3 .70) 
IR (KBr) :  V111ax 1 672, 1 654, 1 6 1 6, 1 5 9 1  and 1 569 cm·
1 
98 
MS :  mle 382 (M\ C20H 1408), 367 (M
+ - CH3 , C 1 9H 1 10s), 353 (M
+ - CHO, C 1 9H 1 301), 339 (367 - CO, 
C 1sH 1 101), 3 1 1 (339 - CO, C 1 1H 1 106) 
Biological Activity: 
P388 activity: IC50 = 304 ng/mL 
Antimicrobial activity: 2 mm zone of inhibition against Trichophyton 
mentagrophtes at a concentration of 60 µg/disk. 
Antiviral activity: none detected 
Bikaverin is a red pigment produced by many fungal isolates and commonly occurs in 
Fusarium species. 179 It has been shown that bikaverin is identical with 'lycopersin' 
fr F . I . . 1 73 1 30 18 1 d . th , . , fr M . . .  182 om usarzum ycoperszcz ' ' an w1 mycogomn om ycogone ;aapzz. 
Bikaverin has antitumour activity inhibiting Erlich ascites carcinoma, leukaemia 
L5178, and sarcoma 37 with ED50 values of 0.5, 1.4 and 4.2 µg/mL, respectively. 1 83 
Bikaverin also shows marked and specific antiprotozoal activity. It causes cessation of 
extension growth and induces vacuolation and other morphological symptoms of 
ageing when applied to a variety of fungi. 1 73 · 1 84 Bikaverin has also been found to 
inhibit mitochondrial functions in isolated rat liver and to be an efficient haemolytic 
agent. 1 ss 
5.4 Structural E lucidation of WJ3.31 . 1  (Bassiati n)  
WJ3.31. 1 was obtained as colourless powder. The HREIMS showed molecular weight 
at 261.13685 (M+), indicating a molecular fonnula C 1 5H 1 9N03 (calculated mass : 
261.13649, M+). The 1H NMR, APT and HSQC spectra of WJ3.31. l (Table 5.3) 
indicated the presence of two aliphatic methyl groups ( � 0.76 and 0.85), one N­
methyl group (� 32.6, bi-1 3.02), one methylene group (bi-1 3.20 and 3.28), three 
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methine groups (OJ- 1 2.30, 2.99 and 4.40), one aromatic quaternary (&:: 134.3) and two 
carbonyl carbon atoms (&:: 165.7 and 167.5). The IR absorptions at 1745 and 1670 
cm- 1 indicated that these two carbonyl carbons were an ester carbonyl and an amide 
carbonyl respectively. Although fifteen carbons were suggested by HREIMS, only 
thirteen carbons could be observed from APT and CIGAR spectra. This indicated 
there were two carbons with identical chemical shi fts with others. These two carbons 
should be aromatic carbons because five aromatic protons (bi; 7.13 - 7.33) were 
measured by integration of 1H NMR data while only four aromatic carbon signals (&:: 
134.3, 128.4, 129.4 and 129.9) can be seen on the 1 3C NMR spectrum. Thus, a 
monosubstituted phenyl group was proposed in the structure. The methine group at &:: 
81.4 ( bi ;  2.99) was ascribed to be an oxygen-bearing methine by its chemical shift. 
By examining the COSY spectrum (Table 5.3), a partial structure -CH2-CH was 
suggested by the correlations of methylene protons ( bi ;  3 .20, 3 .28) to a methine proton 
at bi ;  4.40. The partial structure (CH3)2 CH-CH-0- was deduced by the correlations of 




1 5  
'-.__..;,f' CIGAR 
Me 
Figure 5.7 Structure of WJ3.31. l (bassiatin) 
The connection of these functional groups was achieved mainly by analysis of the 
CIGAR spectrum (Table 5.3). The long range correlations of the proton at bi; 3.20 in 
the methylene group to the aromatic carbons at &:: 129 .9 (C-12, C-16) and &:: 134.3 
(C-11) and bi-, 4.40 (H-3) to &:: 134.3 (C-11), led to the connection of C-10 to the 
phenyl group (Figure 5.7). The long range correlations of OJ-1 3.02 (N-CH3) to &:: 62.9 
(C-3) and &:: 165.7 (C-5), and bi; 4.40 (H-3) to &:: 165.7 (C-5) resulted in the 
connection of C-3 to N-4 then to C-5. The connection between C-2 and C-3 was 
THE LIBRARY 
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Chapter 5 Fusarium sp. (A l 45 )  1 00 
assumed by the long rang correlation of bi-1 3.20 (H- 1 0) to &: 1 67.5 (C-2). Finally, the 
planar structure as shown in Figure 5.7 was suggested for WJ3.3 1 . 1 .  From a literature 
search, this compound was found to be bassiatin, previously isolated from Beauveria 
bass iana. 1 86 
The stereochemistry of WJ3.3 1 . 1  was detennined as shown in Figure 5.8 by 
comparing the 1 H and 1 3C NMR data (Table 5.3) and the optical rotation ( [a] 020 
+ 1 20.0 °, c 0.2, CHCJ3) of WJ3.3 1 .  l with the four isomers synthesized by 
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Figure 5.8 Stereostructure of WJ3.3 1 . 1  (bassiatin) 
Biological Activity : 
P388 activity: IC5o > 1 2500 ng/mL 
Antimicrobial activity: none detected 
Antiviral activity: none detected 
Bassiatin was isolated as a platelet aggregation inhibitor. The inhibitory activity (IC5o) 
of bassiatin against rabbit platelet aggregation induced by ADP, collagen and 
arachidonic acid was 1 .9 x 1 0-4 M, 3. 8 x 1 0-4 M and 3. 8 x 1 0-4 M, respectively, only 
slightly less active than adenosine. 1 86 
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Table 5.3 1H, 1 3C, HSQC, COSY and CIGAR NMR data for WJ3.31.1 a 
no. 
COSY 
1 0 1  
C -"7 H 
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1 3 , 1 5  1 28.4 (CH) 7.33 (2H, m) 7 . 1 3  1 34.3 7. 1 3 ,,,,,,-.. -· -··••••ri••""""""--t----- -- ---+--------t---------- -----1 1 29 .4 (CH) 7 .32 ( I H, m) i 7 .33 _N __  C_H_3 -+--'-(�---�'-)-+-- 3 .02 (3H, s) 1 
1 4  
62.9, 1 65 .7 
' 1 H NM R spectra recorded a t  500 MHz in CDCh, 13C NM R spectra recorded a t  1 25 M Hz in CDC h .  
b 1 H chemical shift values (oppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
d long range 1 H- 13C correlation from H to C or C to H observed in the CIGAR experiment. 
5.5 Structu ral E lucidation of WJ3.25.8 (Beauveric in )  
WJ3.25.8 was obtained as pale yellow needles. The 1 H and 1 3C NMR spectra (Table 
5.4) of WJ3.25.8 showed similarities to that of WJ3.31.1 (Table 5.3) in terms of the 
observed chemical shifts and the multiplicity of the peaks: two methyl doublets (6J.- 1 
0.40 and 0.79), one N-methyl singlet (bi� 3.00), one methylene group (� 2.96 and 
3.36, AB system), three methine groups (� 1.99, multiplet, � 4.88, doublet and bi�  
5.52, quartet), five aromatic protons (bi� 7.18 - 7.24), one aromatic quaternary (� 
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136.8) and two carbonyl carbon atoms (et 169.6 and 170. 1). The presence of a phenyl 
group was suggested by the NMR data of C- 1 1  to C- 16 (Table 5.4). The methine 
signal at bi- 1 4.88 (et 75.6) were assumed to be an oxygen-bearing methine group by 
its chemical shift. 
In the COSY spectrum (Table 5.4) of WB.25.8, couplings were observed between 
two methyl groups (6'-1 0.40 and 0.79) and one methine group at 8H 1.99, which in tum 
was coupled with another methine group at 6' -1 4.88. This led to the partial structure 
(CH3)2 CH-CH-0-. The fragment -CH2-CH- was determined by the couplings of the 
methylene group ( 6'-1 2.96 and 3.36) with the third methine group (6'-1 5.52). 
In the CIGAR spectrum (Table 5.4), long-range correlations were observed between 
N-methyl protons (6'-1 3.00) to a carbonyl carbon at et 169.6 (C-5) and to a methine 
carbon at et 57.4 (C-3). This led to the coru1ection of C-3 to N-4 then to C-5. The 
long-range correlations of the methylene (bi-1 2.96 and 3.36) protons and the oxygen­
bearing methine proton ( 6'-1 4.88) to another carbonyl carbon (et 170. 1) resulted in the 
connection of C-10 to C-2 through C-3 and C-2 to C-6 through an oxygen 
respectively. The correlation of the proton at 6J-i 1.99 (H-7) to the carbonyl carbon at 
et 169.6 (C-5) led to the connection of C-5 to C-6. Finally, the connection of C-10 to 
the phenyl group was determined by long-range correlations observed between the 
methylene group (H- l Oa, H-lOb) to the quaternary carbon at et 136.8 (C-11) and the 
aromatic carbon at et 129.0 (C-12, C-16). From these results, the planar structure of 
WB.25.8 was proposed as depicted in Figure 5.9, which is the same as that of 
WJ3.31.1 (Figure 5.7). 
� CIGAR 
9 
Figure 5.9 Structure I for WB.25.8 
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At this point, WJ3.25.8 was assumed to be an isomer of WJ3.31.1, but mass spectra 
indicated the molecular weight of WJ3.25.8 was 783 Daltons [EI: 783 (M+), ES: 
784.2386 (M + H)\ 782.2600 (M - Ht] rather than 261 Daltons as found for 
WJ3.31.1. Thus, WJ3.25.8 was proposed to be a trimer of WJ3.3 l .1 and this was 
supported by the high resolution mass spectrum (HREIMS), which suggested the 
molecular fonnula C45H57N
3
09 (M+ 783.41100, calculated mass: 783.40948). The 
symmetry and cyclic nature of WJ3.25.8 was indicated by the simplicity of the 1H and 
1 3C N MR spectra (Figure 5.11, Figure 5.12), thus, the planar structure II, a 
cyclodepsipeptide, was suggested for WJ3.25.8 (Figure 5.10). This structure 1 s 
identical to beauvericin, an antibiotic of the enniatin family. The 1 H and 1 3C NMR 
data, mass spectrum and optical rotation ( [a] o20 +61.0 °, c=l, methanol) of WJ3.25.8 
were in good agreement with those reported for beauvericin. 1 87• 1 88 The absolute 
stereochemistry has been established as a cyclic hexadepsipeptide of alternating L-N­














Figure 5.10 Structure II for WJ3.25.8 
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Figure 5. 12 1 3C NMR (APT) spectrum of WJ3.25.8 (in CDC13) 
20 ppm 
Chapter 5 Fusarium sp. (A145) 1 05 
Table 5.4 1H, 1 3C, HSQC, COSY and CIGAR NMR data for WJ3.25.8a 
no. 
2 1 70. 1 (C) J I 
COSY 
· - --� t 57 4 (CH) -- �=�{ii :. :
O
�t ��6 
CIGAR0 I H -"7 C C -"7 H 
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' 1 H NMR spectra recorded at 500 M Hz in CDCii, 13C NMR spectra recorded at 1 25 MHz in CDC'3. 
b 1 H chemical shift values (8ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). ' primary, secondary, tertiary and quaternary carbons, assigned by APT. d long range 1H- 13C correlation from H to C or C to 1-1 observed in the CIGAR experiment. 
Biological Activity: 
P388 activity: IC50 = 4126 ng/mL 
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Antimicrobial activity: 1 mm, 3 mm and 2 mm zones of inhibition against Bacillus 
subtilis, Candida albicans and Trichophyton mentagrophtes respectively at a 
concentration of 40 µg/disk. 
Antiviral activity: none detected 
Beauvericin was first isolated as a substance toxic to brine shrimp (Artemia salina) 
from Beauveria bassiana. 1 87 It was subsequently isolated from other fungi such as 
Fusarium semitectum and F. moniliforme var. subglutinans as a toxic principle 
against Colorado potato beetles, 1 89 from powdered Bai Jiang Yong (a dried, Beauveria 
bassiana-fermented Bomlyx mari pupa, used as an anticonvulsant in traditional 
Chinese medicine, 1 90 and from the entomopathogenic fungi Paecilomyces fumoso­
roseus 1 9 1 and P. tenuipes. 192 Beauvericin showed insecticidal activity against 
mosquito larvae. 1 87' 1 88 It also showed an inhibitory effect on a high potassium-induced 
tonic contraction in guinea pig tenia coli. The mechanism may be due to the 
noncompetitive inhibition of Ca2+ entry through the voltage-dependent Ca2+ channel 
of the intestinal smooth muscle cell. It is also reported that beauvericin inhibited ADP 
induced platelet aggregation with an IC50 of 6.4 x 10 -s M . 1 86 Synthetic beauvericin 
had strong antimicrobial activity in vitro against a variety of microorganisms, 
including Candida albicans, Escherichia coli, Sarcina lutea and Staphylococcus 
aureus. 193 
5.6 Discussion 
Three compounds were isolated from the filtrate of a marine Fusarium sp. (A l45) 
through bioassay-guided separation. The compounds were structurally assigned as 
bikaverin (compound 5.1), bassiatin (WJ3.3 1. l )  and beauvericin (WJ3.25.8) based 
mainly on MS, 1 H and 1 3C NMR and a series of 2D NMR spectra. Bikaverin showed 
strong activity (IC50 304 ng/mL) while beauvericin exhibited moderate activity (IC5o 
4126 ng/mL) in the assay against the P388 murine leukaemia cell line. The isolation 
of bassiatin is the first report of its production by a Fusarium species. Bassiatin 
consists of N-methyl-L-phenylalanine and (-)-(R)-2-hydroxy-3-methyl butyric acid 
and beauvericin is a cyclic trimer of bassiatin. In the study by Kagan1izono and co-
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workers, 1 86 both bassiatin and beauvericin showed inhibitory activities against platelet 
aggregation. Although a series of activities has been reported for beauvericin, the 
literature on the bioactivity of bassiatin is very limited. In light of the structural 
similarities between these two compounds, it may be useful to investigate other 
activities of bassiatin, especially insecticidal activity. 
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Chapter 6 
ASPERGILLUS SP. (A1 51 ) 
6 . 1  I ntroduction 
6. 1 .  1 General 
The genus Aspergillus has a worldwide distribution and is one of the most common of 
all groups of fungi. Species of Aspergillus are among the most economically 
important fungi, being very widely used for synthesis of chemicals, biosynthetic 
transformations and enzyn1e production. Since ancient times, Aspergillus species have 
been used in the preparation of soy sauce in China and other Asian countries. The 
ability of these fungi to produce several organic acids, especially citric acid, has 
created major industries worldwide. Aspergillus enzymes are used for such diverse 
applications as starch processing, cheese manufacturing, juice clarification, brewing, 
dough conditioning, wine modification, food preservation and instant tea production. 
They are, however, also one of the greatest contaminants of natural and man-made 
organic products, and a few species are pathogenic to man and animals. The aspergil li 
are also one of the most important mycotoxin-producing groups of fungi when 
growing as contaminants on cereals, oil seeds and other foods. 
6. 1 .2  Identification of Aspergillus species 
The genus Aspergillus now contains more than 200 species 194 and is a relatively large 
taxon among the Hyphomycetes. It is characterised by the fonnation of conidiophores 
with large, heavy wal led stipes and swol len apices, termed vesicles. Vesicles bear 
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crowded phialides or metulae and phialides, which characteristically are all borne 
simultaneously. This character unequivocally distinguishes Aspergillus from 
Penicillium. Differentiation of Aspergillus species is based primarily on head 
complexity- whether metulae and phialides are produced, or phialides alone and 
conidial colour. In species Jacking teleomorphs, Aspergillus colony coloration is 
dominated by conidial colour. No other Hyphomycete genus produces conidia of such 
diverse colours, which are consistently associated with particular species. 1 95 
6. 1.3 Bioactive metabolites from Aspergillus species 
Aspergilli readily produce a variety of secondary metabolites when grown on artificial 
media in the laboratory and some of these occur naturally when grown on food or feed 
products. Literature on secondary metabolites isolated from the Aspergillus genus is 
vast: more than 900 compounds have been recorded in Antibase,75 many of which 
have overt biological activity including mammalian toxicity. A number of metabolites 
are important in human health and include: 
Aflatoxins 
Aflatoxins, produced mainly by Aspergillus jlavus, A. parasiticus and A. nominus, 
are by far the most widely studied mycotoxins and poisoned thousands of poultry, 
pigs and trout in the early 1960s. They are highly substituted coumarins containing a 
double furan ring. The four main naturally produced aflatoxins are B 1 , B2, G 1 and G2 
(Figure 6. 1). 
Aflatoxin B 1 is hepatotoxic and one of the most potent animal carcinogens known. In 
human liver cell tissue culture, doses of 10 µg/mL are lethal. 1 96 Since aflatoxins were 
associated with food contamination, the content of aflatoxins in foods and feeds was 
eventually regulated in many countries. 1 97 The possibility that aflatoxins are 
responsible for the high incidence of liver cancer in parts of Africa where people 
consume groundnut products was suggested as early as 1962. 1 98 Yet today, in 
populations with relatively high exposure, a role for aflatoxins as a risk factor for 
primary liver cancer in humans is still not clear. 1 99 
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Figure 6.1 Structures of aflatoxins 
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Ochratoxins are isocoumarin compounds (Figure 6.2) produced by A .  ochraceus and 
related species.200 Ochratoxin A (OTA) is a potent nephrotoxin, teratogen, and 
carcinogen20 1 while its natural analogs, such as ochratoxin B and C, showed no or 
much less toxicity in animals than OT A.202•203 InJ1alation of OTA can lead to renal 
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Figure 6.2 Structures of ochratoxins 
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Sterigmatocystin (Figure 6.3) and its derivatives such as dihydrosterigmatocystin, 0-
methylsterigmatocystin and 0-methyldihydrosterigrnatocystin are produced mainly by 
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A. versicolor. 207 Sterigmatocystin is an intermediate in the biosynthetic pathway 
leading to the aflatoxins. While acutely toxic and carcinogenic208 it is not as toxic as 
aflatoxin B 1 • It is also reported that sterigmatocystin and 5-methoxysterigmatocystin 





Figure 6.3 Structure of sterign1atocystin  
These metabolites (Fumitremorgins A to N)2 1 0-2 1 2 are a senes of diketopiperazines 
produced by certain strains of A. fumigatus. 2 13 
MeO MeO :� 
0 -H 
Me 
Me Fumitremorgin A Fumitremorgin C 
Figure 6.4 Structures of fumitremorgins 
Fumitremorgins A (Figure 6.4) and B were first isolated in  197 12 14-2 16 as tremorgenic 
mycotoxins since they caused severe tremor and convulsions in experimental animals 
due to neurotoxic properties.2 1 7'2 1 8  In 1 998, Fumitremorgin C (Figure 6.4) was found 
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to be effective in treating MDR (multi-drug resistance) which is a major problem in 
cancer chemotherapy.2 1 9 Thereafter interest in this class of compounds led to the 
synthesis of a series of analogs.2 20,22 1 
Sphingofungins 
Sphingofungins were isolated from the cultivation of Aspergillus fumigatus (ATCC 
20857) by the Merck group in 1 992.222 These compounds have four consecutive chiral 
centers and a trans olefinic group in their polar head moiety (Figure 6.5). They were 
found to inhibit the biosynthesis of sphingolipids due to their activity as 
serinepalmitoyl transferase inhibitors.223 Sphingofungins A, B, C and D showed a 
limited spectrum of antifungal activity but were especially effective against 
















Figure 6.5 Structures of sphingofungins 
6.2 Taxonomy of Aspergillus sp.  (A1 51 ) 
�H 
COOH 
In this present work, the producing organism, strain No. A l  51, was isolated from 
saline lake sand in western Australia. The identification of strain A 151 was made as 
described by Pitt and Hocking. 1 07 
Morphological and cultural characteristics : Colonies on Czapek yeast extract agar 
(CY A) 48-55 mm in diameter (7 days, 25 °C), wrinkled, dense and velutinous, white 
at first and becomes green with the forming of conidial heads, reverse pale. Colonies 
on malt extract agar (MEA) 50-6 1 mm in diameter (7 days, 25 °C), similar to those on 
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CY A but less dense and with conidia in duller colours, reverse greenish. Colonies on 
25% glycerol nitrate agar (G25N) 8-10 mm diam (7 days, 25 °C). No growth at 5 °C. 
Growth at 37 °C is exceptionally rapid, colonies on CY A 29-35mm in diameter in 2 
days. This strain can grow at 50 °C. 
Conidial apparatus develops as erect conidiophores. Tips of conidiophores enlarge 
and form vesicles with many phialides producing conidia in long dry chains. Conidial 
heads are compactly columnar, 33-47 µm in diameter, green to dark green. 
Conidiphores are unbranched, smooth and pale green, stipes 210-330 µm x 4-5 µm in 
size. Vesicles are flask-shaped, 14-25 µm in diameter, fe1tile over half or more of the 
enlarged area, bearing phialides only, the lateral ones characteristically bent so that 
the tips are approximately parallel to the stipe axis. Phialides crowded, pale green, 6-8 
µm long. Conidia are globose to subglobose, roughened, green in mass and 2 - 3 µm 
in diameter. 
Figure 6.6 Aspergillus fumigatus (a) colonies on CY A (7 days, 25 °C); (b) 
conidiophores, stained with 0.025% lactofuchsin; (c) conidia. Bars = 10 µm 
The characteristics of strain A l5  l are consistent with the descriptions of Aspergillus 
Ju · · b p· d H ki 101 K ak. . 224 d S 194 mtgatus given y 1tt an oc ng, oz 1ew1cz, an amson. 
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6.3 Cultu ring and Isolation 
6.3. 1 Culturing and extraction 
Aspergillus fumigatus (CANU A15 l )  was grown in a liquid medium of half strength 
potato dextrose broth at 26 °C. Two batches were cultured. The first batch (big broth 
I) was cultured for four weeks and the second batch (big broth II) was cultured for 
eleven weeks. Each culture was filtered under suction and the mycelium and filtrate 
extracted separately with EtOAc. The EtOAc extracts were then evaporated under 
reduced pressure. The extracts were assayed for activity against the P388 murine 
leukaemia cell line. The filtrate extract from big broth I and the mycelial extract from 
big broth II showed significant activity while the filtrate extract from big broth II and 
the mycelial extract from big broth I exhibited very weak activity (Table 6.1). The 
HPLC profiles of these 4 extracts were also different from one another. This result 
indicated that the length of the culture period had a great influence on the secondary 
metabolites produced by this strain of Aspergillus fumigatus. The two active extracts 




Table 6.1 Yield and activity of extracts from Aspergillus fumigatus (A l 51) 
Big Broth I (5 L, 4 weeks) Big Broth J I  (2 L, 1 1  weeks) 
Filtrate Extract Mycelial Extract Filtrate Extract Mycelial Extract 
590.9 mg 932 . 1 mg 1 36.7 mg 227 .7 mg 
activity 2 1 89 ng/mL 2335 1 ng/mL 4 1 250 ng/mL 1 207 ng/mL 
6.3.2 Chromatography of the active extract from big broth II 
An outline of the isolation is illustrated in Scheme 6.1. 
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Scheme 6.1 
Aspergillusfumigatus (A l 5 1 )  Big Broth I I  (2 L) [ 1 /2 PDB, shake, 1 1  weeks] 
Extract with EtOAc 
Filtrate extract ( 1 36 .7 mg) 
[ 4 1 250] 
Mycelium extract (227.7 mg) 
[ 1 207] 
Wash with hexanes 
1 1 5 
Residue ( 1 1 8 .3 mg) Hexanes extract ( I  09 .4 mg) 
( fatty acid) 
Diol column (20 g) 
40% - 60% EtOAc/ Hexanes 1 00% EtOAc 
WJ3 .42 .2 (26.9 mg) 
[606] 
Xanthocillin-X dimethyl ether 
[ ] : P388 activity ( IC50 = ng/mL) 
WJ3 .42 . 1 0  to l 3  ( 1 6.2 mg) 
[2795] 
The mycelial extract from big broth II was washed with hexanes three times to 
remove fatty acids. The residue (118.3 mg) was applied to a Diol (normal-phase) 
column, eluted with a stepped gradient from hexanes to EtOAc and then to MeOH. 
Seventeen fractions were collected. Fraction WJ3.42.2, eluted with 40-60% 
EtOAc/hexanes was a pure compound which showed strong activity against the P388 
murine leukaemia cell line (IC50 = 606 ng/mL). The structural elucidation of the 
active compound WJ3.42.2 is discussed in section 6.4 . Fractions WJ3.42.10 to 13 
showed the same 1H NMR and HPLC profile to that of WJ3.40. 1 1  to 14. For further 
purification see section 6.3.3 (Fraction 3.37.6, then sub.fraction WJ3.40.11 to 14). 
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6. 3.3 Chromatography of the active extract from big broth I 
An outl ine of the isolation is i l lustrated in Scheme 6.2. 
Scheme 6.2 Big Broth I (5 L) [ 1 /2 PDB, shake, 26 °C, 4 weeks] 
Filtrate extract (590.9 mg) 
[2 1 89] 
WJ3 .37.2 ( 1 7 .2 mg) 
[2880] 
C 1 8 colunm (50 g) 
WJ3 .37.6 ( 1 07.0 mg) 
[7976] 
Extract with EtOAc 
Mycelium extract (932 . 1  mg) 
[20 1 02] 
WJ3 .37 .7 (62.9 mg) 
[774 1 ]  
Diol colunm (20g) 
1 1 6 
20% EtOAc/DCM 20% EtOAc/DCM 40% EtOAc/DCM 
WJ3 .47 .2+3 
( 4.4 mg) 
[>1 2500] 
1 2a-furnitremorgin C 
Diol colunm (20 g) 
WJ3.47.5 
(9.2 mg) 
[> 1 2500] 
fumagillin 
WJ3 .40. 1 l to 14 ( 1 2 .0 mg) 
c stallised with acetone 
residues 
W J3 .40. 1 1  to 14 R 
crystals (2 .9 mg) 
WJ3.40. 1 1  to 1 4  C 
[2795] 
Diol colunm (20g) 
60% EtOAc/DCM 











[ ] : P388 activity (IC50 = ng/mL) 
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The filtrate extract (590.9 mg) of big broth I was separated on a C 1 s (50 g) column, 
eluted with a stepped gradient from 10% MeOH/H20 to MeOH and then CH2Clz. 
Fifteen fractions were collected. Fractions WJ3.37.2, 6 and 7 were active against the 
P388 cell line (IC50 = 2880, 7976 and 7741 ng/mL respectively). 
Fraction WJ3.37.7 (62.9 mg) was further chromatographed on 20 g of Diol, using 
CH2Clz/hexanes (50% to 100%), Et0Ac/CH2Ch (20% to 100%) and MeOH/EtOAc 
(50% to 100%) as the eluent. Twenty eight fractions were collected and their 
combination based mainly on comparisons of 1H NMR spectra. Subfractions 
WJ3.47.2+3, WJ3.47.5 and WJ3.47. 8+9, eluted with 20 - 40% Et0Ac/CH2Ch, 
afforded three pure compounds ( fumitremorgin C, 4.4 mg; fumagillin 9.2 mg; 
fumagiringillin, 6.9 mg). In the P388 assay, all three pure compounds showed no 
notable activity (IC50 >12500 ng/mL). So all the other subfractions from WJ3.37.7 
were submitted for P388 assay, but again, no activity was detected in those fractions. 
Because the mass recovered from sub fractions WJ3 .4 7 .x was very close to that of the 
crude one, absorption of active compounds on the Diol column does not seem 
possible. The loss of activity might be due to decomposition of active component (s) 
or that the activity of fraction WJ3.37.7 was a synergistic effect of inactive 
components. 
Fraction WJ3.37.6 (107.0 mg) was subjected to further purification usmg Diol 
(normal phase) column. The chromatography was carried out using a hexanes - DCM 
- EtOAc - MeOH stepped gradient. Subfraction WJ3 .40.11 to 14, eluted with 40-60% 
EtOAc/DCM, showed biological activity (P388, IC50 = 2795 ng/mL). Due to the poor 
solubility of this fraction in all the solvents available, crystallisation was used for 
purifying the active compound(s). White crystals formed in acetone. Also because of 
the poor solubility of the crystals in all the solvents available for NMR spectroscopy, 
the information obtained from 1 3C NMR and CIGAR spectra is very limited. No 
structural identification was achieved. 
Fraction WJ3.37.2 (17.2 mg) was further chromatographed using normal phase (Diol) 
flash chromatography. The column was eluted using a 50% DCM/hexanes - DCM -
EtOAc - MeOH stepped gradient. The fractions were combined based mainly on 1 H 
NMR spectroscopic analysis. Subfractions WB.54.11 and 12 to 16, eluted with 60% 
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and 80% EtOAc/DCM respectively, showed activity against the P388 cell line (IC5o = 
3552, 3552 ng/mL, respectively). Analysis of the 1 H NMR spectra identified that the 
major components in these active fractions were simple benzenoid compounds closely 
related to what had been isolated previously from the extract of Phoma sp (K3 l) (see 
Chapter 4). Due to the relatively simple chemical structure and the low yield at this 
stage of purification, the compounds responsible for the activity in this fraction were 
not pursued further. 
6.4 Structu ral E lucidation of WJ3.42.2 
WJ3.42.2 was obtained as greenish-yellow needles. The HREIMS showed a peak at 
316.12060 indicating the formula C20H 1 6N202 (calcd. 316.12118). The simplicity of 
the NMR spectra (Table 6.2) of WJ3.42.2 was suggestive of a high degree of 
symmetry. In the 1H NMR spectrum, one set of 1,4-disubstituted benzene protons (bi1 
6.97 and 7.78), an olefinic proton (bi- 1 7.00) and methoxyl protons (� 3.86) were 
observed. The CIGAR experiment (Table 6.2) revealed the following structural 
information. The methoxyl protons at bj1 3.86 and the aromatic protons at 8i1 6.97 and 
7.78 showed coITelations to a quaternary aromatic carbon at £\: 161.3. The aromatic 
proton at � 6.97 also coITelates to another quaternary aromatic carbon at £\: 125.0. 
Furthermore, long-range coITelations were observed from � 7.00 to £\: 131.9 and 
116.4, and from � 7.78 to £\: 127.6. The isocyano group was deduced from the 
quaternary 1 3C NMR signals at £\: 173.5 which showed no co1Telations in the CIGAR 
spectrum, and by the molecular formula of WJ3.42.2. Accordingly, compound 
WJ3.42.2 contains partial structure I (Figure 6.7). 
c-








Figure 6.7 Partial structure I of WJ3.42.2 
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On the basis of the molecular weight there must be two units of partial structure I .  
Therefore, the structure of  compound WJ3.42.2 was suggested as  shown in  Figure 6.8. 
c-
I l l 0"-.._ I 
N+ Me 
I I  
�I � 8  7� 5� 3 I 
6 4 
#° I I ' 1 3 I l l 0 1 2' I c-
Me 
1 4 
Figure 6.8 Structure of WB.42.2 ( xanthocillin-X dimethyl ether) 
The relative stereochemistry of compound WB.42.2 was finally determined by a 
single-crystal X-ray diffraction analysis .  A computer-generated perspective drawing 





Figure 6.9 Structure of WB.42.2 determined by X-ray crystallographic study 
From a literature search, compound WJ3.42.2 was found to be identical to 
xanthocillin-X dimethyl ether.225 -227 
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Table 6.2 ' H, 1 3C, HSQC, COSY and CIGAR NMR data for WJ3.42.2a 
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' 1 H NM R spectra recorded at 500 MHz in CDCli, 13C NMR spectra recorded at 1 25 M Hz in CDC'3. 
b 'H chemical shift values (b'ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
d long range 1 H- 13C correlation from H to C or C lo H observed in the CIGAR experiment. 
Biological Activity: 
1 20 
Biological testing of xanthocillin X dimethyl ether (WJ3.42.2) in this study showed it 
to have significant cytotoxicity against the P388 murine leukaemia cell line (IC50 606 
ng/mL). Other activities have also been reported in the literature: xanthocillin 
dimethyl ether inhibited Newcastle disease, Herpes simplex, and vaccinia viruses, and 
also inhibited the growth of Bacillus subtilis. 228 Anti tumour activity was shown in in 
vitro and in viva mouse tests with LD50 being >120 mg I/kg in mice. Tumour growth 
in humans is inhibited by the administration of xanthocillin X dimethyl ether in the 
range 100-3000 mg/day for an average adult patient.229 
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6.5 Structural  E lucidation of WJ3.47.2+3 
WJ3.47.2+3 was obtained as a pale yellow powder. The molecular formula was 
determined to be C22H25N303 [Found 380.1975 (MH
+), calcd: 380.1974] by HRESMS 
measurement. 
In the 1 H NMR spectrum, WJ3.47.2+3 showed signals due to an N-H proton (bi-1 7.79, 
br s, H-1) and a 1,2,4-trisubstituted benzene ring (bi-1 7.43, d, ]=9.0 Hz, H- 16 ;  bi-1 6.81, 
dd, ]=8.0, 2.0 Hz, H-17 and bi-1 6.85, d, J=l.5 Hz, H-19) being part of a 2,3,6-
substituted indole system, and an olefinic proton (bi-1 4.90, dd, ]=10.0, 1.5 Hz, H-2 1), 
a methoxy (bi- 1 3.83, s, 18-0CH3) and two methyl (bi-I 1.64, d, J=l.0 Hz, H-23 and bi-1 
1.99, d, J=l.5 Hz, H-24) groups along with signals due to several methine and 
methylene groups (Table 6.3). The 1 3C NMR spectrum of WJ3.47.2+3, analyzed by 
the APT method, indicated the presence of two amide carbonyls (&: 169.7, C-5 and &:; 
165.9, C-11), an oxygen-bearing aromatic carbon (&: 156.7, C-18) and a methoxy ( &:; 
56.0, 18-0CH3) ,  two methyl (&: 18.3, C-24 and &:; 25.9, C-23) groups and four 
methylene (&: 22.1, C-13; &:; 23.2, C-8; &:; 28.8, C-7 and &:; 45.6, C-9) groups 
together with seven methines and five quaternary carbons (Table 6.3). 
A close inspection and interpretation of the I H and 1 3C NMR spectra of WJ3 .4 7 .2+ 3 
by HSQC and COSY experiments (Table 6.3) led to the partial structures as shown in 
bold in Figure 6.10. 
COSY 
6 7 
� long-range correlation (CIGAR) 
Figure 6.10 Planar structure for WJ3.47.2+3 
8 
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The CIGAR spectrum was then obtained in order to determine the total structure of 
WJ3.47.2+3. In the indole system (Figure 6.10), the benzene protons H-16 (6i-1 7.43), 
H-17 (5i- ,  6.8 1 )  and the methoxy protons at bi- ,  3.83 showed long-range correlations to 
the oxygen-bearing quaternary carbon at et 1 56.7 (C-18), while H-17 and H- 1 9  (6i- i  
6.85) and H- 1 6  showed long-range correlations to  the quaternary carbons at et 120.9 
(C- 1 5) and at et 1 37.2 (C-20), respectively. Therefore, C- 1 8  (et 156.7), C-15 (et 
120.9) and C-20 (et 137.2) could be assigned. The other two quaternary carbons in 
the indole system, C-2 and C- 1 4, were assigned based on the long-range correlations 
of H-16, N-H (5i ,  7.79) and the methylene protons at bi-, 3.09 (H-13a) and 3.5 1  (H-
13b) to et 106.5 (C- 1 4) and H-13 and H-3 (6i-1 5.98) to et 132.3 (C-2). The correlation 
peaks observed between H-3 and H-6 (6i-i 4.1 1 )  to et 1 69.7 (C-5) and between H-13a 
and H-12 (6i-1 4. 1 8) to et 165.9 (C- 1 1 )  led to the assignment of the two amide 
carbonyls. The assignment of C-22 was suggested by the long-range correlations 
between H-23 (bi- 1 1 .64), H-24 (6i-! 1 .99) and H-3 to the quaternary carbon at et 1 34.2. 
Finally, the connectivities were determined by extensive analysis of the CIGAR 
spectrum. As shown in Figure 6.10, both H-13a and H- 1 3b showed long-range 
correlations to the carbons C-14 ( et 1 06.5) and C-2 ( et 132.3), and also to C- 1 1  ( et 
1 65.9) and C- 1 5  (et 120.9), respectively. This allowed C- 1 4  and C-11 to be connected 
through C-13 and C- 1 2. The correlation peaks between H-3 to C-12, C-2, C- 1 4  and C-
5 led to the connection of C-3 to N-4 and then to C-12, C-3 to C-2 and C-3 to N-4 and 
then to C-5 respectively. The connectivity of C-5 and C-6 was detennined by the 
long-range correlation of H-6 to C-5. The formation of the five membered 
heterocyclic ring by connection of C-6 and C-9 across the nitrogen atom at position 
10 was supported by the chemical shift values of C-6 (et 59.4) and C-9 (et 45.6). 
Thus, the planar structure of WJ3.47.2+3 was deduced (Figure 6.10). From a literature 
search, this compound was found to be identical to fumitremorgin C, previously 
isolated from A. fumigatus in 1 977.230 
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no. 1 1 3C o < COSY 
! I 
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• 1 H N M R  spectra recorded at 500 MHz in CDCl3, 13C N M R  spectra recorded at 1 25 M Hz in CDCh. 
b 1 H chemical shift values (o ppm from SiMe,) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' pri mary, secondary, tertiary and quaternary carbons, assigned by APT. 
d long range 1 H- 1 3C cmTelation from H to C observed in the CIGAR experiment. 
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The assignment of the stereochemistry of WJ3.47.2+3, as shown in Figure 6. 1 1, was 
based on the comparison of the 1H and 13C NMR data with that of the two isomers of 
fumitremorgin C. They had previously been synthesized by Hino et a/. 23 1  This 
determination was also supported by the optical rotation of WJ3.47.2+3 which 
showed [a)o-1 1.9 ° in MeOH (c 0.53) at 20 °C ( 12a-fumitremorgin C showed [a] 0 -
13 ° (c 0.53, MeOH) while 12�-fumitremorgin C has a rotation of +239 ° (c 0.11, 
MeOH) at 28 °C.23 1  
H 0 
1 3  9 
1 5  
� 20 




Figure 6. 1 1 Structure for WJ3.47.2+3 (12a-fumitremorgin C) 
Biological Activity: 
No activity was exhibited m cytotoxicity or antimicrobial assays even though 
fumitremorgin C was reported to be a tremorgenic mycotoxin as early as 1977.230 It 
was also reported that fumitremorgin C showed an inhibitory activity on the cell cycle 
progression of mouse tsFT2 l O cells in  the M phase with a MIC value 4. 1 µM. As 
products of oncogenes and tumour suppressor genes are involved in the regulation of 
the mammalian cell cycle, cell cycle inh ibitors were thought to be good candidates for 
cancer chemotherapy and also to be a source for providing molecular probes useful in 
elucidating the regulatory mechanism of the cell cycle.232 The other i nteresting 
activity of fumitremorgin C is that this compound can enhance the sensitivity of a 
mitoxantrone-selected colon carcinoma cell line, Sl-Ml-3.2 to various antitumour 
agents thereby reversing multi -drug resistance.220 
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6.6 Structural El ucidation of WJ3.47.5 
WJ3.47.5 was obtained as a pale yellow powder. Analysis of the HRESMS ( [M+H+], 
m/z 459.2375, calcd. 459.2383) and the 1 3C NMR spectrum (Table 6.4) of WJ3.47.5 
led to the molecular formula C26H3407 The 1 3C NMR spectrum showed all 26 
carbons, which were identified as four methyls, four methylenes, four methines, nine 
olefinic methines, three quaternary carbons, and two carbonyl carbons by the HSQC 
and APT spectra (Table 6.4). The COSY spectrum (Table 6.4) of WJ3.47.5 revealed 
the substructures from H-2 (5.- 1 1.09 & 2.10) to H-4 (5i-i 2.03) through H-1 (6i-i 1.86 & 
1.98), H-6 (5i-i 5.7 1) and H-5 (bi-1 3.68), from H-2' ( 5i-i 2.64) to H-4' (5.- 1 5.20) through 
H-3' ( 5i-i 2.15 & 2.37), and from H-2" (bi 1 5.99) to H-9" (bi- 1 5.93) (bold lines in Figure 
6.12). In the CIGAR spectrum (Table 6.4) of WJ3.47.5, the correlations of H-6' (bi- 1 
1.73) and H-7' (bi 1 1.64) to C-4' (� 118.7) and C-5' (� 135.1) and H-3' to C-5' led to 
the connectivity of C-6' and C-7' to C-4' through C-5' (Figure 6.12). The chemical 
shifts of C-1' (� 59.0) and C-2' (� 61.2) suggested that they are oxygen-bearing 
carbons. The connectivity of C-1' to C-2', and the spiroepoxide moiety was indicated 
by the correlation peaks observed between H-3 'b ( bi-1 2.3 7) to C-1' and the 
connectivity of C-8' (� 14.0) to C-4 through C- 1' was indicated by the correlations of 
H-4 and H-8' (bi- 1 1.2 1) to C-1', H-8' to C-2', H-2' to C-4 and H-4 to C-8'. The 
correlations of H-7a ( 5i-i 2.55) to C-2 (� 29.5), H-7a, H-7b (5i-i 2.99) and H-4 to C-3 
(� 59.7) led to the connectivity of C-2 to C-3 and then to C-4, and Jed to the 
connectivity of a spiroepoxide moiety, C-3 to C-7. The spiroepoxide was also 
suggested by the chemical shifts of C-3 and C-7 (� 59.7 and 51.0, respectively). The 
methoxy group ( � 56.9, 5i-i 3.43) was assigned based on the correlations of H-5 to C-
8 (� 56.9) and H-8 (bi-1 3.43) to C-5 (� 79.5). Two carbonyl carbons, C-1" (� 166.3) 
and C-10" (� 170.8), were assigned by the correlations observed between H-2" (bi-1 
5.99) and H-3" (bi-1 7.28) to C-1 ", and between H-8" (5i-i 7.33) and H-9" (bi-1 5.93) to C­
l O". The connectivity of C-6 to C-1" through an oxygen and C-1 O" to a hydroxy group 
were made based on the chemical shifts of C-1" and C- 1 O" and the molecular fonnula 
of WJ3.47.5. Thus, the planar structure of WJ3.47.5 was proposed as shown in Figure 
6.12. This proposed structure is identical to fumagillin, a known fungal metabolite. 





Figure 6 . 1 2  Planar structure of WB.47.5 
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The stereochemistry of  WB .47.5 was confirmed as shown in Figure 6. 1 3  by li terature 
data comparison.233 The single crystal X-ray study233 revealed that the cyclohexyl ring 
is in a chair confomiation (as shown in Figure 6 . 1 3), the oxygen of the spiroepoxide 
ring is quasi-axial, the C-4 substituent and the methoxy group on C-5 are in equatorial 
positions, the decatetraenedioyl sidechain is attached through an axially orientated 











Figure 6 . 1 3  Stereostructure of WB.47.5 (fumagi l l in)  
6' 
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Table 6.4 'H, ' 3C, HSQC, COSY and CIGAR NMR data for WJ3.47.5a 
I COSY I i 
59 .7(vw), 79.5(vw) 
1 27 
¥[�; . ----2 03 (1H, d; i-i oJ _ 3�6_C �19 s_ 
--�----?.�.:����!. 
_ __! 3 .68 ( 1 H , dd, 1 1 .0, 2 .5 )  i 2 .03 , 5 . 7 1  I 48 .3 , 56:_9,_6_6._6 __ , 
6 I 66.6 (CH) 
. 
5 .7 1 ( 1 H , m) I 1 . 86, 1 .98, 3 .68 I 
,---+------+----------+- --·-·· ..... , __ ____ ... J. _____ ____ _ 
2.99 1 29.5 , 59 .7 -7 H7a: 2 . 55  ( l H , d, 4 .0) 
H7b: 2 .99 ( l H, d, 3 . 5 )  2 .55  I 59.7 I 
.... -··--······-··-····-···-· --····················--·-·-··· ········· ···- ···· 
1--+------! - --
�. s::��;;i i 3 .43 (3 H , s) 79.5 ... ,., .. , ... _,, _________ , .............. , ..... _________  , .... ....... ,, .. , ______ _ 
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! H3 'a: 2 . 1 5  ( l H, m) 2 .3 7, 2 .64 , 5 .20 !
I 
59.0(w), 6 1 .2, 1 1 8 .7, 1 35 . 1  
27 .5 (CH2) · - ·- · ·- --- ···· ·--- - - - -- - - --- --·------- ·---·-· · .. ··· 
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) -· - .... / · ·· ·
-
-
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2" 1 23 . 6  (CH) i 5 .99 ( 1 H , d, 1 5 .5)  I 7 .28 1 34 .3 , 1 66 .3 __ _ ,,_ --, ............ '"''"""""'''""'''' H __ ,,,,,,,,,,,.,.,,,_, .. ,,,,_, __ ,,m,,,,,.,,, __ ... ,,,,,,,,._,, .. .,,,,,,,, , ___ .. ,,, ...... ,,, .. ,,,,, __ , .. ,, ________ _ 






2 ..... 8 __ �? 1:��) 1_4 .��- � !��-_J __ 5-�?���
43 - - · ··· ······--- 1 �-6._3 _ ....... 
4" 
5"  
1 3 4 .3 (CH) 
1 40.0 (CH ) 
6.43 ( I H , m) 6 .60, 7 .28 1 40.0 
6.60 ( J H , m) 6 .43 1 33 .5 ,  1 43 .7  - - ---·-··-··········-··--............ ............. ,,,-,....................................... . ..................... . _______ , ....................... -....... ...................... , ......... ·---··---------···-· 
..... 
6" 1 39.0 (CH) 6 .59 ( l H , m) 6 .47 1 34 .3 , 1 45 .4 
.............. +····-···---·-·---- ·i -· ···--·······-···························· .. ·· ........................... ............................ +--·-·······-······················-··············· .. ··-···-·············-········· ........ , ......... ·-··-···-·--....... .......... ·---·- .. ............ ,. __ 
7" 1 33 .5 (CH) 
8" 1 45 .4  (CH) 
9" 1 22 .4 (CH) 
6 .47 ( J H , m) 6 .59, 7 .33 
7 .3 3  ( l H , dd, 1 5 .5 ,  1 1 .5 )  5 .93 , 6.47 
+····--·---····· .. ·· 
5 .93 ( l H, d, 1 5 .0) 7 .3 3  
1 39.0 
1 70 .8 
1 33 . 5 ,  1 70 .8 
- ._ .. , ..................... ____ ,., .... --+---------+----- - --------· - ·----· --, 
1 0" 1 70 .8 (C) I 
' 1 H NM R spectra recorded at 500 M Hz in CDCl3, 13C NM R spectra recorded at 1 25 M Hz in CDC!,. 
b 1 1-1 chemical shift values (o ppm from SiMe4) followed by number of protons, multiplicity and coupling constant (J/Hz). 
' primary, secondary, tertiary and quaternary carbons, assigned by APT. 
d long range 1 H- 1 3C correlation from H to C observed in the CIGAR experiment. 
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Biological Activity of Fumagillin: 
P388 Activity: IC50 >12500 ng/mL. 
Antimicrobial activity: 3 mm zone of inhibition against Bacillus subtilis at a 
concentration of 60 µg/disk. 
Antiviral activity : CYT >+, TYP 4 for Polio virus at a concentration of 40 µg/disk. 
The anticancer activity of fumagillin has Jong been recognised234 though no activity 
against the P388 cell line was exhibited in assays in this present work. As a potent 
angiogenesis (new blood vessel formation) inhibitor fumagillin suppresses the growth 
of a wide variety of tumours,235•236 but because of toxic side-effects it cannot be 
utilised. Derivatives with less side-effects have been synthesized, and one of them 
(TNP-470, Figure 6.14) is now undergoing clinical trials for the treatment of a variety 
of cancers.237•238 Fumagillin and its synthetic analogue TNP470 (Figure 6.14) are 
currently the only treatment against cryptosporidiosis and against microsporidiosis 
caused by Enterocytozoon bieneusi, which are frequent and fatal in AIDS 
patients.239•24° Fumagillin has also acquired importance in veterinary medicine against 
microsporidiosis of bees and fish.24 1 -243 It is a strong antiparasitic and amoebicidal 
compound244 and one of two chemotherapeutics capable of controlling proliferative 
kidney disease of salrnonid fish infected by an unclassified myxosporean parasite, the 
so-called 'PKX'.245 
Me 
0 �  
,,, � ,, // ,,, Me ,, 
Figure 6.14 Structure of TNP-470 
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6.7 Structu ral E lucidation of WJ3.47.8+9 
WJ3.47.8+9 was also obtained as a pale yellow powder. The molecular formula was 
deduced from the HRESMS as C26H3608, showing an accurate mass at m/z 475.2343 
[(M-H+), calcd. 475.2332]. The 1 H (Figure 6.19) and 1 3C NMR spectra (Table 6.5) of 
WJ3.47.8+9 and those of WJ3.47.5 (fumagillin, Table 6.4) were very similar, except 
for the chemical shifts of four oxygen-bearing carbons (&:: 5 1.0, 59.0, 59.7 and 61.2) 
in the two spiroepoxide rings of fumagillin which were shifted down field (&:: 77. 1, 
78.7, 8 1.0 and 85.3) in WJ3.47.8+9. The 1 3C NMR spectrum of WJ3.47.8+9 showed 
twenty six signals, which could be classified, by the APT spectrum, as thirteen 
methine, four methylene, four methyl, and five quaternary carbons. The assignment of 
proton(s) attached to their corresponding carbons was readily accomplished by the 
HSQC technique (Table 6.5). The COSY spectrum (Table 6.5) of WJ3.47.8+9 
revealed the connectivity from H-9 (&- 1 2. 19) through H-1 (bi i  3.68), H-2 (bi ,  5.67), H-
3 (bii 1.93, 2.07) to H-4 (bi- , 1.63, 1.71), from H-10 (� 3.37) to H-1 1 (� 2.09, 2.39) 
and then to H-12 (bii 5.29), and from H-2' to H-9' (bold line, Figure 6.15). The 
CIGAR spectral data (Table 6.5, Figure 6.20) of WJ3.47.8+9 demonstrated the 
following information: the connectivity of the methoxy group (&:: 57.1, � 3.39) to C-
1 (&:; 76.9) was determined by the correlations of H-1 to C- 17 and H-17 to C- 1; the 
connectivity of C-4 (&:; 27.9) to C-9 (&:; 54.1) through C-5 (&:; 8 1.0) was deduced by 
the correlation peaks between H-4P (bi- 1 1.71) and H-1 to C-5 and between H-4P to C-
9; The correlation peaks between H-6a (bii 3.8 1) and H-6b (� 3.65) to C-5 and H-6a 
to C-9 allowed the connection of C-5 to C-6 ( &:; 77 .1 ); The connectivity of C-8 and C-
6 through oxygen was assumed by their chemical shifts (&:; 85.3 and 77. 1, 
respectively) and supported by the correlation of H-6a to C-8; The correlations 
observed between H-9 and H-10 (bi i 3.37) to C- 14 (&:: 15.7) and H-9, H-10 and H- 14 
to C-8 led to the connection of C- 14 to C-8 then to C-9, and C- 14 to C-8 then to C­
l 0. The connectivity of C-16 (&:; 26.l )  and C-15 (&:: 18.1) to C- 12 (&:: 121.9) through 
C- 13 (&:; 133.3) was deduced by the correlations between H-12 and H-15 (&- 1 1.64) to 
C-16, between H- 12 and H-16 (� 1.71) to C-15, and between H- 1 l a, H- l 1b, H-15 
and H-16 to C-13. The connectivity of the two carbonyl carbons with C-2' and C-9' 
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was made based on the correlations of H-2' (bi-1 5.98) and H-3' (bi-1 7.30) to C-1' (� 
166.3) and H-8' (bi- ,  7.36) and H-9' (bi-1 5.95) to C-10' (� 170.7). The assigim1ent of 
C-1' and C-10' were deduced by comparison of the chemical shifts of WJ3.47.8+9 
with those of fumagillin.233 The IR spectrum of compound WJ3.47.8+9 showed 
absorptions at 1706 and 1627 cm- 1 , confirming the presence of carbonyl 
functionalities in WJ3.47.8+9. The planar structure was determined as shown in 
Figure 6.15. Compound WJ3.47.8+9 is a new compound and has been named 




Figure 6.15 The planar structure of WJ3.47.8+9 
OH 
The relative stereochemistry of WJ3.47.8+9 was assigned on the basis of coupling 
constants and a 2D NOESY (Table 6.5) experiment. The protons of the cyclohexyl 
ring are denoted a or p, indicating their positions below or above the reference plane 
of the cyclohexyl ring. The large coupling constant between H-1 and H-9 (12.0 Hz) 
and the small coupling constant between H-2 and H-1 (3.0 Hz) indicated that H-1 and 
H-9 were axial while H-2 was equatorial. A chair confo1mation of the six-membered 
ring as shown in Figure 6.17 was suggested. Therefore, the methoxy group on C-1 is 
equatorial while the decatetraenedioyl side chain is axial. An NOE correlation 
between the proton at C-1 and the methyl protons at C-8, clearly position these groups 
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on the same side of the molecule (Figure 6.16). The NOE correlation between H-12 
and H-16 indicated that H-12 and H-16 were in a cis relationship while H-12 and H-
15 were in a trans arrangement. The assignment of stereochemistry across the ring 
junction was guided by the observation of a positive NOE correlation between H-4a 
and H-9. This correlation allowed the assignment of trans stereochemistry to be made. 
The two possible stereoisomers were model1ed using the Chem 3D programe. After 
energy minimisation the H-9/H-4 proton distances were 3.931 and 4.250A for the cis 
isomer while for the trans isomer the inter-proton distances were 2.783 and 3.677A. 
This assignment was also supported by the measurement of the spatial distance 
between H-3 and H-6. If 5-0H was in a �  position, H-6 should be distal from H-3 and 
no NOE should be observed. If 5-0H was in an a position, the close distance (2.396 
A) between one of the protons at C-3 and one of the protons at C-6 should show a 
NOE correlation. No NOE correlation was observed between the C-3 and C-6 protons 
in the NOESY experiment. The stereochemistries of the four conjugated double bonds 
were determined as all-£ based on the coupling constants (J 2,,3, =15.5 Hz, J s·.9· =15.5 
Hz) and the NOE correlations between H-2' and H-4', H-3' and H-5', H-4' and H-6', H-
5' and H-7', H-6' and H-8', and H-7' and H-9' (Figure 6. 16). The stereochemistry of the 
hydroxyl group at C-10 could not be assigned with any certainty. However, a positive 
NOE correlation was observed between H-9 and H- 10. Together, these observations 
led to assignment of the relative stereochemistry shown in Figure 6.17 for 
WJ3.47.8+9. 
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Figure 6.16 NOE correlations in NOESY spectrum of WJ3.47.8+9 
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By checking the retention times and UV spectra in the HPLC profiles of the pure 
compound WJ3.47.8+9 and the crude extract (filtrate extract of big broth I), it was 
determined that WJ3.47.8+9 originally existed in the crude extracts. 
Mechanism of the formation of WJ3.47.8+9: 
Fumagillin was assumed to be a precursor of WJ3.47.8+9 and the fom1ation of the 
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Figure 6.18 The proposed formation of WJ3.47.8+9 
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Biological activity of WJ3.47.8+9 : 
P388 activity: > 12500 ng/mL 
Antimicrobial activity: none detected 
6.8 Discussion 
A marine strain of Aspergillus fumigatus (Al51) was incubated in V2 PDB for 
different culture periods. The metabolites of 4-week broth were totally different from 
those of 11-week broth. It was indicated that the length of the culture period greatly 
influenced the production of secondary metabolites. From the mycelium of the broth 
cultured for eleven weeks, one biologically active compound, xanthocillin-X dimethyl 
ether (IC50 606 ng/mL for the P388 cell line), was obtained. From the filtrate of the 
broth cultured for four weeks, two known compounds, 12a.-fumitremorgin C and 
fumagillin, and a novel compound, fumagiringillin, were isolated. All three 
compounds showed no notable P388 activity although the crude extract exhibited 
moderate activity with an IC50 of 7741 ng/mL. The loss of activity was likely due to 
the decomposition of active component (s) or that the activity of crude extract was a 
synergistic effect of inactive components. 
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Figure 6.19 1H NMR spectrum of WJ3.47.8+9 
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Table 6 .5  1 H,  1 3C, HSQC, COSY and CIGAR NMR data for WJ3 .47 .8+9a 
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Chapter 7 
EXPERIMENTAL 
7 . 1  General Methods 
7. 1 .  1 Maintenance of fungal stock cultures 
Stock cultures were maintained on potato dextrose agar (PDA) slants at 4 cc and 
subcultures were taken every two months. Frozen vegetative mycelia (FVM) were 
prepared by aseptically transferring a portion of the slant grown on PDA plates and 
incubating at 25 cc for 3 - 4 days in the dark; agar discs (4 mm in dian1.) were then 
cut from the growing margin of colonies and frozen in 10% glycerol in distilled water 
at -80 cc until used. 
7. 1 .2  Culture media 
CMA (corn meal agar): CMA (Difeo) 17.0 g, distilled water 1 OOO mL. 
CSA (Czapek solution agar): CSA (Difeo) 49.0 g, distilled water 1 OOO mL. 
CYA (Czapek yeast extract agar): K2HP04 1 g, yeast extract (GibcoBRL) 5 g, Czapek 
concentrate (consisting of NaN03 30.0 g, KCI 5.0 g, MgS04. 7H20 5.0 g, FeS04 . 
7H20 0.1 g and distilled water 100 mL) 10 mL, trace metal solution (CuS04 . 5H20 
0.5 g, ZnS04 . 7H20 1 g, distilled water 100 ml) 1 mL, Sucrose 30 g, agar 
(GibcoBRL) 15 g, distilled water 1 OOO mL. 
G25N (25% glycerol nitrate agar): K2HP04 0.75 g, yeast extract (GibcoBRL) 3.7 g, 
glycerol (AR) 250 g, Czapek concentrate (consisting of NaN03 30.0 g, KCI 5.0 g, 
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MgS04. 7H20 5.0 g, FeS04 . 7H20 0.1 g and distilled water 100 mL) 7.5 mL, agar 
(GibcoBRL) 12 g, distilled water 750 mL. 
MEA (malt extract agar): MEA (GibcoBRL) 50.0 g, distilled water 1000 mL. 
PDA (potato dextrose agar): PDA (GibcoBRL) 39.0 g, distilled water 1 OOO mL. 
SDA (Sabouraud dextrose agar): SDA (GibcoBRL) 65.0 g, distilled water 1000 mL. 
S-PDA (seawater potato dextrose agar): PDA (GibcoBRL) 39.0 g, fresh filtered 
seawater (Sumner, Christchurch, New Zealand) 1000 mL. 
YEA (yeast extract agar): YEA (Oxoid) 23.0 g, distilled water 1000 mL. 
Yi MEB (half strength malt extract broth): malt extract (Oxoid) 8.5 g, meat peptone 
(GibcoBRL) 1.5 g, distilled water 1000 mL. 
Y2 PDB (half strength potato dextrose broth): PDB (Difeo) 12.0 g, distilled water 
1000 mL. 
Y2 S-MEB (half strength seawater malt extract broth): malt extract (Oxoid) 8.5 g, 
meat peptone (GibcoBRL) 1.5 g, fresh filtered seawater (Sumner, Christchurch, ew 
Zealand) 1 OOO mL. 
Y2 S-PDB (half strength seawater potato dextrose broth): PDB (Difeo) 12.0 g, fresh 
filtered seawater (Sumner, Christchurch, New Zealand) 1 OOO mL. 
Y2 YEB (half strength yeast extract broth): yeast extract (GibcoBRL) 3.0 g, Bacto 
peptone 5.0 g, glucose D (+) (AR, BDH) 10.0 g, distilled water 1000 mL. 
7. 1 .3  Biological assays
246 
Cytotoxicity 
P388 murine leukaemia cell line (ATCC CCL 46, P388Dl) was used. A 2-fold 
dilution series of the san1ple of interest was incubated for 72 hours with the P388 
cells. The growth indicator was the yellow dye MTT tetrazolium which is reduced to 
purple MTT formazan by healthy cells. The result is expressed as an IC5o (ng/mL) 
which means the concentration of a sample required to reduce the P388 cell growth by 
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50% (comparative to control cells). The assay was carried out in 96-well microtitre 
plate using mitomycin C as a standard cytotoxin. Media, cell and solvent controls 
were included with each assay run. 
Antimicrobial assay 
Antimicrobial activity was detected using a zone of inhibition assay. The bacteria 
tested against were Bacillus subtilis (ATCC 19659), Escherichia coli (ATCC 25922) 
and Pseudomonas aeruginosa (ATCC 27853). The fungi tested against were Candida 
albicans (ATCC 14053), Trichophyton mentagrophytes (ATCC 28 185) and 
Cladosporium resinae (P AMS Dept., University of Canterbury). Each bacterium or 
fungus (at a known concentration) was mixed with Mueller Hinton or potato dextrose 
agar and poured into Petri dishes to produce a ' lawn' of bacterium/fungus. Samples of 
interest were then pipetted onto 6 millimetre diameter filter paper disks. The solvent 
was evaporated before the disks were placed onto the above prepared seeded agar. 
Antibiotic controls were run with each batch: Gentamycin (10 µg/disk) was used for 
E.coli and P.aeruginosa; Chloramphenicol (30 µg/disk) was used for B. subtilis; 
Nystatin ( 100 units/disk) was used for C.albicans, C. resinae and T mentagrophytes. 
Suitable solvent controls were also used in every assay run. The result was measured 
in millimetres as the radius of inhibition (mass/disk). 
Antiviral assay 
Antiviral activity was detected using two viruses: Herpes simplex virus type 1 (Strain 
F, ATCC VR 733) and Polio virus type 1 (Pfiser vaccine strain). The former is a non­
enveloped virus with a single standard RNA genome and a site of replication in the 
host cytoplasm while the latter is an enveloped virus �ith a double stranded DNA 
genome and a site of replication in the host nucleus. BSC- I cells (African Green 
Monkey kidney cell line, ATCC CCL 26) were used as the host for these viruses. 
Samples of interest are pipetted onto 6 millimetre diameter filter paper disks and their 
solvents evaporated. These are then placed directly onto infected BSC-1 cells and 
incubated for 24 hours at 37 °C in an atmosphere containing 1.5% C02 . The host cells 
were then examined with an inverted microscope for the size of antiviral (i.e. viral 
inhibition) and or cytotoxic zones, and the type of cytotoxicity. 
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Antiviral or cytotoxic (CYT) results : 
ND no discernible antiviral or cytotoxic effects 
+- minor effects located under the disc 
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+ antiviral or cytotoxic zone 1-2 mm excess radius from the disc (25% zone) 
2+ antiviral or cytotoxic zone 2-4 mm excess radius from the disc (50% zone) 
3+ antiviral or cytotoxic zone 4-6 mm excess radius from the disc (75% zone) 
4+ antiviral or cytotoxic zone over the whole well (100% zone) 
Cytotoxicity types (TYP) :  A visual interpretation of the cells change when compared 
to control cells : TYP l : defined nuclei; TYP2: stringy; TYP3: scruffy; TYP4: rounded; 
TYP5: clumped; TYP6 : blown up; TYP7: granular. 
7. 1 .4 High performance liquid chromatography (HPLC) 
Analytical high performance liquid chromatography (HPLC) was carried out on a 
Shimadzu LC-lOAD VP liquid chromatograph, equipped with a SPD-MlOA VP 
photodiode array detector. Columns were kept at a constant temperature of 40°C with 
a CTO-MlOAD VP oven. Reverse phase HPLC was performed on a Phenomenex 
Prodigy C 1 8  5-0DS column (3 µm, 250 x 4.6 mm). All samples were filtered through 
a syringe filter (0.45 µrn) prior to injection. 
Conditions for a standard reverse phase (C 1 8  column) HPLC: 
Mobile phase solvents : CH3CN (ACN, HPLC grade) 
H20 (purified with a Milli-Q deionising system) 
Flow rate: 1 mL/min 
Solvent system: started with 10% ACN/H20 and maintained isocratic for 2 
min; a linear gradient to 75 % ACN/H20 in 12 min; isocratic at 75 % ACN/H20 for 
10 min; a linear gradient to 100 % ACN in 2 min; isocratic at 100 % ACN for 4 min. 
Semi-preparative HPLC was performed on a Shimadzu LC-4A with a Shirnadzu SPD-
2A S single wavelength UV detector. Solvents used were degassed with helium. 
Reverse phase HPLC was carried out on an Alltech C 1 8  column (10 µrn, 250 x 10 
mm) with variable concentrations of CH3CN (HPLC grade) in H20 (Milli-Q). 
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7. 1 .5  Column chromatography 
Column chromatography was performed with glass columns of certain dimensions. 
Reverse phase column chromatography was performed with J.T.Baker C 1 8 (40 µm 
prep LC packing). Normal phase column chromatography was carried out with 
J.T.Baker DIOL (40 µm prep LC packing). Gel permeation column chromatography 
was performed on Sephadex LH-20 (Pharmacia Biotech AB). Samples were applied 
onto the column in two ways: Extracts were dissolved in a small amount of the initial 
mobile phase and applied to the top of the column bed (LH-20 and some Diol column 
chromatography), or, extracts were dissolved in an appropriate solvent and C 1 8  or Diol 
(for C 1 8 or Diol column chromatography, respectively) was added. The solvent was 
then removed under reduced pressure using a rotary evaporator and the dry power was 
transferred to the top of the column bed. All solvents used for chromatography were 
of commercial grade and distilled once, except for MeOH which was distilled twice. 
Reverse phase C 1 8 and normal phase DIOL columns were run under pressure (0.5 
kPa) with oxygen-free N2 gas. 
7. 1.6 Thin layer chromatography 
Thin layer chromatography (TLC) was performed on precoated Merck silica gel 60 
F254 (0.2 mm) aluminium sheets and Merck DIOL F254 (0.2 mm) glass-backed plates. 
TLC plates were initially viewed under a UV lamp and subsequently sprayed with 
10% phosphomolybdic acid in ethanol followed by heating under an IR lamp. 
7. 1. 7 Nuclear magnetic resonance (NMR) 
NMR spectra were recorded at 23°C on a Varian UNITY INOVA-500 spectrometer, 
operating at 500 MHz and 125 MHz for 1 H and 1 3C, respectively. Other experiments 
described in this thesis, including, COSY, 2D-TOCSY, 2D-NOESY, HSQC and 
CIGAR were all recorded on the INOV A 500 spectrometer at 500 MHz. 
Tetramethylsilane (TMS) was used as an internal reference. The spectrometer was 
fitted with a pulsed field gradient MLD driver with a 5 mm Indirect Detection Probe. 
Chemical shifts in this thesis are described in parts per million (ppm), on the 5 scale, 
and referenced to the appropriate solvent peaks : CDC'3 referenced to CHC'3 at bi-1 
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7.26 ppm ( 1 H) and CHC13 at � 77.0 ppm (
13C); CD30D referenced to CHD20D at bf- I  
3.30 ppm ( 1 H) and CHD20D at � 49.3 ppm ( 13C); Acetone-d6 referenced to 
CD3(CHD2)CO at bi-1 2.17 ppm ( 1H) and (CD3)2CO at � 29.2 ppm and 204.1 ppm 
(
1 3C), respectively. 
1 H and 13C NMR spectra were recorded with acquisition time (AT) of 1.892 s and 1.3 
s, respectively. 2D NOESY experiments were run using an AT of 0. 150 s and a 
mixing time of 0.40 s. COSY and 2D TOCSY experiments were all recorded with an 
AT of 0.150 s and a Dl  of 1.0 s. HSQC experiments were recorded with an AT of 
0.140 s, a D l  of 1.0 s and 1Jrn = 140 Hz. CIGAR experiments were run with an AT 
of 0.250 s, a Dl of 1.0 s and nlrn = 8.0 Hz. The spectral windows for each experiment 
varied according to the sample being exan1ined. 
7. 1. 8 Mass spectrometry 
Electron impact (EI) mass spectra were obtained on a Kratos MS80RF A mass 
spectrometer, operating with a 4 kV accelerating potential, 70 eV and a source 
temperature of 250°C. 
Electrospray Ionisation (ES) mass spectra were recorded on a Micromass LCT 
spectrometer using a probe voltage of 3200 V, an operating temperature of l 50°C and 
a source temperature of 80°C. Samples were protonated with formic acid for positive 
ion mode or deprotonated with diethylamine for negative mode. 
7. 1 .9  UV-Vis and IR spectroscopy 
Ultraviolet-visible (UV-vis) spectra were recorded on a GBC UVNIS 920 
spectrometer. 
lnfrared (IR) spectra were recorded on a Shimadzu FTIR-8201 PC spectrometer. 
Spectra were obtained in a solution of chloroform or on a KBr disc. 
7. 1. 10  Optical rotation 
Optical rotations were measured with a Perkin Elmer 341 polarimeter at 20°C with a 
wavelength of 589 nm. 
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7. 1 . 1 1  Solvents 
Commercial grade EtOAc, DCM and petroleum ether were distilled once. 
Commercial grade MeOH was distilled twice and H20 was treated by reverse osmosis 
and subsequently filtered through a 0.45 µm Millipore filter prior to use. 
7.2 Work Described i n  Chapter Two 
7.2. 1 Growth of isolates on solid media 
Six agar media were used: PDA, S-PDA, MEA, YEA, SDA and CSA. 
The study on growth rate was conducted in 85 mm Petri dishes containing 20 mL of 
test media. All the media for a single experiment of a series of replicated experiments 
were made at one time and permitted to "dry" in the plates for three days before use. 
Inoculum was prepared by cutting agar discs, 4 mm in diam., from the perimeter of a 
7-day colony grown at 25 °C on PDA. The inoculum discs were inverted on to the 
centre of Petri dishes and the dishes were sealed with parafilm to prevent drying. Then 
the dishes were placed in sealed plastic bags and incubated at 25 °C in the dark. The 
diameters of the 24 hour colonies were measured and used as a base to calculate the 
rate of growth over the following few days until the colony reached the edge of the 
plate. Two colony diameters, each at right angles to the other, were measured and the 
average of these was recorded as the colony diameter. For each medium, 5 replicated 
experiments were carried out. 
7.2.2 Growth of isolates in liquid media 
Media: Y2 PDB, Y2 MEB, Y2 YEB, Y2 S-PDB (for isolates A145 and A151), Y2 S-MEB 
(for isolates A34, A l  16, A127, A128 and A266). S- means seawater. 
The medium was dispensed at 125 mL per 250-mL Erlenmeyer flask, with 2 
replicates for each designed condition. The flasks were closed with cotton plugs and 
autoclaved, then inoculated with 4 mycelial discs (8mm in diam.) cut from the 
growing margin of a 7-day colony at 25 °C on PDA. They were incubated at 26 °C for 
28 days under shake (180 rpm) or static conditions. 
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The two replicated cultures were combined and homogenised with an Ultra-turrax® 
(Janke & Kunkle). They were then filtered through Celite 545 under suction to 
separate mycelium and filtrate. Both parts were extracted three times with 50 mL of 
EtOAc. The EtOAc solutions from the filtrate and mycelium were combined, dried 
over MgS04 and concentrated in vacuo to afford an extract. The extract was made up 
to 10 mg/mL in methanol for bioassay. 
7.2.3 Chemical screening (1) - solid phase extraction 
The extract was dissolved in methanol to make up a standard solution at 50 mg/mL. If 
the extract tested was less than 50 mg, then 800 µL MeOH was added so that 4 x 200 
µL aliquots for screening could be obtained. 3 mL C1 8 (J.T.Baker, 40 µm) and CBA 
(J.T.Baker, 40 µm) cartridges and 6 mL LH-20 cartridge (contain 1.5 g LH-20) were 
chosen for initial screening. The solvent systems were as follows: C 1 8 cartridge: 1 :  1 
methanol/H20, methanol, 1 :  1 CBA cartridge: 3:2 
methanol/aqueous 0.05 M ammonium acetate, 3:2 methanol/2% aqueous ammonia, 
4:1 methanol/aqueous 0.05% TFA. LH-20 cartridge: straight MeOH. Three fractions 
from each of C1 s  and CBA cartridges and three or four fractions from the LH-20 
cartridge were taken. All fractions were dried and the residues were dissolved in 200 
µL solvent and submitted for P388 assay. The procedure is outlined below with the 
extract from fungus N60 (Chaetomium sp.) as an example. 
Crude Extract l mL (50 mg/mL) 
200�tL 
C 1 8  (polarity) 
,, ,, 
Fraction 2 
P388 activity >625000 <4875 










• ' 2 3 I 





29557 1 <4875 
In this example, the bioactive component(s) were of medium polarity (fraction 2 off 
C 1 8), non-ionic (eluted off CBA in fraction 1 )  with molecules weight smaller than 750 
Daltons (retained on LH-20, fraction 3). 
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7.2.4 Chemical screening (2) - HPLC microtitre plate collection 
The most active fraction from the LH-20 cartridge in chemical screening ( 1) was 
subjected to analytical HPLC (C 1 8  column, standard conditions) and eluates were 
collected into a 96 well microtitre plate (Nunclon ™, made in Denmark, Nalge Nunc 
International). For each sample, a total of 89 fractions was collected at 15 sec. 
intervals (approximately 250 µL/well at a flow rate 1 mL/min) and 2 min 5 sec delay. 
This microtitre plate was a master plate and two daughter plates were generated from 
it by transferring 50 µL and 5 µL aliquots respectively from each well of the master 
plate. The daughter plates were dried in a centri fugal evaporator and then assayed for 
P388 activity. Once the wells containing the bioactivity were located from the 
daughter plates, ESMS of the corresponding active wells in the master plate were 
carried out. Finally, a search on Antibase75 with the information of UV, MS and 
fungus source was perfo1med. Dereplication and the identification of the active 
compounds was attempted. 
7.3 Work Described in  Chapter Th ree 
7.3. 1 Culturing and extraction of Chaetomium sp. (A34) 
The fungus strain CANU A34, collected from saline mud in western Australia, was 
identified as a Chaetomium species and deposited in the Department of Plant and 
Microbial Sciences, University of Canterbury, Christchurch, New Zealand (Code: 
CANU A34). The fungal isolate was grown on PDA Petri dishes for 7 days at 25 °C 
in the dark. Then mycelial disks (8 mm in diameter) were cut from the growing 
margin of the colony and inoculated into half strength malt extract seawater broth. A 
total of 1 1  L of broth was inoculated with 32 myceliaf disks per litre of broth. The 
broth was incubated at 26 °C in the dark for 30 days on a rotary shaker at 180 rpm. 
The culture was then filtered through Celite 545 under suction to separate to a broth 
supernatant and a mycelial cake. The mycelial cake was washed with distilled water 
three times and disrupted with an Ultra-turrax®. Then the mycelium and filtrate were 
extracted separately with EtOAc ( 1  L x 3 t imes for mycelium, 4 L x 3 times for 
filtrate). The EtOAc fractions were kept overnight at 4 °C to allow the water to 
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separate. Then the water phase was discarded and the EtOAc phase dried with 
MgS04. The EtOAc extracts were evaporated under reduced pressure to yield 284.2 
mg of pale yellow extract from the filtrate and 2242.9 mg of yellowish brown extract 
from the mycelium. The two extracts were assayed against the P388 murine 
leukaemia cell line and both showed significant activity (IC50 234 ng/mL for filtrate 
extract and 25 ng/mL for mycelial extract). Since the HPLC profiles of the two 
extracts were similar and mycelial extract showed stronger activity, the latter was 
selected for chromatography. 
7.3.2 Chromatography of Chaetomium sp. (A34) extracts 
The mycelial extract (2000.0 mg) of Chaetomium sp. (A34) was separated on a 
reverse phase (C 1 8 , 50 g) column. The column was eluted using a stepped gradient 
from 10% MeOH/H20 to MeOH, increasing the concentration of MeOH in 20% steps 
from 10% MeOH/H20 to 50% MeOH/H20 and in 10% steps from 50% MeOH/H20 
to 100% MeOH every 100 mL of solvent (200 mL for 100% MeOH). Then the 
column was eluted with 20% CH2Ch/MeOH (200 mL), 50% CH2Cli/MeOH (100 
mL), 100% CH2Ch (200 mL) and finally washed out with 100% MeOH (200 mL). 
Fifteen fractions were collected and assayed for activity against the P388 murine 
leukaemia cell line. Fractions A34- 1-5 to A34-1-1 l were active (IC50 <97.5 - 5199 
ng/mL). The activity concentrated in the fractions A34-1-6 to 9 and decreased 
gradually in adjacent fractions. Checking with HPLC (C 1 8  column, standard 
condition), fractions A34- l-6, 7, 8, 9 and 10 showed nearly the same HPLC profile: 
all having a major peak at RT 15.00 minutes with several minor peaks differing only 
in ratios. Fractions A34-1-5 and A34-1-11 showed different HPLC profiles with a 
very small peak at RT 15.00 minutes. Therefore the peak at RT 15.00 minutes 
represented the major activity observed. The 1H NMR spectra also revealed that 
fractions A34-1-6, 7, 8, 9 and 10 contained the same major compound. This 
compound was in higher concentrations in the fractions A34-1-6 and 7 while in 
relatively lower concentrations in fractions A34-l -8, 9 and 10. A34- l -11 was 
predominantly fatty acids and A34- l -5 was a complex mixture. 
Fractions A34- 1-6 (166 mg) and A34- l-7 (200 mg) were combined and 
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chromatographed using a normal phase (Diol, 15 g) column. The column was eluted 
accordingly with 5%, 10%, 20%, 40%, 60% and 80% Et0Ac/CH2C]z (20 mL for each 
concentration), 100% EtOAc (20 mL), 5% MeOH/EtOAc (15 mL), 10% 
MeOH/EtOAc (15 mL) and finally washed out with 100% MeOH (35 mL). Thirteen 
fractions were collected and combination of the fractions was based on the analysis of 
TLC. Although all the fractions showed activity against the P388 cell line, fractions 
A34-Dl  and D2 were the most active and the activity decreased gradually in the 
following fractions. The HPLC profiles of fractions A34-D2 to D6 were very close, 
all showing a major peak at RT 15.00 minutes and several minor peaks varying in 
different fractions. Fractions A34-D7 to Dl 3 only had a minor peak at 15.00 minutes. 
It was then confirmed that the peak of RT 15.00 minutes in the HPLC (C 1 8 column, 
standard conditions) profiles was responsible for the P388 activity and that the 
compound represented by this peak had poor solubility in the solvent used. Because 
the active compound had the highest concentration and the largest mass in A34-D2, 
this fraction was used for further purification. 
A34-D2 (65.0 mg) was further purified using a semi-preparative HPLC (C 1 8 column, 
reverse phase), eluted with 40% ACN/H20 isocratically. Although six peaks were 
collected, only fraction A34-D2-2, collected from a major peak of the HPLC profile 
was a pure compound (47.9 mg). A34-D2-2 showed very significant activity against 
the P388 cell line with IC50 11.2 ng/mL. Fractions A34-D2-1 and A34-D2-6 were 
complex mixtures with a small amount of A34-D2-2. Fractions A34-D2-3, 4 and 5 
were mixtures in which A34-D2-2 was still a major compound together with two or 
three related compounds. To obtain these minor compounds, A34-D2-3 (1.7 mg) was 
further chrornatographed with a long, thin LH-20 column (2.5 g), washed with straight 
MeOH. No pure compounds were obtained. A34-D2-4 (3.0 mg) was further purified 
with another semi-preparative HPLC (C 1 8 column, reverse phase), eluted with 48% 
ACN/H20 isocratically. Again, no pure related compounds were achieved. 
To obtain compounds related to A34-D2-2, fraction A34- l-9 was selected for further 
chromatography because this fraction showed a relatively higher content of related 
compounds in the HPLC profile. A34- l-9 (306 mg) was applied onto nonnal phase 
(Diol, 15 g) column, eluted by a gradient solvent system from 100% CH2Cli to EtOAc 
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and then to MeOH. Sixteen fractions were collected and the related compounds were 
found in the fractions A34-9-2 and A34-9-3 by HPLC and 1H NMR spectra. Fraction 
A34-9-3 (31.3 mg) was further chromatographed with another Diol column (15 g, 
normal phase), using a gradient solvent system from 50% hexane/CH2Cli to CH2Cli 
and then to EtOAc. Fifteen fractions were collected and related compounds were 
located in the fractions A34-9-3-6 and A34-9-3-7. These two fractions were purified 
separately by semi-preparative HPLC (C 1 8  column, reverse phase), eluted with 45% 
ACN/H20 isocratically. Possibly due to the same reason mentioned above, no pure 
related compounds were obtained. 
Fraction A34-9-2 (11 1.1 mg) was further purified on a second Diol column ( 16 g, 
normal phase), eluted with a solvent system from 100% hexane to CH2Cl2 and then to 
EtOAc. Fourteen fractions were collected and the related compounds were located in 
fractions A34-9-2-7 and A34-9-2-8. Since these two fractions showed nearly the same 
HPLC profiles as that of A34-9-3-6 and A34-9-3-7, no further work was carried out. 
7.3.3 Taxonomy of Chaetomium sp. (N60) 
Media used in taxonomy: Malt extract agar (MEA) and· 25 % glycerol nitrate agar 
(G25N) (see section 7.1.2 ). 
Ten replicated experiments were carried out for each condition. 
7.3.4 Culturing and extraction of Chaetomium globosum (N60) 
A strain of Chaetomium globosum (CANU N60) was collected from saline sand in 
New Zealand and deposited in the culture collection of the Department of Plant and 
Microbial Sciences, University of Canterbury, Christchurch, New Zealand. The 
isolate was grown on PDA solid medium for 5 days at 25 °C in the dark. Mycelial 
disks (8 mm in diameter) were cut from the outer regions of the colony and used for 
incubating Yi MEB (see section 7.1.2 ) cultures. Two litres of such broth were 
inoculated (32 mycelial disks per litre of broth) and incubated at 26 °C in the dark for 
four weeks on a rotary shaker at 180 rpm. The culture was then filtered through Celite 
545 under suction to separate mycelium and filtrate. The mycelium was washed with 
distilled water three times and disrupted with an Ultra-turrax®. Then the rnycelium 
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and filtrate were extracted separately with EtOAc (200 mL x 4 times for mycelium, 2 
L x 4 times for filtrate). The extracts were dried with MgS04 and evaporated under 
reduced pressure to yield 234 mg of yellowish brown extract from the filtrate and 294 
mg of brownish red extract from the mycelium. The two extracts were assayed against 
the P388 murine leukaemia cell line and both showed significant activity (IC50 1942 
ng/mL for filtrate extract and 2325 ng/mL for mycelial extract). Because the HPLC 
profiles of the two extracts were identical, they were combined before further 
purification. 
7.3.5 Chromatography of Chaetomium globosum (N60) extract 
The crude extract (480 mg) was chromatographed on a reverse phase (C 1 8 , 50 g) 
column. The column was eluted using a stepped gradient from 10% MeOH/H20 to 
MeOH, increasing the concentration of MeOH in 20% steps from 10% MeOH/H20 to 
50% MeOH/H20 and in l 0% steps from 50% Me0H/H20 to 90% MeOH/ H20 every 
100 mL of solvent. Then the column was eluted with 100% MeOH (200 mL), 20% 
CH2Cb/MeOH (100 mL), 50% CH2Ch/MeOH (100 mL), 100% CH2Ch (200 mL) 
and finally washed out with 100% MeOH with 0.05� TFA (200 mL). Fourteen 
fractions were collected and combination of the fractions was based on HPLC 
analysis. On the assay against the P388 murine leukaemia cell line, fractions N60 1.5, 
1.6, 1.7 and 1.8 (eluted with 70% MeOH/H20, 70% MeOH/H20, 80% Me0H/H20 
and 90% MeOH/H20 respectively) showed significant activities (IC50 8469, 3660, 
3660 and 3886 ng/mL, respectively). Fraction N60 1.9 (eluted with 100% MeOH) 
exhibited weak P388 activity (IC5o 12134 ng/mL). 
7 .3 .5 . 1 Separation of fraction N60 1 .6 
Fraction N60 1.6 (116.5 mg) was applied on a normal phase (Diol, 16 g) column, 
eluted with a stepped gradient from CH2Ch to EtOAc then to MeOH: 100% CH2Cb 
(30mL), 5% EtOAc/CH2Cb (20 rnL), 30% EtOAc/CH2Ch (20 rnL), 50% 
Et0Ac/CH2Cb (10 mL), 80% EtOAc/CH2Ch (10 mL), 100% EtOAc (10 mL), 5% 
MeOH/EtOAc (20 rnL), 50% MeOH/EtOAc (20 mL) and 100% MeOH (20 mL). 
Fifteen subfractions were collected and combination of the sub fractions was based on 
HPLC. The UV profiles revealed that compounds of interest were collected in 
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subfractions N60 1.6.3 to 9. Subfractions N60 1.6.7 and 1.6. 8, eluted with 50% and 
80% Et0Ac/CH2Ch respectively, gave a pure compound [N60 1.6. 7+8, 4.9 mg]. 
Subfractions N60 1.6.3 and N60 1.6.4, eluted with 5% Et0Ac/CH2Cl2 , contained a 
major compound of crude N60 1.6. Because subfraction N60 1.6.3 contained less 
impurity than N60 1.6.4, the former was selected for further purification. Subfraction 
N60 1.6.3 was applied on another Diol column ( 12 g) and eluted with 70% 
CH2Ch/hexanes isocratically. Thirty-four fractions were collected. The expected pure 
compound (N60 1.6.3. 10- 19, 4.9 mg, a major compound of N60 1.6) was obtained in 
the fractions N60 1.6.3. 10 to N60 l .6.3. 19. 
7.3.5.2 Separation of fraction N60 1 .7 
Fraction N60 1.7 (78.5 mg) was further chromatographed by a Diol ( 16 g) column, 
eluted with gradient solvent system of CH2Ch/EtOAc/MeOH: 100% CH2Ch (30 mL), 
5%, 10%, 20%, 50%, 80% Et0Ac/CH2Ch (20 mL each), 100% EtOAc ( 10 mL), 50% 
MeOH/EtOAc (20 mL), 80% MeOH/EtOAc (20 mL) and 100% MeOH (30 mL). A 
total of seventeen subfractions was collected and combination of the sub fractions was 
based on HPLC analysis. Subfractions N60 1.7.4 to N60 1.7. 10 contained compounds 
of interest. N60 1.7.4 and N60 1.7.5 was a pure compound ( 14.4 mg) which 
represented a major peak on the HPLC profile of the crude extract. Subfractions N60 
1.7.6 to 10 were mixtures containing the same compound of interest. Among these 
fractions, N60 1.7.8 was the most promising one for obtaining the expected 
compound. Subfraction N60 1.7.8 (2.6 mg) was further purified with a LH-20 (2 g) 
column, eluted with straight MeOH. The expected pure compound was obtained in 
fraction N60 178.8 ( 1.5 mg). 
The UV profiles and 1H NMR spectra revealed that fractions N60 1.7.2 and N60 1.7.3 
contained compounds totally different from the major compounds in the crude extract. 
Subfractions N60 1.7.3 was a pure compound while N60 1.7.2 consisted of equal 
amounts of compound N60 1.7.3 and a compound related to it, nan1ely N60 1.7.2A. 
Because no P388 activity was detected in these two fractions and the 1H NMR signals 
of compound N60 1.7.2A could be distinguished from that of N60 1.7.3, no further 
purification was attempted for fraction N60 1.7.2. 
Chapter 7 Experimental 1 50 
7 .3 .5 .3  Separation of fraction N60 1 .8 
Fraction N60 1.8 (15.2 mg) was further chromatographed on a Dial (normal phase, 12 
g) column. The column was eluted with a gradient solvent system consisting of 
hexanes-EtOAc-MeOH: 100% hexanes (30 mL), 10% EtOAc/hexanes (30 mL), 20% 
EtOAc/hexanes (60 mL), 30% EtOAc/hexanes (30 mL), 40% EtOAc/hexanes (30 
mL), 60% EtOAc/hexanes (30 mL), 80% EtOAc/hexanes (30 mL), 100% EtOAc (50 
mL), 20% MeOH/EtOAc (30 mL), 50% MeOH/EtOAc (30 rnL), 100% MeOH (50 
mL). A total of 29 subfractions was collected and combination of the subfractions was 
based on the analysis of 1 H NMR spectra. Subfractions N60 1.8.14 and 15, eluted 
with 100% EtOAc, yielded a pure compound (N60 1.8.14+ 15, 7.9 mg) structurally 
related to compound N60 1.7.4+5. Subfractions N60 1.8.12 and 13, eluted with 80% 
EtOAc/hexanes were combined. The combined subfraction (N60 1.8.12+ 13) was 
relatively pure and contained only two compounds which were structurally similar to 
compound N60 1.8.14+ 15. The ratio of the two compounds was nearly 1 :1. Due to the 
small amount of mass (6.1 mg) and due to the fact that the 1 H NMR signals of the two 
compounds could be distinguished from each other 111 the spectrum, no further 
purification was carried out for this subfraction. 
7 .3 .5 .4 Separation of fraction N60 1 .5 
Fraction N60 1.5 (52.3 mg) was further purified using a normal phase (Dial, 12 g) 
column. The column was eluted with a gradient solvent system as the following: 10% 
to 100% EtOAc/hexanes (increasing EtOAc concentration in 10% steps every 30 mL 
of solvent from 10% to 60% EtOAc/hexanes and every 50 mL of solvent from 70% 
EtOAc/hexanes to 100% EtOAc), 20% MeOH/EtOAc (30 rnL), 50% MeOH/EtOAc 
(30 mL) and 100% MeOH (100 mL). A total of 30 subfractions was collected and 
combination of the subfractions was based on the analysis of 1 H NMR spectra. 
Subfraction N60 1.5.10, eluted with 80% EtOAc/hexanes, gave a pure compound 
(N60 1.5.10, 5.0 mg) which was structurally related to the major compound N60 
1.7.4+5. Subfractions N60 1.5.11, 12 and 13, eluted with 90% EtOAc/hexanes, 
contained a compound of interest. The three subfractions were combined (13.5 mg) 
and applied onto another Dial column (16 g) for further purification. The column was 
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eluted with a solvent system consisting of EtOAc and hexanes, increasing EtOAc 
concentration in 10% steps from 30% to 60% EtOAc/hexanes every 30 mL of solvent, 
then to 70% EtOAc/hexanes (150 mL), 80% EtOAc/hexanes (30 mL), 90% 
EtOAc/hexanes (30 mL) and finally to 100% EtOAc (50 mL). Nine fractions were 
collected. Fractions N60 1511.4 and N60 1511.5, eluted with 70% EtOAc/hexanes, 
yielded a pure compound (N60 15 1 1. 4+5, 5.1 mg). 
7 .3 .5 .5  Separation of fract ions N60 1 .9 and N60 1 . 1 0  
The 1 H NMR spectra of fractions N60 1.9 and N60 1. 10 were identical but different 
from that of the major compound N60 1.7.4+5. Although fraction N60 1.9 showed 
mild activity while fraction N60 1. 10 was inactive in the assay against the P388 cell 
line (IC50 12134 and > 12500 ng/mL, respectively), they were combined for further 
purification. 
The combined fraction (total 22.1 mg) was chromatographed with a Diol (normal 
phase, 12 g) column. The column was eluted with a gradient solvent system from 
hexanes to EtOAc then to MeOH: 100% hexanes (50 mL), 5% EtOAc/hexanes (50 
mL), 20% EtOAc/hexanes (100 mL), 30% to 70% EtOAc/hexanes (increasing EtOAc 
concentration in 10% steps every 50 mL of solvent), 90% EtOAc/hexanes (40 rnL), 
100% EtOAc (50 mL), 50% MeOH/EtOAc (50 mL), 100% MeOH (50 rnL). A total of 
twenty-eight subfractions was collected and combination of the subfractions was 
based on analysis of 1 H NMR spectra. Subfraction N60 1910. la, eluted with 100% 
hexanes to 30% EtOAc/hexanes, contained a target compound. This subfraction (6.6 
mg) was further purified by another normal phase (Diol, 10 g) column, eluted with a 
solvent system of EtOAc/hexanes. The EtOAc concentration was increased in 5% 
steps from 100% hexanes to 30% EtOAc/hexanes every 40 mL of solvent, then the 
column was washed out with 50% EtOAc/hexanes (50 mL). Twenty-six fractions 
were collected. The expected pure compound (N60 19 10.la.22-25, 3.2 mg) was 
obtained in fractions N60 19 10. la.22, 23, 24 and 25, eluted with 30% 
EtOAc/hexanes. 
20 ° Chaetoglobosin Q (N60 1.6.7+8) [a]o  -100 (c 0.10, MeOH); UV (MeOH) Amax 
(log c) 220 (4.46), 282 (3.73), 291 (3.67) nm; IR (CHCh) Ymax 3689, 3544, 3060-3240 
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(br), 2360, 1695, 1685, 1602, 1188 cm· ' .  
Chaetoglobosin R (N60 1 511.4+5) [a]020 -100
° 
(c 0.10, MeOH); UV (MeOH) 
Amax (log E) 217 (4.81), 289 (4.05) nm; IR (CHCb) Vmax 3689, 3535, 3080-3240 (br), 
2360, 1691, 1683, 1602, 1193 cm· ' .  
Chaetoglobosin S (N60 178.8) Obtained as colourless powder; [a] 020 -80
° 
(c  0. 10, 
MeOH); UV (MeOH) Amax (log E) 220 (4.39) ,  283 (3.58), 290 (3.54) nm; IR (CHCh) 
Vmax 3691, 3481, 2360, 2341, 1697, 1685, 1604, 1463 cm· ' .  
7.4 Work Described in  Chapter Four 
7.4. 1 Culturing and extraction of Phoma sp. (K31) 
A Phoma sp. (K3 l) was isolated from a driftwood sample in Canada and deposited in 
the culture collection of the Department of Plant and Microbial Sciences, University 
of Canterbury, Christchurch, New Zealand (CANU K31). It was grown on PDA Petri 
dishes for 8 days at 25 °C in the dark. Mycelial disks (8 mm in diameter) were cut 
from the growing edge of the colony and transferred into Y2 PDB (32 mycelial disks 
per litre of broth). The broth was incubated at 26 °C in the dark under static 
conditions. Two batches were cultured. The first batch (6 L), big broth I ,  was cultured 
for four weeks and the second batch (2 L), big broth II ,  was cultured for eleven weeks. 
Each culture was filtered through Celite 545 under suction to separate to a broth 
supernatant and a mycelial cake. The mycelial cake was washed with distilled water 
three times and disrupted with an Ultra-turrax®. The filtrate and mycelium were 
extracted separately with EtOAc (200 mL x 3 times per litre of filtrate and 200 mL x 3 
times for each mycelial cake). The EtOAc extracts were dried with MgS04 and then 
evaporated under reduced pressure. They were then assayed for activity against the 
P388 murine leukaemia cell line. The filtrate extract (867.8 mg) from big broth I 
showed moderate activity (IC50 6248 ng/mL) while filtrate extract from big broth II 
and mycelial extracts from both big broth I and II  showed no activity (IC50 > 12500 
ng/mL). The active extract was therefore selected for further purification. 
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7.4. 2 Chromatography of Phoma sp. (K31) extract 
The filtrate extract (867.8 mg) from big broth I (6 L) of Phoma sp. (K31) was 
chromatographed on a reverse phase (C 1 8 , 50 g) column. The column was eluted using 
a stepped gradient from 10% MeOH/H20 to MeOH, increasing the concentration of 
MeOH in 20% steps from 10% MeOH/H20 to 50% MeOH/H20 and in 10% steps 
from 50% MeOH/H20 to 100% MeOH every 100 mL of solvent, then the column was 
eluted with 20% CH2Ch/MeOH (100 mL), 50% CH2C)i/MeOH (100 mL) and 100% 
CH2Ch (100 mL). Fourteen fractions were collected and combination was based on 
TLC (silica gel 60 F254) . The first three fractions (K31-1 to 3), eluted by 10-50% 
MeOH/H20, showed activity against the P388 murine leukaemia cell line. Since the 
P388 activities of fractions K31-1 and K31-3 were very weak (IC50 >10, OOO ng/mL), 
only fraction K3 l-2 (IC50 8688 ng/mL) was selected for further chromatography. 
Fraction K31-2 (256.3 mg) was purified using a LH-20 column (12 g), eluted with 
MeOH isocratically. Fourteen fractions were collected and combination was based on 
TLC (silica gel 60 F254) . Though all the fractions (2 mg/mL) were submitted for P388 
assay, only very weak activities were recovered from fractions K3 l -2-3 and K31-2-4 
(IC50 18531 and 17984 ng/mL, respectively). 
Fractions K31-2-3 (109.0 mg) and K31-2-4 (29.9 mg) showed the same HPLC 
profiles. They were combined and applied onto another LH-20 (12 g) column. The 
column was washed with straight MeOH and seven fractions were collected. The 
P388 activity was found in the fraction K3 l -2-(3+4)-4, though still very weak (IC50 
18224 ng/mL). Fraction K31-2-(3+4)-4 was renamed as K3 l -a due to the long code. 
The fraction K3 l -a (97 .9 mg) was further chromatographed on a normal phase (Diol, 
15 g) column, eluted with a gradient solvent system composed of hexane/EtOAc (1 :2, 
80 mL), 100% EtOAc (80 mL) and EtOAc/MeOH ( I :  1, 80 mL). Sixteen fractions 
were collected and combination was based on TLC (Diol). The HPLC profiles and 1H 
NMR spectra of these fractions indicated that K31-a-6 to a-11 was a pure compound 
(5.2 mg, 2,5-dihydroxybenzoic acid, see Chapter 4, 4.3 ), K31-a-4 was a mixture of 
which the major compound structurally related to K31-a-6 to a-11, K3 l -a-5 was a 
mixture of K31-a-4 and K31-a-6 to a-11, K31-a-2 and K31-a-3 were complex 
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mixtures where the major compound was the same as that of K31-a-4, K31-a-1 and 
K31-a-12 to a-16 showed no signals in the 1H NMR experiment. K31-a-4 was 
selected for further puri fication. 
Fraction K31-a-4 (9.2 mg) was further purified using a semi-preparative HPLC (C 1 8  
column, reverse phase), eluted with 5% ACN/H20 isocratically. Three peaks were 
collected. The expected pure compound was obtained in the fraction K31-a-4-2 ( 1 .3 
mg, 2,5-dihydroxybenzyl alcohol, see Chapter 4, 4.4 ). Fractions K31-a-4-1 (1.1 mg) 
and K3 l-a-4-mixture (3.5 mg) were impure mixtures. 
7.5 Work Described in  Chapter Five 
7. 5. 1 Culturing and extraction of Fusarium sp. (A 145) 
A Fusarium sp. (A l45) was isolated from saline lake sand in western Australia and 
deposited in the culture collection of the Department of Plant and Microbial Sciences, 
University of Canterbury, Christchurch, New Zealand (Code: CANU A l45). The 
isolate was grown on PDA Petri dishes for 7 days at 25 °C in the dark. Mycelial disks 
(8 mm in diameter) were cut off from the growing margin of the colony and 
transferred into half strength potato dextrose broth. Four litres of broth were 
inoculated with 32 mycelial disks per litre of broth. The broth was cultured for 5 
weeks at 26 °C on a rotary shaker at 180 rpm. The culture was then filtered through 
Celite 545 under suction to separate to a broth supernatant and a mycelial cake. The 
filtrate and mycelium were extracted separately with EtOAc ( 1  L x 3 times for filtrate 
and 300 mL x 3 times for mycelium). The EtOAc fractions were kept overnight in  the 
refrigerator to allow water to separate. The water phase was discarded and the EtOAc 
phase dried with MgS04 . The EtOAc extracts were then evaporated under reduced 
pressure and yielded 243.6 mg of dark red extract from the filtrate and 674.8 mg of 
orange extract from the mycelium. The two extracts were assayed against the P388 
cell line. The filtrate extract showed strong activity while the mycelium extract 
exhibited very weak activity (IC5o < 975 and 23167 ng/mL, respectively). Thus, the 
filtrate extract was selected for chromatography. 
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7.5.2 Isolation o f  compound 5.2 (beauvericin) 
The filtrate extract (243.6 mg) of Fusarium sp. (A145) was chromatographed on a 
reverse phase (C 1 8 , 50 g) column. The colw1m was eluted using a stepped gradient 
from 10% MeOH/H20 to MeOH, increasing the concentration of MeOH in 20% steps 
from 10% MeOH/H20 to 50% MeOH/H20 and in 10% steps from 50% MeOH/H20 
to 100% MeOH every 100 mL of solvent. The column was then eluted with 20% 
CH2Ch/MeOH, 50% CH2Cl2/Me0H and 100% CH2Ch in 100 mL for each kind of 
solvent system and finally washed with 200 mL of 100% MeOH. Fourteen fractions 
were collected. Fractions WB.25.7, 8, 9, 10, 1 1  and 12, eluted by 90% MeOH/H20 to 
100% CH2Ch, showed significant activity against the P388 Murine leukaemia cell 
line (IC50 = 183 - 465 1 ng/mL). 
The 1 H NMR spectra showed that fractions WB.25.7 and 8 contained the same major 
compound. The HPLC profiles revealed that WB.25.8 was a pure compound (87.2 
mg, compound 5.2, beauvericin, see section 5.5 , Chapter 5) while WB.25.7 was a 
mixture with compound 5.2 being the major one (> 90%). Therefore, no further work 
was carried out for WB.25.7. 
EI-MS for WB.25.8: m/z 783 [M+], 692, 592, 505, 43 1, 392, 33 1, 262, 244, 170, 134, 
9 1  
7.5.3 Isolation of compound 5. 1 (bikaverin) 
The active fractions WB.25. 1 1  and 12 were combined (60.8 mg, WB.25. 1 1+ 12) and 
further chromatographed on a normal phase (Diol, 16 g) column, eluted with 100% 
hexanes (30 mL), 10 % CH2Cl2/hexanes (30 mL), 20 - 90 % CH2Ch/hexanes 
(increasing CH2Cl2 concentration in 10% steps every 50 mL of solvent), 100 % 
CH2Ch (70 mL) and then 50% MeOH/CH2Cl2 (50 mL) and 100% MeOH ( 100 mL). 
A total of 37 subfractions was collected and combination was based mainly on 1H 
NMR spectra. The active fractions - subfractions WB.28.13 to 32, actually contained 
only one compound and this compound always mixed with fatty acid. The poor 
solubility of this compound (compound 5. 1) was suggested by its broad distribution in 
10 consecutive subfractions. Subfractions WB.28. 13 to 32 were combined and dried 
(20.4 mg), and then washed with hexanes ( 10 mL x 3) to remove fatty acid. The 
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residue was dried and then crystallised with chloroform to achieve red needles (7.5 
mg). The red needles were compound 5. 1 (bikaverin, see section 5.3 , Chapter 5). 
7.5.4 Isolation of compound 5.3 (bassiatin) 
The 1H N MR spectra of WJ3.25.9 and 10 indicated that they were mixtures of WJ3. 
25.8 (beauvericin) and WB.25. 1 1- 12 (bikaverin) and therefore, no further work was 
conducted with these two fractions. Fraction WJ3.25.5, though inactive in the assay 
against the P388 cell line (IC50 > 12500 ng/mL), had a 1H NMR spectrum that showed 
the major compound in this fraction might be structurally similar to compound 5.2. 
Therefore, further purification was carried out for this fraction. Fraction WJ3.25.5 
( 12.8 mg) was applied on a normal phase (Dial, 20 g) column, eluted with a gradient 
solvent system from hexanes to CH2C'2 then to MeOH: 0% to 60% CH2C)z/hexanes 
(increasing CH2Ch concentration in 20% steps every 20 mL of solvent), 80% 
CH2Ch/hexanes ( 100 mL), 100% CH2C)z (50 mL), 10% MeOH/CH2Ch (50 mL), 
50% MeOH/CH2C)z (50 mL) and 100% MeOH ( 100 mL). Twenty one subfractions 
were collected and combination was based mainly on 1H N MR spectra. The 
metabolite closely related to compound 5.2 was collected in subfraction WJ3.3 1. 1, 
eluted with 100% hexanes to 60% CH2C12/hexanes and was shown to be pure by 
HPLC (0.9 mg, compound 5.3, bassiatin, see section 5.4 Chapter 5). 
7 .6 Work Described i n  Chapter Six 
7.6. 1 Taxonomy of Aspergillus fumigatus (A151) 
Media used in taxonomy: Czapek yeast extract agar (CY A), 25 % glycerol nitrate agar 
(G25N) and malt extract agar (MEA) (see section 7.1.2 ). 
Ten replicated experiments were carried out for each condition. 
7. 6.2 Culturing and extraction of Aspergillus fumigatus (A151 ) 
An Aspergillus fumigatus (CANU A l5 1) was isolated from saline lake sand in 
western Australia and deposited in the culture collection of the Department of Plant 
and Microbial Sciences, University of Canterbury, Christchurch, New Zealand (Code: 
CANU Al5 1). The isolate was grown on PDA plates for 7 days at 25 °C, then 
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mycelial disks (8 mm in diameter) were transferred into liquid medium (32 disks per 
litre of liquid medium) consisting of half strength potato dextrose broth (1/2 PDB) 
and then incubated at 26 °C on a rotary shaker at 180 rpm. Two batches were 
cultured. The first batch (5 L), big broth I, was cultured for four weeks and the second 
batch (2 L), big broth II, was cultured for eleven weeks. Each culture was filtered 
through Celite 545 under suction to separate to a broth supernatant and a rnycelial 
cake. The mycelial cake was washed with distilled water three times and disrupted 
with an Ultra-turrax®. The mycelium and filtrate were extracted three times separately 
with EtOAc. The EtOAc extracts were then evaporated under reduced pressure and 
assayed against the P388 murine leukaemia cell line. Filtrate extract from big broth I 
and the mycelium extract from big broth II showed significant activity against the 
P388 murine leukaemia cell line (IC50 2189 and 1207 ng/mL, respectively). The two 
active extracts were used for further purification. 
7.6.3 Chromatography of mycelial extract from big broth II 
The mycelial extract (227.7 mg) from big broth II was washed with hexanes three 
times. The residue and hexanes extract were then analysed by 1 H NMR. The 1H NMR 
spectrum of the hexanes extract showed characteristic fatty acid peaks as identified 
previously while the spectrum of the residue showed totally different signals. The 
residue (118.3 mg) was applied to a Diol (normal-phase, 20 g) column. The column 
was eluted using a stepped solvent gradient from 100% hexanes to 80% EtOAc/ 
hexanes, increasing the EtOAc concentration in 20% steps every 50 mL of solvent, 
then 100% EtOAc (200 mL), 20% MeOH/ EtOAc (50 mL), 50% MeOH/ EtOAc (50 
mL) and finally eluted with 100% MeOH (50 mL). A total of seventeen fractions was 
collected. Biological assessment of the fractions located P388 activity in fractions 
WJ3.42.1, 2, 3, 4 and 10 to 13 (IC50 606 - 2795 ng/mL). By 1 H NMR and HPLC 
profile, Fraction WJ3.42.2, eluted with 40-60% EtOAc/hexanes was shown to be a 
pure compound which was identified as xanthocillin - X dimethyl ether (see Chapter 
6, 6.4 ). Fractions WJ3.42.1, 3 and 4 were predominatly compound WJ3.42.2 with 
very few impurities. Fractions WB.42.10 to 13 gave the same 1H NMR and HPLC 
profile to that of WJ 3.40.11 to 14. For further purification see section 7.6.4 (Fraction 
3.37.6, then subfraction WJ 3.40.11 to 14). 
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7. 6.4 Chromatography of filtrate extract from big broth I 
The filtrate extract (590.9 mg) of big broth I was separated on a reverse phase (C 1 8, 50 
g) column. The column was eluted using a stepped gradient from 10% MeOH/H20 to 
90% MeOH, increasing the concentration of MeOH in 20% steps from 10% 
MeOH/H20 to 50% MeOH/H20 and in 10% steps from 50% MeOH/H20 to 90% 
MeOH/H20 every 100 mL of solvent. Then the column was eluted with 100% MeOH 
(200 mL), 20% CH2Cb/MeOH (100 mL), 50% CH2Ch/MeOH (100 mL), 100% 
CH2Cl2 (200 mL) and finally washed with 100% MeOH (80 mL). Fifteen fractions 
were collected. The activity against the P388 cel l line was located in fractions 
WJ3.37.2 (IC50 = 2880 ng/mL, 17.2 mg), WJ3.37.6 (IC50 = 7976 ng/mL, 107.0 mg) 
and WJ3.37.7 (IC50 = 774 1 ng/mL, 62.9 mg), eluted with 30% Me0H/H20, 70% 
MeOH/H20 and 80% MeOH/H20, respectively. 
Fraction WJ3.37.7 (62.9 mg) was further chromatographed on a nom1al phase (Diol, 
20 g) column, eluted with a gradient solvent system from 50% CH2Ch/hexanes to 
100% CH2Ch then to 100% MeOH: 50% CH2Cl2/hexanes (50 mL), 80% 
CH2Ch/hexanes (50 mL), 100% CH2Cb (50 mL), 20% Et0Ac/CH2Ch (50 mL), 40% 
Et0Ac/CH2Ch (50 mL), 60% Et0Ac/CH2Ch (100 mL), 80% Et0Ac/CH2Ch (50 
mL), 100% EtOAc (50 mL), 50% MeOH/EtOAc (50 mL) and 100% MeOH ( 100 
mL). A total of 28 subfractions was col lected and combination was based mainly on 
1 H NMR spectra. By checking with HPLC, subfractions WJ3.47.2+3, WJ3.47.5 and 
WJ3.47.8+9, eluted with 20%, 20% and 40% Et0Ac/CH2Ch respectively, afforded 
three pure compounds. WJ3.47.8+9 proved to be a new compound which was named 
fumagiringillin (see section 6.7 Chapter 6). WJ3.47.2+3 (see section 6.5 Chapter 6) 
and WJ3.47.5 (see section 6.6 Chapter 6) were detem1ined to be the known 
compounds - 12-a fumitremorgin C and fumagillin respectively. 
Although fraction WJ3.37.7 showed activity in the P388 assay ((IC50 7741 ng/mL), no 
such activity was detected in the subfractions (WJ3.47.x) including the three pure 
compounds after Diol column chromatography. The loss of activity might be due to 
decomposition of active component (s) or that the activity of fraction WJ3.37.7 was a 
synergistic effect of inactive components in subfractions WJ3.47.x. 
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Fraction WJ3.37.6 (107.0 mg) was further purified using a Diol (normal phase, 20 g) 
column, eluted with a gradient solvent system of hexanes - CH2Ch - EtOAc - MeOH. 
Forty subfractions were collected. Subfraction WB.40.11 to 14, eluted with 40-60% 
EtOAc/ CH2Ch, showed activity against the P388 murine leukaemia cell line (IC5o = 
2795 ng/mL). The solubility of WB.40.11 to 14 was very poor in all solvents 
available. Therefore, crystallisation was used for purification and white crystals 
obtained in acetone. The poor solubility meant the 13C NMR and CIGAR data were 
very limited and no structural identification was achieved. 
Fraction WJ3.37.2 (17.2 mg) was applied onto a normal phase (Diol, 20 g) column 
and eluted using a gradient solvent system consisting of hexanes, CH2Ch, EtOAc and 
MeOH. Thirty three subfractions were collected and combination was made by 
analysis of 1 H NMR spectra. Subfractions WJ3.54.1 l and WB.54.12 to 16, eluted 
with 60% and 80% EtOAc/DCM respectively, showed activity against the P388 cell 
line (IC50 = 3552 and 3552 ng/mL, respectively). The 1H NMR spectra of the active 
fractions revealed that the major components in these fractions were simple benzenoid 
compounds structurally related to those isolated previously from the extract of Phoma 
sp (K31) (see Chapter 4). Due to the relatively simple chemical structure and the low 
yield at this stage of purification, the compounds responsible for the activity in these 
fractions were not pursued further. 
20 
° 
WJ3.47.8+9 Obtained as pale yellow powder; [a] 0 -12.5 (c 1.0, MeOH); UV 
(MeOH) Amax (log E) 317 (sh, 2.18), 332 (2.29), 348 (2.23) nm; IR (CHCl3) V111ax 3687, 
3398 (br), 2972, 1706, 1627, 1236, 1051, 1041 cm- 1 • 
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